"yearstart","yearend","locationabbr","locationdesc","datasource","topic","category","question","response","age","gender","raceethnicity","riskfactor","riskfactorresponse","data_value_unit","data_value_type","data_value","data_value_footnote_symbol","data_value_footnote","low_confidence_limit","high_confidence_limit","numerator","sample_size","locationid","topicid","categoryid","questionid","responseid","datavaluetypeid","ageid","genderid","raceethnicityid","riskfactorid","riskfactorresponseid","geolocation"
"2016","2016","NY","New York","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Congenital glaucoma","0-17 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","0.74","0","500","36","TCOND","CDXC5","QDXC5","R5_7","CRDPREV","AGE017","GF","ALLRACE","RFHT","RFYES","POINT (-75.54397043 42.82700103)"
"2016","2016","AK","Alaska","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Secondary glaucoma","All ages","Female","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","0.92","0","400","2","TCOND","CDXC5","QDXC5","R5_10","CRDPREV","AGEALL","GF","ALLRACE","RFDM","RFYES","POINT (-147.722059 64.84507996)"
"2016","2016","VT","Vermont","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Senile cataract","0-17 years","Male","All races","Diabetes","No","%","Crude Prevalence","0",,,"0","0.22","0","1700","50","TCOND","CDXC6","QDXC6","R6_1","CRDPREV","AGE017","GM","ALLRACE","RFDM","RFNO","POINT (-72.51764079 43.62538124)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Aphakia and disorders of lens","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0.02",,,"0.02","0.02","3000","14874100","59","TCOND","CDXC6","QDXC6","R6_6","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT",
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Senile cataract","18-39 years","All genders","All races","Diabetes","No","%","Crude Prevalence","0.04",,,"0.02","0.07","0","38100","99","TCOND","CDXC6","QDXC6","R6_1","CRDPREV","AGE1839","GALL","ALLRACE","RFDM","RFNO",
"2016","2016","OR","Oregon","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Congenital glaucoma","65-84 years","Female","All races","Hypertension","No","%","Crude Prevalence","0",,,"0","0.41","0","900","41","TCOND","CDXC5","QDXC5","R5_7","CRDPREV","AGE6584","GF","ALLRACE","RFHT","RFNO","POINT (-120.1550313 44.56744942)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Senile cataract","40-64 years","Female","All races","Hypertension","No","%","Crude Prevalence","3.65",,,"3.63","3.67","165600","4537800","59","TCOND","CDXC6","QDXC6","R6_1","CRDPREV","AGE4064","GF","ALLRACE","RFHT","RFNO",
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Congenital glaucoma","0-17 years","All genders","All races","Hypertension","Yes","%","Crude Prevalence","0.04",,,"0.02","0.08","0","17900","59","TCOND","CDXC5","QDXC5","R5_7","CRDPREV","AGE017","GALL","ALLRACE","RFHT","RFYES",
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Low-tension glaucoma","65-84 years","Female","All races","Diabetes","No","%","Crude Prevalence","0.13",,,"0.11","0.16","100","81500","59","TCOND","CDXC5","QDXC5","R5_3","CRDPREV","AGE6584","GF","ALLRACE","RFDM","RFNO",
"2016","2016","MT","Montana","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","18-39 years","Male","All races","Diabetes","No","%","Crude Prevalence","0.03",,,"0","0.12","0","5700","30","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGE1839","GM","ALLRACE","RFDM","RFNO","POINT (-109.4244206 47.06652897)"
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Glaucoma suspect","18-39 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","0.56",,,"0.02","2.86","0","200","99","TCOND","CDXC5","QDXC5","R5_4","CRDPREV","AGE1839","GM","ALLRACE","RFDM","RFYES",
"2016","2016","FL","Florida","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Congenital Cataract","65-84 years","Female","All races","Diabetes","No","%","Crude Prevalence","0.02",,,"0","0.1","0","5700","12","TCOND","CDXC6","QDXC6","R6_3","CRDPREV","AGE6584","GF","ALLRACE","RFDM","RFNO","POINT (-81.92896054 28.93204038)"
"2016","2016","MN","Minnesota","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Congenital glaucoma","0-17 years","Female","All races","Diabetes","No","%","Crude Prevalence","0.01",,,"0","0.03","0","39000","27","TCOND","CDXC5","QDXC5","R5_7","CRDPREV","AGE017","GF","ALLRACE","RFDM","RFNO","POINT (-94.7942005 46.35564874)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Primary open-angle glaucoma","18-39 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","0","0","223300","59","TCOND","CDXC5","QDXC5","R5_2","CRDPREV","AGE1839","GF","ALLRACE","RFHT","RFYES",
"2016","2016","OH","Ohio","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Open-angle glaucoma","0-17 years","Female","All races","Hypertension","No","%","Crude Prevalence","0",,,"0","0","0","149500","39","TCOND","CDXC5","QDXC5","R5_1","CRDPREV","AGE017","GF","ALLRACE","RFHT","RFNO","POINT (-82.40426006 40.06021014)"
"2016","2016","ID","Idaho","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Glaucoma suspect","0-17 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","1.83","0","200","16","TCOND","CDXC5","QDXC5","R5_4","CRDPREV","AGE017","GM","ALLRACE","RFDM","RFYES","POINT (-114.36373 43.68263001)"
"2016","2016","OH","Ohio","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Secondary glaucoma","0-17 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","0.61","0","600","39","TCOND","CDXC5","QDXC5","R5_10","CRDPREV","AGE017","GM","ALLRACE","RFDM","RFYES","POINT (-82.40426006 40.06021014)"
"2016","2016","FL","Florida","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Primary open-angle glaucoma","All ages","Male","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","0","0","147100","12","TCOND","CDXC5","QDXC5","R5_2","CRDPREV","AGEALL","GM","ALLRACE","RFHT","RFYES","POINT (-81.92896054 28.93204038)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Glaucoma suspect","40-64 years","All genders","All races","Diabetes","No","%","Crude Prevalence","2.12",,,"2.11","2.13","220800","10415100","59","TCOND","CDXC5","QDXC5","R5_4","CRDPREV","AGE4064","GALL","ALLRACE","RFDM","RFNO",
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Non-congenital cataract","18-39 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","0.92","0","400","99","TCOND","CDXC6","QDXC6","R6_2","CRDPREV","AGE1839","GALL","ALLRACE","RFDM","RFYES",
"2016","2016","ME","Maine","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Low-tension glaucoma","65-84 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","3.62","0","100","23","TCOND","CDXC5","QDXC5","R5_3","CRDPREV","AGE6584","GM","ALLRACE","RFHT","RFYES","POINT (-68.98503134 45.25422889)"
"2016","2016","WY","Wyoming","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Aphakia and disorders of lens","All ages","Female","All races","Diabetes","No","%","Crude Prevalence","0.01",,,"0","0.04","0","15500","56","TCOND","CDXC6","QDXC6","R6_6","CRDPREV","AGEALL","GF","ALLRACE","RFDM","RFNO","POINT (-108.1098304 43.23554134)"
"2016","2016","VA","Virginia","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Congenital glaucoma","0-17 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","1.83","0","200","51","TCOND","CDXC5","QDXC5","R5_7","CRDPREV","AGE017","GM","ALLRACE","RFDM","RFYES","POINT (-78.45789046 37.54268067)"
"2016","2016","MN","Minnesota","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Low-tension glaucoma","18-39 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","0.53","0","700","27","TCOND","CDXC5","QDXC5","R5_3","CRDPREV","AGE1839","GM","ALLRACE","RFDM","RFYES","POINT (-94.7942005 46.35564874)"
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Non-congenital cataract","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0.14",,,"0.11","0.17","100","59700","99","TCOND","CDXC6","QDXC6","R6_2","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT",
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Open-angle glaucoma","18-39 years","Male","All races","Diabetes","No","%","Crude Prevalence","0.05",,,"0.05","0.05","2400","4765700","59","TCOND","CDXC5","QDXC5","R5_1","CRDPREV","AGE1839","GM","ALLRACE","RFDM","RFNO",
"2016","2016","AZ","Arizona","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","All Cataracts","0-17 years","Female","All races","Hypertension","No","%","Crude Prevalence","0.04",,,"0.03","0.06","0","67800","4","TCOND","CDXC6","QDXC6","R6_ALL","CRDPREV","AGE017","GF","ALLRACE","RFHT","RFNO","POINT (-111.7638113 34.86597028)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Secondary glaucoma","40-64 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","0.14",,,"0.13","0.15","1000","692400","59","TCOND","CDXC5","QDXC5","R5_10","CRDPREV","AGE4064","GM","ALLRACE","RFDM","RFYES",
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","18-39 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","0.14",,,"0.12","0.17","100","82800","59","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGE1839","GM","ALLRACE","RFDM","RFYES",
"2016","2016","AK","Alaska","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","0-17 years","Female","All races","Diabetes","No","%","Crude Prevalence","0",,,"0","0.11","0","3500","2","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGE017","GF","ALLRACE","RFDM","RFNO","POINT (-147.722059 64.84507996)"
"2016","2016","ME","Maine","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.07","0","6800","23","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT (-68.98503134 45.25422889)"
"2016","2016","AZ","Arizona","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Congenital glaucoma","18-39 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","0.2","0","1800","4","TCOND","CDXC5","QDXC5","R5_7","CRDPREV","AGE1839","GF","ALLRACE","RFDM","RFYES","POINT (-111.7638113 34.86597028)"
"2016","2016","OH","Ohio","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","0-17 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","0.61","0","600","39","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGE017","GM","ALLRACE","RFDM","RFYES","POINT (-82.40426006 40.06021014)"
"2016","2016","KY","Kentucky","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","All Glaucoma","40-64 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","5.4",,,"5.07","5.75","900","17400","21","TCOND","CDXC5","QDXC5","R5_ALL","CRDPREV","AGE4064","GM","ALLRACE","RFDM","RFYES","POINT (-84.77497105 37.64597027)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Aphakia and disorders of lens","40-64 years","All genders","All races","Hypertension","Yes","%","Crude Prevalence","0.06",,,"0.06","0.06","2100","3487300","59","TCOND","CDXC6","QDXC6","R6_6","CRDPREV","AGE4064","GALL","ALLRACE","RFHT","RFYES",
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Low-tension glaucoma","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.08",,,"0.08","0.08","5000","6257700","59","TCOND","CDXC5","QDXC5","R5_3","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT",
"2016","2016","NC","North Carolina","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Glaucoma suspect","0-17 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","0.33",,,"0.01","1.84","0","300","37","TCOND","CDXC5","QDXC5","R5_4","CRDPREV","AGE017","GF","ALLRACE","RFDM","RFYES","POINT (-79.15925046 35.46622098)"
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Senile cataract","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.04","0","16800","99","TCOND","CDXC6","QDXC6","R6_1","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT",
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Open-angle glaucoma","65-84 years","Male","All races","Diabetes","No","%","Crude Prevalence","1.18",,,"1.1","1.26","800","67700","59","TCOND","CDXC5","QDXC5","R5_1","CRDPREV","AGE6584","GM","ALLRACE","RFDM","RFNO",
"2016","2016","NY","New York","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Primary open-angle glaucoma","65-84 years","Female","All races","Diabetes","No","%","Crude Prevalence","0",,,"0","0.05","0","7600","36","TCOND","CDXC5","QDXC5","R5_2","CRDPREV","AGE6584","GF","ALLRACE","RFDM","RFNO","POINT (-75.54397043 42.82700103)"
"2016","2016","OK","Oklahoma","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Posterior capsular opacity","65-84 years","Male","All races","Diabetes","No","%","Crude Prevalence","0.23",,,"0.03","0.81","0","900","40","TCOND","CDXC6","QDXC6","R6_4","CRDPREV","AGE6584","GM","ALLRACE","RFDM","RFNO","POINT (-97.52107021 35.47203136)"
"2016","2016","GA","Georgia","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Senile cataract","65-84 years","Male","All races","Diabetes","No","%","Crude Prevalence","4.17",,,"3.51","4.91","100","3300","13","TCOND","CDXC6","QDXC6","R6_1","CRDPREV","AGE6584","GM","ALLRACE","RFDM","RFNO","POINT (-83.62758035 32.83968109)"
"2016","2016","US","National","MSCANCC","Service Utilization","Eye Exams","Proportion of patients who had an eye exam in selected year","By any provider type","0-17 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","95.41",,,"94.89","95.88","6800","7100","59","TUTL","CUTLEX","QUTLEX","REXANY","CRDPREV","AGE017","GF","ALLRACE","RFHT","RFYES",
"2016","2016","MT","Montana","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","18-39 years","All genders","All races","Hypertension","No","%","Crude Prevalence","0.04",,,"0.01","0.1","0","11200","30","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGE1839","GALL","ALLRACE","RFHT","RFNO","POINT (-109.4244206 47.06652897)"
"2016","2016","TN","Tennessee","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","All Glaucoma","18-39 years","Male","All races","Diabetes","No","%","Crude Prevalence","0.34",,,"0.31","0.37","400","129500","47","TCOND","CDXC5","QDXC5","R5_ALL","CRDPREV","AGE1839","GM","ALLRACE","RFDM","RFNO","POINT (-85.77449091 35.68094058)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Keratoconus","65-84 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","0.03",,,"0.01","0.06","0","20800","59","TCOND","CDXC16","QDXC16","R16_1","CRDPREV","AGE6584","GF","ALLRACE","RFHT","RFYES",
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","All ages","Female","All races","Diabetes","No","%","Crude Prevalence","0.21",,,"0.21","0.21","29700","14123700","59","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGEALL","GF","ALLRACE","RFDM","RFNO",
"2016","2016","SD","South Dakota","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Open-angle glaucoma","All ages","Female","All races","Diabetes","No","%","Crude Prevalence","0.26",,,"0.19","0.35","0","16800","46","TCOND","CDXC5","QDXC5","R5_1","CRDPREV","AGEALL","GF","ALLRACE","RFDM","RFNO","POINT (-100.3735306 44.35313005)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Other/unspecified glaucoma","40-64 years","Female","All races","Diabetes","No","%","Crude Prevalence","0.13",,,"0.13","0.13","7300","5623300","59","TCOND","CDXC5","QDXC5","R5_9","CRDPREV","AGE4064","GF","ALLRACE","RFDM","RFNO",
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","All Cataracts","All ages","Male","All races","Diabetes","Yes","%","Crude Prevalence","10.82",,,"9.55","12.19","200","2200","99","TCOND","CDXC6","QDXC6","R6_ALL","CRDPREV","AGEALL","GM","ALLRACE","RFDM","RFYES",
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Glaucoma suspect","65-84 years","Female","All races","Hypertension","No","%","Crude Prevalence","1.68",,,"1.59","1.78","1200","70300","59","TCOND","CDXC5","QDXC5","R5_4","CRDPREV","AGE6584","GF","ALLRACE","RFHT","RFNO",
"2016","2016","AL","Alabama","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","All Cataracts","18-39 years","Female","All races","Diabetes","No","%","Crude Prevalence","0.15",,,"0.12","0.18","100","68200","1","TCOND","CDXC6","QDXC6","R6_ALL","CRDPREV","AGE1839","GF","ALLRACE","RFDM","RFNO","POINT (-86.63186076 32.84057112)"
"2016","2016","OK","Oklahoma","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Glaucoma suspect","65-84 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","1.36",,,"0.38","3.42","0","300","40","TCOND","CDXC5","QDXC5","R5_4","CRDPREV","AGE6584","GM","ALLRACE","RFHT","RFYES","POINT (-97.52107021 35.47203136)"
"2016","2016","IN","Indiana","MSCANCC","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Color blindness","40-64 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","0.01",,,"0","0.05","0","13700","18","TCOND","CDXC12","QDXC12","R12_2","CRDPREV","AGE4064","GF","ALLRACE","RFDM","RFYES","POINT (-86.14996019 39.76691045)"
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","All Cataracts","65-84 years","Female","All races","Diabetes","No","%","Crude Prevalence","5.94",,,"3.55","9.25","0","300","99","TCOND","CDXC6","QDXC6","R6_ALL","CRDPREV","AGE6584","GF","ALLRACE","RFDM","RFNO",
"2016","2016","AK","Alaska","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Secondary glaucoma","All ages","Female","All races","Hypertension","No","%","Crude Prevalence","0.01",,,"0","0.05","0","12700","2","TCOND","CDXC5","QDXC5","R5_10","CRDPREV","AGEALL","GF","ALLRACE","RFHT","RFNO","POINT (-147.722059 64.84507996)"
"2016","2016","AK","Alaska","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Senile cataract","0-17 years","Female","All races","Hypertension","No","%","Crude Prevalence","0",,,"0","0.11","0","3500","2","TCOND","CDXC6","QDXC6","R6_1","CRDPREV","AGE017","GF","ALLRACE","RFHT","RFNO","POINT (-147.722059 64.84507996)"
"2016","2016","TX","Texas","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Primary open-angle glaucoma","All ages","Female","All races","Hypertension","No","%","Crude Prevalence","0",,,"0","0","0","1104100","48","TCOND","CDXC5","QDXC5","R5_2","CRDPREV","AGEALL","GF","ALLRACE","RFHT","RFNO","POINT (-99.42677021 31.82724041)"
"2016","2016","CO","Colorado","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","All Glaucoma","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","1.05",,,"0.52","1.9","0","1000","8","TCOND","CDXC5","QDXC5","R5_ALL","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT (-106.1336109 38.84384076)"
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","All Cataracts","0-17 years","Female","All races","Diabetes","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"99","TCOND","CDXC6","QDXC6","R6_ALL","CRDPREV","AGE017","GF","ALLRACE","RFDM","RFYES",
"2016","2016","ID","Idaho","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Senile cataract","65-84 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","9.72",,,"5.99","14.69","0","200","16","TCOND","CDXC6","QDXC6","R6_1","CRDPREV","AGE6584","GF","ALLRACE","RFHT","RFYES","POINT (-114.36373 43.68263001)"
"2016","2016","MI","Michigan","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Secondary glaucoma","0-17 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","0.74","0","500","26","TCOND","CDXC5","QDXC5","R5_10","CRDPREV","AGE017","GM","ALLRACE","RFHT","RFYES","POINT (-84.71439027 44.66131954)"
"2016","2016","PR","Puerto Rico","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","18-39 years","All genders","All races","Hypertension","No","%","Crude Prevalence","0",,,"0","0.11","0","3300","72","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGE1839","GALL","ALLRACE","RFHT","RFNO","POINT (-66.590149 18.220833)"
"2016","2016","MO","Missouri","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Open-angle glaucoma","40-64 years","Male","All races","Diabetes","No","%","Crude Prevalence","0.71",,,"0.66","0.77","600","91000","29","TCOND","CDXC5","QDXC5","R5_1","CRDPREV","AGE4064","GM","ALLRACE","RFDM","RFNO","POINT (-92.56630005 38.63579078)"
"2016","2016","US","National","MSCANCC","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Any vision screening","All ages","All genders","All races","Hypertension","Yes","%","Crude Prevalence","0.29",,,"0.29","0.3","11700","4020000","59","TUTL","CSCRN","QSCRN","RSCNANY","CRDPREV","AGEALL","GALL","ALLRACE","RFHT","RFYES",
"2016","2016","AZ","Arizona","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Low-tension glaucoma","18-39 years","Female","All races","Diabetes","No","%","Crude Prevalence","0",,,"0","0","0","93600","4","TCOND","CDXC5","QDXC5","R5_3","CRDPREV","AGE1839","GF","ALLRACE","RFDM","RFNO","POINT (-111.7638113 34.86597028)"
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","All ages","Female","All races","Diabetes","Yes","%","Crude Prevalence","1.38",,,"0.93","1.98","0","2100","99","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGEALL","GF","ALLRACE","RFDM","RFYES",
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Other/unspecified glaucoma","65-84 years","All genders","All races","Hypertension","No","%","Crude Prevalence","0",,,"0","0.92","0","400","99","TCOND","CDXC5","QDXC5","R5_9","CRDPREV","AGE6584","GALL","ALLRACE","RFHT","RFNO",
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Other/unspecified glaucoma","All ages","Female","All races","Diabetes","No","%","Crude Prevalence","0.04",,,"0.03","0.06","0","57600","99","TCOND","CDXC5","QDXC5","R5_9","CRDPREV","AGEALL","GF","ALLRACE","RFDM","RFNO",
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Night blindness","0-17 years","Male","All races","Hypertension","No","%","Crude Prevalence","0",,,"0","0","0","3421900","59","TCOND","CDXC12","QDXC12","R12_3","CRDPREV","AGE017","GM","ALLRACE","RFHT","RFNO",
"2016","2016","IN","Indiana","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Secondary glaucoma","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.02","0","72400","18","TCOND","CDXC5","QDXC5","R5_10","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT (-86.14996019 39.76691045)"
"2016","2016","US","National","MSCANCC","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Any vision screening","40-64 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","0.2",,,"0.19","0.2","3400","1719900","59","TUTL","CSCRN","QSCRN","RSCNANY","CRDPREV","AGE4064","GF","ALLRACE","RFHT","RFYES",
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Glaucoma suspect","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","1.21",,,"1.15","1.28","1400","112800","99","TCOND","CDXC5","QDXC5","R5_4","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT",
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Myopic degeneration","0-17 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","0.11",,,"0.05","0.22","0","7100","59","TCOND","CDXC4","QDXC4","R4_9","CRDPREV","AGE017","GF","ALLRACE","RFHT","RFYES",
"2016","2016","MO","Missouri","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Glaucoma suspect","0-17 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","1.83","0","200","29","TCOND","CDXC5","QDXC5","R5_4","CRDPREV","AGE017","GM","ALLRACE","RFDM","RFYES","POINT (-92.56630005 38.63579078)"
"2016","2016","MO","Missouri","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Non-congenital cataract","0-17 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","1.83","0","200","29","TCOND","CDXC6","QDXC6","R6_2","CRDPREV","AGE017","GM","ALLRACE","RFHT","RFYES","POINT (-92.56630005 38.63579078)"
"2016","2016","IL","Illinois","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","All Glaucoma","65-84 years","Male","All races","Hypertension","No","%","Crude Prevalence","2.27",,,"1.63","3.07","0","1800","17","TCOND","CDXC5","QDXC5","R5_ALL","CRDPREV","AGE6584","GM","ALLRACE","RFHT","RFNO","POINT (-88.99771018 40.48501028)"
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Other/unspecified glaucoma","18-39 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","1.83","0","200","99","TCOND","CDXC5","QDXC5","R5_9","CRDPREV","AGE1839","GM","ALLRACE","RFDM","RFYES",
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Non-congenital cataract","18-39 years","All genders","All races","Diabetes","No","%","Crude Prevalence","0.02",,,"0.01","0.04","0","38100","99","TCOND","CDXC6","QDXC6","R6_2","CRDPREV","AGE1839","GALL","ALLRACE","RFDM","RFNO",
"2016","2016","NE","Nebraska","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Low-tension glaucoma","All ages","Male","All races","Diabetes","No","%","Crude Prevalence","0.01",,,"0","0.02","0","47300","31","TCOND","CDXC5","QDXC5","R5_3","CRDPREV","AGEALL","GM","ALLRACE","RFDM","RFNO","POINT (-99.36572062 41.64104099)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Primary open-angle glaucoma","40-64 years","All genders","All races","Hypertension","No","%","Crude Prevalence","0",,,"0","0","0","8254600","59","TCOND","CDXC5","QDXC5","R5_2","CRDPREV","AGE4064","GALL","ALLRACE","RFHT","RFNO",
"2016","2016","SD","South Dakota","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","All Glaucoma","18-39 years","Male","All races","Hypertension","No","%","Crude Prevalence","0.38",,,"0.24","0.57","0","5800","46","TCOND","CDXC5","QDXC5","R5_ALL","CRDPREV","AGE1839","GM","ALLRACE","RFHT","RFNO","POINT (-100.3735306 44.35313005)"
"2016","2016","UT","Utah","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Secondary glaucoma","0-17 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","3.62","0","100","49","TCOND","CDXC5","QDXC5","R5_10","CRDPREV","AGE017","GF","ALLRACE","RFHT","RFYES","POINT (-111.5871306 39.36070017)"
"2016","2016","VT","Vermont","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Senile cataract","65-84 years","Female","All races","Diabetes","No","%","Crude Prevalence","0.96",,,"0.02","5.38","0","100","50","TCOND","CDXC6","QDXC6","R6_1","CRDPREV","AGE6584","GF","ALLRACE","RFDM","RFNO","POINT (-72.51764079 43.62538124)"
"2016","2016","US","National","MSCANCC","Service Utilization","Vision Correction","Percentage of people who had a vision correction visit or supplies claim","Eyeglasses","40-64 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","0.41",,,"0.39","0.42","2800","692400","59","TUTL","CVC","QVC","RGLASS","CRDPREV","AGE4064","GM","ALLRACE","RFDM","RFYES",
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Congenital Cataract","40-64 years","Female","All races","Diabetes","No","%","Crude Prevalence","0",,,"0","0.02","0","20200","99","TCOND","CDXC6","QDXC6","R6_3","CRDPREV","AGE4064","GF","ALLRACE","RFDM","RFNO",
"2016","2016","NV","Nevada","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Congenital Cataract","All ages","Female","All races","Diabetes","No","%","Crude Prevalence","0.01",,,"0","0.02","0","108200","32","TCOND","CDXC6","QDXC6","R6_3","CRDPREV","AGEALL","GF","ALLRACE","RFDM","RFNO","POINT (-117.0718406 39.49324039)"
"2016","2016","WY","Wyoming","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Congenital glaucoma","All ages","Female","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","0.31","0","1200","56","TCOND","CDXC5","QDXC5","R5_7","CRDPREV","AGEALL","GF","ALLRACE","RFHT","RFYES","POINT (-108.1098304 43.23554134)"
"2016","2016","AZ","Arizona","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Other/unspecified glaucoma","0-17 years","Male","All races","Hypertension","No","%","Crude Prevalence","0.01",,,"0","0.02","0","71400","4","TCOND","CDXC5","QDXC5","R5_9","CRDPREV","AGE017","GM","ALLRACE","RFHT","RFNO","POINT (-111.7638113 34.86597028)"
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Other/unspecified glaucoma","40-64 years","Male","All races","Diabetes","No","%","Crude Prevalence","0.09",,,"0.05","0.14","0","18500","99","TCOND","CDXC5","QDXC5","R5_9","CRDPREV","AGE4064","GM","ALLRACE","RFDM","RFNO",
"2016","2016","IA","Iowa","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","All Cataracts","18-39 years","All genders","All races","Diabetes","No","%","Crude Prevalence","0.09",,,"0.07","0.11","100","80200","19","TCOND","CDXC6","QDXC6","R6_ALL","CRDPREV","AGE1839","GALL","ALLRACE","RFDM","RFNO","POINT (-93.81649056 42.46940091)"
"2016","2016","ID","Idaho","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","All Cataracts","18-39 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","1.12",,,"0.59","1.93","0","1100","16","TCOND","CDXC6","QDXC6","R6_ALL","CRDPREV","AGE1839","GM","ALLRACE","RFDM","RFYES","POINT (-114.36373 43.68263001)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","Strabismus","0-17 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","2.29",,,"2.01","2.59","200","10700","59","TCOND","CDXC9","QDXC9","R9_1","CRDPREV","AGE017","GM","ALLRACE","RFDM","RFYES",
"2016","2016","KY","Kentucky","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Primary open-angle glaucoma","0-17 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","1.22","0","300","21","TCOND","CDXC5","QDXC5","R5_2","CRDPREV","AGE017","GF","ALLRACE","RFDM","RFYES","POINT (-84.77497105 37.64597027)"
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","65-84 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.56",,,"0.11","1.68","0","500","99","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGE6584","GALL","ALLRACE","RFALL","RFTOT",
"2016","2016","MO","Missouri","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","All Glaucoma","0-17 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","0.42",,,"0.01","2.62","0","200","29","TCOND","CDXC5","QDXC5","R5_ALL","CRDPREV","AGE017","GM","ALLRACE","RFHT","RFYES","POINT (-92.56630005 38.63579078)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Keratoconus","40-64 years","Female","All races","Hypertension","No","%","Crude Prevalence","0.07",,,"0.07","0.07","3200","4537800","59","TCOND","CDXC16","QDXC16","R16_1","CRDPREV","AGE4064","GF","ALLRACE","RFHT","RFNO",
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","All Cataracts","All ages","Female","All races","All patients","Total","%","Crude Prevalence","2.5",,,"2.49","2.51","371900","14874100","59","TCOND","CDXC6","QDXC6","R6_ALL","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT",
"2016","2016","ID","Idaho","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Open-angle glaucoma","0-17 years","All genders","All races","Hypertension","No","%","Crude Prevalence","0",,,"0","0","0","111400","16","TCOND","CDXC5","QDXC5","R5_1","CRDPREV","AGE017","GALL","ALLRACE","RFHT","RFNO","POINT (-114.36373 43.68263001)"
"2016","2016","HI","Hawaii","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Glaucoma suspect","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0.77",,,"0.16","2.21","0","400","15","TCOND","CDXC5","QDXC5","R5_4","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT (-157.8577494 21.30485044)"
"2016","2016","AL","Alabama","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","All Cataracts","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","0.07",,,"0.05","0.1","0","40500","1","TCOND","CDXC6","QDXC6","R6_ALL","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT (-86.63186076 32.84057112)"
"2016","2016","US","National","MSCANCC","Service Utilization","Vision Correction","Percentage of people who had a vision correction visit or supplies claim","Eyeglasses","40-64 years","Male","All races","All patients","Total","%","Crude Prevalence","0.26",,,"0.26","0.27","14300","5484200","59","TUTL","CVC","QVC","RGLASS","CRDPREV","AGE4064","GM","ALLRACE","RFALL","RFTOT",
"2016","2016","NJ","New Jersey","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Congenital glaucoma","40-64 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","0.01",,,"0","0.04","0","18900","34","TCOND","CDXC5","QDXC5","R5_7","CRDPREV","AGE4064","GM","ALLRACE","RFDM","RFYES","POINT (-74.27369129 40.13057005)"
"2016","2016","SD","South Dakota","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","All Glaucoma","18-39 years","Male","All races","Diabetes","No","%","Crude Prevalence","0.39",,,"0.25","0.58","0","5900","46","TCOND","CDXC5","QDXC5","R5_ALL","CRDPREV","AGE1839","GM","ALLRACE","RFDM","RFNO","POINT (-100.3735306 44.35313005)"
"2016","2016","CA","California","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Glaucoma suspect","0-17 years","Male","All races","Diabetes","No","%","Crude Prevalence","0.15",,,"0.13","0.17","300","230500","6","TCOND","CDXC5","QDXC5","R5_4","CRDPREV","AGE017","GM","ALLRACE","RFDM","RFNO","POINT (-120.9999995 37.63864012)"
"2016","2016","OH","Ohio","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","0-17 years","Female","All races","Hypertension","No","%","Crude Prevalence","0.01",,,"0.01","0.02","0","149500","39","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGE017","GF","ALLRACE","RFHT","RFNO","POINT (-82.40426006 40.06021014)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Keratoconus","All ages","Female","All races","Diabetes","No","%","Crude Prevalence","0.05",,,"0.05","0.05","7100","14123700","59","TCOND","CDXC16","QDXC16","R16_1","CRDPREV","AGEALL","GF","ALLRACE","RFDM","RFNO",
"2016","2016","PR","Puerto Rico","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Senile cataract","18-39 years","Male","All races","Diabetes","No","%","Crude Prevalence","0.12",,,"0.01","0.43","0","1700","72","TCOND","CDXC6","QDXC6","R6_1","CRDPREV","AGE1839","GM","ALLRACE","RFDM","RFNO","POINT (-66.590149 18.220833)"
"2016","2016","VA","Virginia","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Glaucoma suspect","65-84 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","3.39",,,"1.35","6.93","0","200","51","TCOND","CDXC5","QDXC5","R5_4","CRDPREV","AGE6584","GF","ALLRACE","RFDM","RFYES","POINT (-78.45789046 37.54268067)"
"2016","2016","MD","Maryland","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Low-tension glaucoma","All ages","Male","All races","Diabetes","Yes","%","Crude Prevalence","0.1",,,"0.05","0.19","0","8700","24","TCOND","CDXC5","QDXC5","R5_3","CRDPREV","AGEALL","GM","ALLRACE","RFDM","RFYES","POINT (-76.60926011 39.29058096)"
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Open-angle glaucoma","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0.02",,,"0.01","0.05","0","20600","99","TCOND","CDXC5","QDXC5","R5_1","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT",
"2016","2016","VA","Virginia","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Congenital glaucoma","0-17 years","Female","All races","Diabetes","No","%","Crude Prevalence","0.01",,,"0","0.02","0","69300","51","TCOND","CDXC5","QDXC5","R5_7","CRDPREV","AGE017","GF","ALLRACE","RFDM","RFNO","POINT (-78.45789046 37.54268067)"
"2016","2016","OR","Oregon","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Primary open-angle glaucoma","All ages","Female","All races","Hypertension","No","%","Crude Prevalence","0",,,"0","0","0","152500","41","TCOND","CDXC5","QDXC5","R5_2","CRDPREV","AGEALL","GF","ALLRACE","RFHT","RFNO","POINT (-120.1550313 44.56744942)"
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Posterior capsular opacity","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0.16",,,"0.13","0.2","100","59700","99","TCOND","CDXC6","QDXC6","R6_4","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT",
"2016","2016","ME","Maine","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Primary angle-closure glaucoma","0-17 years","Male","All races","Diabetes","No","%","Crude Prevalence","0",,,"0","0.05","0","6800","23","TCOND","CDXC5","QDXC5","R5_5","CRDPREV","AGE017","GM","ALLRACE","RFDM","RFNO","POINT (-68.98503134 45.25422889)"
"2016","2016","IN","Indiana","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Glaucoma suspect","All ages","Female","All races","Diabetes","No","%","Crude Prevalence","0.75",,,"0.72","0.78","2200","296500","18","TCOND","CDXC5","QDXC5","R5_4","CRDPREV","AGEALL","GF","ALLRACE","RFDM","RFNO","POINT (-86.14996019 39.76691045)"
"2016","2016","OH","Ohio","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","65-84 years","Male","All races","Hypertension","No","%","Crude Prevalence","0.59",,,"0.34","0.96","0","2700","39","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGE6584","GM","ALLRACE","RFHT","RFNO","POINT (-82.40426006 40.06021014)"
"2016","2016","WI","Wisconsin","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Glaucoma suspect","0-17 years","All genders","All races","Diabetes","No","%","Crude Prevalence","0.09",,,"0.08","0.11","100","152000","55","TCOND","CDXC5","QDXC5","R5_4","CRDPREV","AGE017","GALL","ALLRACE","RFDM","RFNO","POINT (-89.81637074 44.39319117)"
"2016","2016","US","National","MSCANCC","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Drain","All ages","Female","All races","Hypertension","Yes","%","Crude Prevalence","0.03",,,"0.03","0.03","600","1971000","59","TUTL","CGLAUTX","QGLAU","RGLADRN","CRDPREV","AGEALL","GF","ALLRACE","RFHT","RFYES",
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Open-angle glaucoma","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0.01","0.01","300","3432700","59","TCOND","CDXC5","QDXC5","R5_1","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT",
"2016","2016","HI","Hawaii","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Senile cataract","65-84 years","All genders","All races","Hypertension","No","%","Crude Prevalence","0",,,"0","3.62","0","100","15","TCOND","CDXC6","QDXC6","R6_1","CRDPREV","AGE6584","GALL","ALLRACE","RFHT","RFNO","POINT (-157.8577494 21.30485044)"
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Primary angle-closure glaucoma","18-39 years","All genders","All races","Hypertension","Yes","%","Crude Prevalence","0.1",,,"0","0.56","0","1000","99","TCOND","CDXC5","QDXC5","R5_5","CRDPREV","AGE1839","GALL","ALLRACE","RFHT","RFYES",
"2016","2016","OH","Ohio","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Low-tension glaucoma","All ages","Female","All races","Diabetes","No","%","Crude Prevalence","0.03",,,"0.03","0.03","200","613800","39","TCOND","CDXC5","QDXC5","R5_3","CRDPREV","AGEALL","GF","ALLRACE","RFDM","RFNO","POINT (-82.40426006 40.06021014)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Diabetic macular edema","All ages","Male","All races","Hypertension","No","%","Crude Prevalence","0.03",,,"0.03","0.03","3500","11794700","59","TCOND","CDXC2","QDXC2","R2_4","CRDPREV","AGEALL","GM","ALLRACE","RFHT","RFNO",
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Other/unspecified glaucoma","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.04","0","18000","99","TCOND","CDXC5","QDXC5","R5_9","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT",
"2016","2016","KY","Kentucky","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Primary open-angle glaucoma","65-84 years","Male","All races","Diabetes","No","%","Crude Prevalence","0",,,"0","0.22","0","1700","21","TCOND","CDXC5","QDXC5","R5_2","CRDPREV","AGE6584","GM","ALLRACE","RFDM","RFNO","POINT (-84.77497105 37.64597027)"
"2016","2016","WY","Wyoming","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","All Glaucoma","All ages","Male","All races","Hypertension","No","%","Crude Prevalence","0.56",,,"0.44","0.7","100","14200","56","TCOND","CDXC5","QDXC5","R5_ALL","CRDPREV","AGEALL","GM","ALLRACE","RFHT","RFNO","POINT (-108.1098304 43.23554134)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Low-tension glaucoma","65-84 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","0.17",,,"0.1","0.27","0","10500","59","TCOND","CDXC5","QDXC5","R5_3","CRDPREV","AGE6584","GM","ALLRACE","RFDM","RFYES",
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Secondary glaucoma","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0.02",,,"0.01","0.03","0","59700","99","TCOND","CDXC5","QDXC5","R5_10","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT",
"2016","2016","OR","Oregon","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Congenital Cataract","18-39 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","0.15",,,"0","0.81","0","700","41","TCOND","CDXC6","QDXC6","R6_3","CRDPREV","AGE1839","GM","ALLRACE","RFDM","RFYES","POINT (-120.1550313 44.56744942)"
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Senile cataract","18-39 years","All genders","All races","Hypertension","No","%","Crude Prevalence","0.04",,,"0.02","0.07","0","37500","99","TCOND","CDXC6","QDXC6","R6_1","CRDPREV","AGE1839","GALL","ALLRACE","RFHT","RFNO",
"2016","2016","HI","Hawaii","MSCANCC","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Vision screening","40-64 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0.63",,,"0.02","3.43","0","200","15","TUTL","CSCRN","QSCRN","RSCNVIS","CRDPREV","AGE4064","GALL","ALLRACE","RFDM","RFYES","POINT (-157.8577494 21.30485044)"
"2016","2016","WV","West Virginia","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Low-tension glaucoma","40-64 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0.13",,,"0.04","0.3","0","4000","54","TCOND","CDXC5","QDXC5","R5_3","CRDPREV","AGE4064","GALL","ALLRACE","RFDM","RFYES","POINT (-80.71264013 38.6655102)"
"2016","2016","VA","Virginia","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","0-17 years","Male","All races","Diabetes","No","%","Crude Prevalence","0.02",,,"0.01","0.03","0","72000","51","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGE017","GM","ALLRACE","RFDM","RFNO","POINT (-78.45789046 37.54268067)"
"2016","2016","KS","Kansas","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","18-39 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0.33",,,"0.09","0.85","0","1200","20","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGE1839","GALL","ALLRACE","RFDM","RFYES","POINT (-98.20078123 38.3477403)"
"2016","2016","DE","Delaware","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Congenital glaucoma","40-64 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","0.04","0","9600","10","TCOND","CDXC5","QDXC5","R5_7","CRDPREV","AGE4064","GALL","ALLRACE","RFDM","RFYES","POINT (-75.57774117 39.00883067)"
"2016","2016","DE","Delaware","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Congenital glaucoma","0-17 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","3.62","0","100","10","TCOND","CDXC5","QDXC5","R5_7","CRDPREV","AGE017","GM","ALLRACE","RFDM","RFYES","POINT (-75.57774117 39.00883067)"
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Open-angle glaucoma","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.04","0","16800","99","TCOND","CDXC5","QDXC5","R5_1","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT",
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Non-congenital cataract","40-64 years","Female","All races","Diabetes","No","%","Crude Prevalence","0.37",,,"0.36","0.38","20800","5623300","59","TCOND","CDXC6","QDXC6","R6_2","CRDPREV","AGE4064","GF","ALLRACE","RFDM","RFNO",
"2016","2016","HI","Hawaii","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","All ages","Female","All races","Diabetes","Yes","%","Crude Prevalence","1.15",,,"0.04","5.69","0","100","15","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGEALL","GF","ALLRACE","RFDM","RFYES","POINT (-157.8577494 21.30485044)"
"2016","2016","TX","Texas","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Primary open-angle glaucoma","0-17 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","0.46","0","800","48","TCOND","CDXC5","QDXC5","R5_2","CRDPREV","AGE017","GM","ALLRACE","RFDM","RFYES","POINT (-99.42677021 31.82724041)"
"2016","2016","ID","Idaho","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Congenital glaucoma","0-17 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","0.61",,,"0.03","2.94","0","200","16","TCOND","CDXC5","QDXC5","R5_7","CRDPREV","AGE017","GF","ALLRACE","RFDM","RFYES","POINT (-114.36373 43.68263001)"
"2016","2016","MN","Minnesota","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","40-64 years","Male","All races","Hypertension","No","%","Crude Prevalence","0.35",,,"0.3","0.41","200","44000","27","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGE4064","GM","ALLRACE","RFHT","RFNO","POINT (-94.7942005 46.35564874)"
"2016","2016","TN","Tennessee","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","All Glaucoma","0-17 years","Female","All races","Hypertension","No","%","Crude Prevalence","0.19",,,"0.16","0.22","200","92200","47","TCOND","CDXC5","QDXC5","R5_ALL","CRDPREV","AGE017","GF","ALLRACE","RFHT","RFNO","POINT (-85.77449091 35.68094058)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Congenital Cataract","65-84 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0.01",,,"0","0.04","0","20100","59","TCOND","CDXC6","QDXC6","R6_3","CRDPREV","AGE6584","GALL","ALLRACE","RFDM","RFYES",
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Other/unspecified glaucoma","65-84 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0.44",,,"0.35","0.54","100","20100","59","TCOND","CDXC5","QDXC5","R5_9","CRDPREV","AGE6584","GALL","ALLRACE","RFDM","RFYES",
"2016","2016","MS","Mississippi","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Primary open-angle glaucoma","All ages","Male","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","0.03","0","10600","28","TCOND","CDXC5","QDXC5","R5_2","CRDPREV","AGEALL","GM","ALLRACE","RFDM","RFYES","POINT (-89.53803082 32.7455101)"
"2016","2016","MD","Maryland","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Glaucoma suspect","65-84 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","4.5",,,"1.36","10.61","0","100","24","TCOND","CDXC5","QDXC5","R5_4","CRDPREV","AGE6584","GF","ALLRACE","RFDM","RFYES","POINT (-76.60926011 39.29058096)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","All Cataracts","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0.13",,,"0.13","0.13","6800","5235500","59","TCOND","CDXC6","QDXC6","R6_ALL","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT",
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","All Glaucoma","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.46",,,"0.39","0.53","200","38500","99","TCOND","CDXC5","QDXC5","R5_ALL","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT",
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Other corneal disorders","65-84 years","Male","All races","Diabetes","No","%","Crude Prevalence","0.22",,,"0.19","0.26","100","67700","59","TCOND","CDXC16","QDXC16","R16_3","CRDPREV","AGE6584","GM","ALLRACE","RFDM","RFNO",
"2016","2016","IN","Indiana","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Congenital glaucoma","All ages","Female","All races","Diabetes","No","%","Crude Prevalence","0",,,"0","0","0","296500","18","TCOND","CDXC5","QDXC5","R5_7","CRDPREV","AGEALL","GF","ALLRACE","RFDM","RFNO","POINT (-86.14996019 39.76691045)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Other/unspecified glaucoma","All ages","Male","All races","Diabetes","Yes","%","Crude Prevalence","0.39",,,"0.38","0.4","3100","796400","59","TCOND","CDXC5","QDXC5","R5_9","CRDPREV","AGEALL","GM","ALLRACE","RFDM","RFYES",
"2016","2016","UT","Utah","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Congenital glaucoma","0-17 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","0.92","0","400","49","TCOND","CDXC5","QDXC5","R5_7","CRDPREV","AGE017","GALL","ALLRACE","RFDM","RFYES","POINT (-111.5871306 39.36070017)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Hereditary chorioretinal dystrophy","0-17 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","0.12",,,"0.06","0.21","0","10700","59","TCOND","CDXC4","QDXC4","R4_8","CRDPREV","AGE017","GM","ALLRACE","RFDM","RFYES",
"2016","2016","MS","Mississippi","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Glaucoma suspect","0-17 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","0.81",,,"0.01","5.12","0","100","28","TCOND","CDXC5","QDXC5","R5_4","CRDPREV","AGE017","GF","ALLRACE","RFDM","RFYES","POINT (-89.53803082 32.7455101)"
"2016","2016","TN","Tennessee","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","0-17 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","0.92","0","400","47","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGE017","GM","ALLRACE","RFHT","RFYES","POINT (-85.77449091 35.68094058)"
"2016","2016","MT","Montana","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Congenital glaucoma","All ages","Male","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","0.23","0","1600","30","TCOND","CDXC5","QDXC5","R5_7","CRDPREV","AGEALL","GM","ALLRACE","RFHT","RFYES","POINT (-109.4244206 47.06652897)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","All Cataracts","All ages","Female","All races","Diabetes","Yes","%","Crude Prevalence","12.33",,,"12.26","12.4","92500","750400","59","TCOND","CDXC6","QDXC6","R6_ALL","CRDPREV","AGEALL","GF","ALLRACE","RFDM","RFYES",
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","Strabismus","0-17 years","Male","All races","Diabetes","No","%","Crude Prevalence","1.44",,,"1.43","1.45","49300","3422000","59","TCOND","CDXC9","QDXC9","R9_1","CRDPREV","AGE017","GM","ALLRACE","RFDM","RFNO",
"2016","2016","NY","New York","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Congenital Cataract","All ages","Female","All races","Diabetes","No","%","Crude Prevalence","0.04",,,"0.04","0.04","400","999300","36","TCOND","CDXC6","QDXC6","R6_3","CRDPREV","AGEALL","GF","ALLRACE","RFDM","RFNO","POINT (-75.54397043 42.82700103)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Other corneal disorders","All ages","Male","All races","Hypertension","Yes","%","Crude Prevalence","0.62",,,"0.61","0.63","12700","2048900","59","TCOND","CDXC16","QDXC16","R16_3","CRDPREV","AGEALL","GM","ALLRACE","RFHT","RFYES",
"2016","2016","OR","Oregon","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","18-39 years","Male","All races","Hypertension","No","%","Crude Prevalence","0.01",,,"0","0.02","0","50300","41","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGE1839","GM","ALLRACE","RFHT","RFNO","POINT (-120.1550313 44.56744942)"
"2016","2016","NH","New Hampshire","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Senile cataract","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.04","0","9000","33","TCOND","CDXC6","QDXC6","R6_1","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT (-71.50036092 43.65595011)"
"2016","2016","WY","Wyoming","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","All Cataracts","18-39 years","Male","All races","Diabetes","No","%","Crude Prevalence","0.11",,,"0.04","0.24","0","5600","56","TCOND","CDXC6","QDXC6","R6_ALL","CRDPREV","AGE1839","GM","ALLRACE","RFDM","RFNO","POINT (-108.1098304 43.23554134)"
"2016","2016","MD","Maryland","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Congenital Cataract","18-39 years","Female","All races","Diabetes","No","%","Crude Prevalence","0.01",,,"0","0.02","0","56500","24","TCOND","CDXC6","QDXC6","R6_3","CRDPREV","AGE1839","GF","ALLRACE","RFDM","RFNO","POINT (-76.60926011 39.29058096)"
"2016","2016","AL","Alabama","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","All Glaucoma","0-17 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","0.7",,,"0","4.93","0","100","1","TCOND","CDXC5","QDXC5","R5_ALL","CRDPREV","AGE017","GM","ALLRACE","RFDM","RFYES","POINT (-86.63186076 32.84057112)"
"2016","2016","AK","Alaska","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","All Glaucoma","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0.39",,,"0.24","0.6","0","5400","2","TCOND","CDXC5","QDXC5","R5_ALL","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT (-147.722059 64.84507996)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Primary open-angle glaucoma","40-64 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","0","0","634400","59","TCOND","CDXC5","QDXC5","R5_2","CRDPREV","AGE4064","GF","ALLRACE","RFDM","RFYES",
"2016","2016","AZ","Arizona","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Secondary glaucoma","0-17 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","3.62","0","100","4","TCOND","CDXC5","QDXC5","R5_10","CRDPREV","AGE017","GF","ALLRACE","RFHT","RFYES","POINT (-111.7638113 34.86597028)"
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","Strabismus","0-17 years","Male","All races","Diabetes","No","%","Crude Prevalence","1.58",,,"1.38","1.8","200","14500","99","TCOND","CDXC9","QDXC9","R9_1","CRDPREV","AGE017","GM","ALLRACE","RFDM","RFNO",
"2016","2016","TX","Texas","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Congenital Cataract","All ages","Female","All races","Diabetes","No","%","Crude Prevalence","0.02",,,"0.02","0.02","200","1198800","48","TCOND","CDXC6","QDXC6","R6_3","CRDPREV","AGEALL","GF","ALLRACE","RFDM","RFNO","POINT (-99.42677021 31.82724041)"
"2016","2016","AR","Arkansas","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Non-congenital cataract","All ages","Female","All races","Diabetes","Yes","%","Crude Prevalence","0.99",,,"0.71","1.35","0","4000","5","TCOND","CDXC6","QDXC6","R6_2","CRDPREV","AGEALL","GF","ALLRACE","RFDM","RFYES","POINT (-92.27449074 34.74865012)"
"2016","2016","SD","South Dakota","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","All ages","All genders","All races","Diabetes","No","%","Crude Prevalence","0.17",,,"0.13","0.22","100","32900","46","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGEALL","GALL","ALLRACE","RFDM","RFNO","POINT (-100.3735306 44.35313005)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","All Glaucoma","18-39 years","Male","All races","Diabetes","No","%","Crude Prevalence","0.45",,,"0.44","0.46","21400","4765700","59","TCOND","CDXC5","QDXC5","R5_ALL","CRDPREV","AGE1839","GM","ALLRACE","RFDM","RFNO",
"2016","2016","LA","Louisiana","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","40-64 years","Male","All races","Hypertension","No","%","Crude Prevalence","0.38",,,"0.35","0.41","600","159500","22","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGE4064","GM","ALLRACE","RFHT","RFNO","POINT (-92.44568007 31.31266064)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Secondary glaucoma","65-84 years","Female","All races","Hypertension","No","%","Crude Prevalence","0.03",,,"0.02","0.05","0","70300","59","TCOND","CDXC5","QDXC5","R5_10","CRDPREV","AGE6584","GF","ALLRACE","RFHT","RFNO",
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Open-angle glaucoma","0-17 years","Female","All races","Hypertension","No","%","Crude Prevalence","0.01",,,"0","0.04","0","16800","99","TCOND","CDXC5","QDXC5","R5_1","CRDPREV","AGE017","GF","ALLRACE","RFHT","RFNO",
"2016","2016","TN","Tennessee","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Congenital glaucoma","0-17 years","Male","All races","Hypertension","No","%","Crude Prevalence","0.02",,,"0.01","0.03","0","97000","47","TCOND","CDXC5","QDXC5","R5_7","CRDPREV","AGE017","GM","ALLRACE","RFHT","RFNO","POINT (-85.77449091 35.68094058)"
"2016","2016","RI","Rhode Island","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","All ages","Male","All races","All patients","Total","%","Crude Prevalence","0.15",,,"0.11","0.2","0","30000","44","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGEALL","GM","ALLRACE","RFALL","RFTOT","POINT (-71.52247031 41.70828019)"
"2016","2016","FL","Florida","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Congenital Cataract","18-39 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","0.01",,,"0","0.04","0","17400","12","TCOND","CDXC6","QDXC6","R6_3","CRDPREV","AGE1839","GF","ALLRACE","RFHT","RFYES","POINT (-81.92896054 28.93204038)"
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Senile cataract","40-64 years","All genders","All races","Diabetes","No","%","Crude Prevalence","3.55",,,"3.37","3.74","1400","38700","99","TCOND","CDXC6","QDXC6","R6_1","CRDPREV","AGE4064","GALL","ALLRACE","RFDM","RFNO",
"2016","2016","TN","Tennessee","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Open-angle glaucoma","65-84 years","Female","All races","Diabetes","No","%","Crude Prevalence","0.84",,,"0.54","1.24","0","2900","47","TCOND","CDXC5","QDXC5","R5_1","CRDPREV","AGE6584","GF","ALLRACE","RFDM","RFNO","POINT (-85.77449091 35.68094058)"
"2016","2016","XX","Missing Location","MSCANCC","Service Utilization","Vision Correction","Percentage of people who had a vision correction visit or supplies claim","Eyeglasses","All ages","Male","All races","Diabetes","Yes","%","Crude Prevalence","0.23",,,"0.08","0.54","0","2200","99","TUTL","CVC","QVC","RGLASS","CRDPREV","AGEALL","GM","ALLRACE","RFDM","RFYES",
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Geographic atrophy","All ages","Male","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","0","0","796400","59","TCOND","CDXC3","QDXC3","R3_3GA","CRDPREV","AGEALL","GM","ALLRACE","RFDM","RFYES",
"2016","2016","VA","Virginia","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Low-tension glaucoma","40-64 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","0.08",,,"0.04","0.15","0","12100","51","TCOND","CDXC5","QDXC5","R5_3","CRDPREV","AGE4064","GF","ALLRACE","RFDM","RFYES","POINT (-78.45789046 37.54268067)"
"2016","2016","MN","Minnesota","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","0.02",,,"0.01","0.04","0","40800","27","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT (-94.7942005 46.35564874)"
"2016","2016","IA","Iowa","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","All Glaucoma","18-39 years","Male","All races","Diabetes","No","%","Crude Prevalence","0.33",,,"0.28","0.39","100","40100","19","TCOND","CDXC5","QDXC5","R5_ALL","CRDPREV","AGE1839","GM","ALLRACE","RFDM","RFNO","POINT (-93.81649056 42.46940091)"
"2016","2016","TX","Texas","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Primary open-angle glaucoma","40-64 years","Male","All races","Diabetes","No","%","Crude Prevalence","0",,,"0","0","0","366700","48","TCOND","CDXC5","QDXC5","R5_2","CRDPREV","AGE4064","GM","ALLRACE","RFDM","RFNO","POINT (-99.42677021 31.82724041)"
"2016","2016","PA","Pennsylvania","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Congenital glaucoma","All ages","Female","All races","Diabetes","No","%","Crude Prevalence","0.01",,,"0.01","0.01","0","409200","42","TCOND","CDXC5","QDXC5","R5_7","CRDPREV","AGEALL","GF","ALLRACE","RFDM","RFNO","POINT (-77.86070029 40.79373015)"
"2016","2016","IA","Iowa","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","65-84 years","All genders","All races","Diabetes","No","%","Crude Prevalence","0.67",,,"0.21","1.6","0","700","19","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGE6584","GALL","ALLRACE","RFDM","RFNO","POINT (-93.81649056 42.46940091)"
"2016","2016","AK","Alaska","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","All Glaucoma","18-39 years","All genders","All races","Hypertension","No","%","Crude Prevalence","0.32",,,"0.22","0.45","0","10600","2","TCOND","CDXC5","QDXC5","R5_ALL","CRDPREV","AGE1839","GALL","ALLRACE","RFHT","RFNO","POINT (-147.722059 64.84507996)"
"2016","2016","ME","Maine","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Low-tension glaucoma","18-39 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","1.22","0","300","23","TCOND","CDXC5","QDXC5","R5_3","CRDPREV","AGE1839","GF","ALLRACE","RFHT","RFYES","POINT (-68.98503134 45.25422889)"
"2016","2016","ME","Maine","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Low-tension glaucoma","All ages","All genders","All races","Diabetes","No","%","Crude Prevalence","0.04",,,"0.03","0.06","0","58300","23","TCOND","CDXC5","QDXC5","R5_3","CRDPREV","AGEALL","GALL","ALLRACE","RFDM","RFNO","POINT (-68.98503134 45.25422889)"
"2016","2016","TX","Texas","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","0-17 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","0.33","0","1100","48","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGE017","GM","ALLRACE","RFHT","RFYES","POINT (-99.42677021 31.82724041)"
"2016","2016","VA","Virginia","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Open-angle glaucoma","18-39 years","Female","All races","Diabetes","No","%","Crude Prevalence","0.04",,,"0.03","0.05","0","105400","51","TCOND","CDXC5","QDXC5","R5_1","CRDPREV","AGE1839","GF","ALLRACE","RFDM","RFNO","POINT (-78.45789046 37.54268067)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","All Glaucoma","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","3.47",,,"3.35","3.59","3200","91000","59","TCOND","CDXC5","QDXC5","R5_ALL","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT",
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Low-tension glaucoma","18-39 years","Male","All races","Diabetes","No","%","Crude Prevalence","0",,,"0","0","0","4765700","59","TCOND","CDXC5","QDXC5","R5_3","CRDPREV","AGE1839","GM","ALLRACE","RFDM","RFNO",
"2016","2016","CA","California","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Primary open-angle glaucoma","18-39 years","Male","All races","Diabetes","No","%","Crude Prevalence","0",,,"0","0","0","339600","6","TCOND","CDXC5","QDXC5","R5_2","CRDPREV","AGE1839","GM","ALLRACE","RFDM","RFNO","POINT (-120.9999995 37.63864012)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Other diabetes related eye disorders","40-64 years","Female","All races","Diabetes","No","%","Crude Prevalence","0",,,"0","0","0","5623300","59","TCOND","CDXC2","QDXC2","R2_5","CRDPREV","AGE4064","GF","ALLRACE","RFDM","RFNO",
"2016","2016","US","National","MSCANCC","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Laser surgery","18-39 years","Female","All races","Diabetes","No","%","Crude Prevalence","0.01",,,"0.01","0.01","300","5139300","59","TUTL","CGLAUTX","QGLAU","RLASER","CRDPREV","AGE1839","GF","ALLRACE","RFDM","RFNO",
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Congenital Cataract","All ages","Male","All races","All patients","Total","%","Crude Prevalence","0.02",,,"0.02","0.02","2800","13843600","59","TCOND","CDXC6","QDXC6","R6_3","CRDPREV","AGEALL","GM","ALLRACE","RFALL","RFTOT",
"2016","2016","CT","Connecticut","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","All Cataracts","All ages","Male","All races","Diabetes","No","%","Crude Prevalence","1.66",,,"1.6","1.73","2400","146400","9","TCOND","CDXC6","QDXC6","R6_ALL","CRDPREV","AGEALL","GM","ALLRACE","RFDM","RFNO","POINT (-72.64984095 41.56266102)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Posterior capsular opacity","65-84 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","0.66",,,"0.51","0.83","100","10500","59","TCOND","CDXC6","QDXC6","R6_4","CRDPREV","AGE6584","GM","ALLRACE","RFDM","RFYES",
"2016","2016","WI","Wisconsin","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Senile cataract","0-17 years","Female","All races","Diabetes","No","%","Crude Prevalence","0.01",,,"0","0.02","0","74500","55","TCOND","CDXC6","QDXC6","R6_1","CRDPREV","AGE017","GF","ALLRACE","RFDM","RFNO","POINT (-89.81637074 44.39319117)"
"2016","2016","UT","Utah","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Glaucoma suspect","0-17 years","Male","All races","Diabetes","No","%","Crude Prevalence","0.04",,,"0.02","0.06","0","52800","49","TCOND","CDXC5","QDXC5","R5_4","CRDPREV","AGE017","GM","ALLRACE","RFDM","RFNO","POINT (-111.5871306 39.36070017)"
"2016","2016","NJ","New Jersey","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","All Glaucoma","18-39 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","2.15",,,"1.63","2.78","100","2600","34","TCOND","CDXC5","QDXC5","R5_ALL","CRDPREV","AGE1839","GM","ALLRACE","RFDM","RFYES","POINT (-74.27369129 40.13057005)"
"2016","2016","WY","Wyoming","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Congenital Cataract","65-84 years","Male","All races","Hypertension","No","%","Crude Prevalence","0",,,"0","3.62","0","100","56","TCOND","CDXC6","QDXC6","R6_3","CRDPREV","AGE6584","GM","ALLRACE","RFHT","RFNO","POINT (-108.1098304 43.23554134)"
"2016","2016","US","National","MSCANCC","Service Utilization","Cataract Surgery","Percentage of people with diagnosed cataract who had a treatment claim","Cataract surgery","65-84 years","Male","All races","Cataract","Yes","%","Crude Prevalence","10.75",,,"9.81","11.75","400","4100","59","TUTL","CCATS","QCATS","RCATSUR","CRDPREV","AGE6584","GM","ALLRACE","RFCAT","RFYES",
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Central retinal vein occlusion","0-17 years","All genders","All races","Diabetes","No","%","Crude Prevalence","0",,,"0","0","0","6701600","59","TCOND","CDXC4","QDXC4","R4_2","CRDPREV","AGE017","GALL","ALLRACE","RFDM","RFNO",
"2016","2016","ME","Maine","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Secondary glaucoma","65-84 years","Male","All races","Diabetes","No","%","Crude Prevalence","0",,,"0","1.83","0","200","23","TCOND","CDXC5","QDXC5","R5_10","CRDPREV","AGE6584","GM","ALLRACE","RFDM","RFNO","POINT (-68.98503134 45.25422889)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Open-angle glaucoma","All ages","Female","All races","Hypertension","No","%","Crude Prevalence","0.22",,,"0.22","0.22","28400","12903100","59","TCOND","CDXC5","QDXC5","R5_1","CRDPREV","AGEALL","GF","ALLRACE","RFHT","RFNO",
"2016","2016","ME","Maine","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Low-tension glaucoma","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.05","0","10400","23","TCOND","CDXC5","QDXC5","R5_3","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT (-68.98503134 45.25422889)"
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Secondary glaucoma","All ages","Male","All races","Diabetes","Yes","%","Crude Prevalence","0.19",,,"0.05","0.48","0","2200","99","TCOND","CDXC5","QDXC5","R5_10","CRDPREV","AGEALL","GM","ALLRACE","RFDM","RFYES",
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Open-angle glaucoma","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.05",,,"0.05","0.05","5000","10084000","59","TCOND","CDXC5","QDXC5","R5_1","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT",
"2016","2016","WA","Washington","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Secondary glaucoma","18-39 years","Male","All races","Hypertension","No","%","Crude Prevalence","0.01",,,"0","0.02","0","92000","53","TCOND","CDXC5","QDXC5","R5_10","CRDPREV","AGE1839","GM","ALLRACE","RFHT","RFNO","POINT (-120.4700108 47.52227863)"
"2016","2016","NV","Nevada","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Senile cataract","65-84 years","Female","All races","Diabetes","No","%","Crude Prevalence","4",,,"2.46","6.11","0","500","32","TCOND","CDXC6","QDXC6","R6_1","CRDPREV","AGE6584","GF","ALLRACE","RFDM","RFNO","POINT (-117.0718406 39.49324039)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Senile cataract","40-64 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","10.44",,,"10.37","10.51","72300","692400","59","TCOND","CDXC6","QDXC6","R6_1","CRDPREV","AGE4064","GM","ALLRACE","RFDM","RFYES",
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","All Glaucoma","65-84 years","Male","All races","Diabetes","No","%","Crude Prevalence","1.94",,,"0.52","4.96","0","200","99","TCOND","CDXC5","QDXC5","R5_ALL","CRDPREV","AGE6584","GM","ALLRACE","RFDM","RFNO",
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Glaucoma suspect","All ages","Male","All races","Diabetes","No","%","Crude Prevalence","0.85",,,"0.85","0.85","110900","13047200","59","TCOND","CDXC5","QDXC5","R5_4","CRDPREV","AGEALL","GM","ALLRACE","RFDM","RFNO",
"2016","2016","AR","Arkansas","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Low-tension glaucoma","All ages","All genders","All races","Diabetes","No","%","Crude Prevalence","0.04",,,"0.03","0.05","100","155800","5","TCOND","CDXC5","QDXC5","R5_3","CRDPREV","AGEALL","GALL","ALLRACE","RFDM","RFNO","POINT (-92.27449074 34.74865012)"
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0.21",,,"0.18","0.24","200","112800","99","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT",
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Congenital glaucoma","65-84 years","Male","All races","Diabetes","No","%","Crude Prevalence","0",,,"0","0.01","0","67700","59","TCOND","CDXC5","QDXC5","R5_7","CRDPREV","AGE6584","GM","ALLRACE","RFDM","RFNO",
"2016","2016","OH","Ohio","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","18-39 years","Male","All races","Diabetes","No","%","Crude Prevalence","0.02",,,"0.01","0.03","0","205600","39","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGE1839","GM","ALLRACE","RFDM","RFNO","POINT (-82.40426006 40.06021014)"
"2016","2016","FL","Florida","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Low-tension glaucoma","0-17 years","Female","All races","Hypertension","No","%","Crude Prevalence","0",,,"0","0","0","196200","12","TCOND","CDXC5","QDXC5","R5_3","CRDPREV","AGE017","GF","ALLRACE","RFHT","RFNO","POINT (-81.92896054 28.93204038)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","Amblyopia","40-64 years","All genders","All races","Hypertension","Yes","%","Crude Prevalence","0.14",,,"0.14","0.14","4900","3487300","59","TCOND","CDXC9","QDXC9","R9_2","CRDPREV","AGE4064","GALL","ALLRACE","RFHT","RFYES",
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Low-tension glaucoma","18-39 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","0.74","0","500","99","TCOND","CDXC5","QDXC5","R5_3","CRDPREV","AGE1839","GM","ALLRACE","RFHT","RFYES",
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","All Cataracts","40-64 years","Female","All races","Diabetes","No","%","Crude Prevalence","4.75",,,"4.73","4.77","267100","5623300","59","TCOND","CDXC6","QDXC6","R6_ALL","CRDPREV","AGE4064","GF","ALLRACE","RFDM","RFNO",
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Low-tension glaucoma","65-84 years","Female","All races","Hypertension","No","%","Crude Prevalence","0.1",,,"0.08","0.13","100","70300","59","TCOND","CDXC5","QDXC5","R5_3","CRDPREV","AGE6584","GF","ALLRACE","RFHT","RFNO",
"2016","2016","CA","California","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Congenital Cataract","0-17 years","Male","All races","Hypertension","No","%","Crude Prevalence","0.02",,,"0.01","0.03","0","230600","6","TCOND","CDXC6","QDXC6","R6_3","CRDPREV","AGE017","GM","ALLRACE","RFHT","RFNO","POINT (-120.9999995 37.63864012)"
"2016","2016","AK","Alaska","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Low-tension glaucoma","40-64 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","0.41","0","900","2","TCOND","CDXC5","QDXC5","R5_3","CRDPREV","AGE4064","GF","ALLRACE","RFHT","RFYES","POINT (-147.722059 64.84507996)"
"2016","2016","IN","Indiana","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Congenital glaucoma","0-17 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","1.22","0","300","18","TCOND","CDXC5","QDXC5","R5_7","CRDPREV","AGE017","GF","ALLRACE","RFDM","RFYES","POINT (-86.14996019 39.76691045)"
"2016","2016","AZ","Arizona","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Congenital Cataract","All ages","Male","All races","Hypertension","Yes","%","Crude Prevalence","0.02",,,"0.01","0.04","0","30400","4","TCOND","CDXC6","QDXC6","R6_3","CRDPREV","AGEALL","GM","ALLRACE","RFHT","RFYES","POINT (-111.7638113 34.86597028)"
"2016","2016","SD","South Dakota","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","All Cataracts","0-17 years","Male","All races","Diabetes","No","%","Crude Prevalence","0.02",,,"0","0.11","0","4900","46","TCOND","CDXC6","QDXC6","R6_ALL","CRDPREV","AGE017","GM","ALLRACE","RFDM","RFNO","POINT (-100.3735306 44.35313005)"
"2016","2016","NV","Nevada","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Secondary glaucoma","0-17 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","3.62","0","100","32","TCOND","CDXC5","QDXC5","R5_10","CRDPREV","AGE017","GM","ALLRACE","RFDM","RFYES","POINT (-117.0718406 39.49324039)"
"2016","2016","ND","North Dakota","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Secondary glaucoma","0-17 years","Male","All races","Hypertension","No","%","Crude Prevalence","0",,,"0","0.14","0","2700","38","TCOND","CDXC5","QDXC5","R5_10","CRDPREV","AGE017","GM","ALLRACE","RFHT","RFNO","POINT (-100.118421 47.47531978)"
"2016","2016","NM","New Mexico","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Secondary glaucoma","18-39 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","1.83","0","200","35","TCOND","CDXC5","QDXC5","R5_10","CRDPREV","AGE1839","GM","ALLRACE","RFDM","RFYES","POINT (-106.240581 34.52088095)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Secondary glaucoma","65-84 years","All genders","All races","Hypertension","Yes","%","Crude Prevalence","0.1",,,"0.07","0.14","0","41700","59","TCOND","CDXC5","QDXC5","R5_10","CRDPREV","AGE6584","GALL","ALLRACE","RFHT","RFYES",
"2016","2016","AZ","Arizona","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Secondary glaucoma","0-17 years","Male","All races","Diabetes","No","%","Crude Prevalence","0.01",,,"0","0.02","0","71400","4","TCOND","CDXC5","QDXC5","R5_10","CRDPREV","AGE017","GM","ALLRACE","RFDM","RFNO","POINT (-111.7638113 34.86597028)"
"2016","2016","CO","Colorado","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","65-84 years","Male","All races","Hypertension","No","%","Crude Prevalence","0.76",,,"0.28","1.64","0","800","8","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGE6584","GM","ALLRACE","RFHT","RFNO","POINT (-106.1336109 38.84384076)"
"2016","2016","KY","Kentucky","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","40-64 years","All genders","All races","Diabetes","No","%","Crude Prevalence","0.77",,,"0.73","0.81","1800","230200","21","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGE4064","GALL","ALLRACE","RFDM","RFNO","POINT (-84.77497105 37.64597027)"
"2016","2016","MD","Maryland","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Congenital glaucoma","All ages","Female","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","0.02","0","20800","24","TCOND","CDXC5","QDXC5","R5_7","CRDPREV","AGEALL","GF","ALLRACE","RFHT","RFYES","POINT (-76.60926011 39.29058096)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Non-congenital cataract","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.02",,,"0.02","0.02","2000","10084000","59","TCOND","CDXC6","QDXC6","R6_2","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT",
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Primary open-angle glaucoma","65-84 years","Male","All races","Diabetes","No","%","Crude Prevalence","0",,,"0","1.83","0","200","99","TCOND","CDXC5","QDXC5","R5_2","CRDPREV","AGE6584","GM","ALLRACE","RFDM","RFNO",
"2016","2016","NE","Nebraska","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Low-tension glaucoma","18-39 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","0.53","0","700","31","TCOND","CDXC5","QDXC5","R5_3","CRDPREV","AGE1839","GM","ALLRACE","RFHT","RFYES","POINT (-99.36572062 41.64104099)"
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","All Glaucoma","18-39 years","All genders","All races","Diabetes","No","%","Crude Prevalence","0.45",,,"0.39","0.52","200","38100","99","TCOND","CDXC5","QDXC5","R5_ALL","CRDPREV","AGE1839","GALL","ALLRACE","RFDM","RFNO",
"2016","2016","MS","Mississippi","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Low-tension glaucoma","65-84 years","All genders","All races","Diabetes","No","%","Crude Prevalence","0",,,"0","0.19","0","1900","28","TCOND","CDXC5","QDXC5","R5_3","CRDPREV","AGE6584","GALL","ALLRACE","RFDM","RFNO","POINT (-89.53803082 32.7455101)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Congenital glaucoma","All ages","Female","All races","Hypertension","No","%","Crude Prevalence","0.01",,,"0.01","0.01","1300","12903100","59","TCOND","CDXC5","QDXC5","R5_7","CRDPREV","AGEALL","GF","ALLRACE","RFHT","RFNO",
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Keratoconus","65-84 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","0.08",,,"0.04","0.16","0","10500","59","TCOND","CDXC16","QDXC16","R16_1","CRDPREV","AGE6584","GM","ALLRACE","RFDM","RFYES",
"2016","2016","US","National","MSCANCC","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Retinal detachment repair","18-39 years","Male","All races","Diabetes","No","%","Crude Prevalence","0.02",,,"0.02","0.02","800","4765700","59","TUTL","CDRTX","QDRTX","RDRRET","CRDPREV","AGE1839","GM","ALLRACE","RFDM","RFNO",
"2016","2016","TN","Tennessee","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Primary open-angle glaucoma","65-84 years","Male","All races","Diabetes","No","%","Crude Prevalence","0",,,"0","0.17","0","2200","47","TCOND","CDXC5","QDXC5","R5_2","CRDPREV","AGE6584","GM","ALLRACE","RFDM","RFNO","POINT (-85.77449091 35.68094058)"
"2016","2016","KS","Kansas","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","All ages","Female","All races","Diabetes","Yes","%","Crude Prevalence","1.92",,,"1.54","2.36","100","4500","20","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGEALL","GF","ALLRACE","RFDM","RFYES","POINT (-98.20078123 38.3477403)"
"2016","2016","ME","Maine","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Secondary glaucoma","18-39 years","Male","All races","Hypertension","No","%","Crude Prevalence","0.02",,,"0","0.07","0","10000","23","TCOND","CDXC5","QDXC5","R5_10","CRDPREV","AGE1839","GM","ALLRACE","RFHT","RFNO","POINT (-68.98503134 45.25422889)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","Strabismus","18-39 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0.33",,,"0.3","0.36","600","178900","59","TCOND","CDXC9","QDXC9","R9_1","CRDPREV","AGE1839","GALL","ALLRACE","RFDM","RFYES",
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Glaucoma suspect","0-17 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","0.91",,,"0.74","1.11","100","10300","59","TCOND","CDXC5","QDXC5","R5_4","CRDPREV","AGE017","GF","ALLRACE","RFDM","RFYES",
"2016","2016","KS","Kansas","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Glaucoma suspect","0-17 years","Male","All races","Diabetes","No","%","Crude Prevalence","0.05",,,"0.03","0.08","0","29600","20","TCOND","CDXC5","QDXC5","R5_4","CRDPREV","AGE017","GM","ALLRACE","RFDM","RFNO","POINT (-98.20078123 38.3477403)"
"2016","2016","WA","Washington","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Low-tension glaucoma","18-39 years","Female","All races","Diabetes","No","%","Crude Prevalence","0",,,"0","0","0","99900","53","TCOND","CDXC5","QDXC5","R5_3","CRDPREV","AGE1839","GF","ALLRACE","RFDM","RFNO","POINT (-120.4700108 47.52227863)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Glaucoma suspect","40-64 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","5.39",,,"5.33","5.45","34200","634400","59","TCOND","CDXC5","QDXC5","R5_4","CRDPREV","AGE4064","GF","ALLRACE","RFDM","RFYES",
"2016","2016","OK","Oklahoma","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Congenital glaucoma","18-39 years","Male","All races","Diabetes","No","%","Crude Prevalence","0",,,"0","0.01","0","61700","40","TCOND","CDXC5","QDXC5","R5_7","CRDPREV","AGE1839","GM","ALLRACE","RFDM","RFNO","POINT (-97.52107021 35.47203136)"
"2016","2016","VT","Vermont","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","All Glaucoma","18-39 years","All genders","All races","Hypertension","No","%","Crude Prevalence","0.4",,,"0.25","0.61","0","5300","50","TCOND","CDXC5","QDXC5","R5_ALL","CRDPREV","AGE1839","GALL","ALLRACE","RFHT","RFNO","POINT (-72.51764079 43.62538124)"
"2016","2016","MA","Massachusetts","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Congenital glaucoma","0-17 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","1.83","0","200","25","TCOND","CDXC5","QDXC5","R5_7","CRDPREV","AGE017","GF","ALLRACE","RFDM","RFYES","POINT (-72.08269067 42.27687047)"
"2016","2016","WI","Wisconsin","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Low-tension glaucoma","0-17 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","1.22","0","300","55","TCOND","CDXC5","QDXC5","R5_3","CRDPREV","AGE017","GM","ALLRACE","RFDM","RFYES","POINT (-89.81637074 44.39319117)"
"2016","2016","NY","New York","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Congenital glaucoma","All ages","Male","All races","Diabetes","Yes","%","Crude Prevalence","0.01",,,"0","0.02","0","75600","36","TCOND","CDXC5","QDXC5","R5_7","CRDPREV","AGEALL","GM","ALLRACE","RFDM","RFYES","POINT (-75.54397043 42.82700103)"
"2016","2016","ID","Idaho","MSCANCC","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Keratoconus","0-17 years","Male","All races","Diabetes","No","%","Crude Prevalence","0.01",,,"0","0.02","0","56500","16","TCOND","CDXC16","QDXC16","R16_1","CRDPREV","AGE017","GM","ALLRACE","RFDM","RFNO","POINT (-114.36373 43.68263001)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Primary open-angle glaucoma","0-17 years","All genders","All races","Diabetes","No","%","Crude Prevalence","0",,,"0","0","0","6701600","59","TCOND","CDXC5","QDXC5","R5_2","CRDPREV","AGE017","GALL","ALLRACE","RFDM","RFNO",
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","All Glaucoma","65-84 years","Male","All races","Diabetes","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"99","TCOND","CDXC5","QDXC5","R5_ALL","CRDPREV","AGE6584","GM","ALLRACE","RFDM","RFYES",
"2016","2016","IL","Illinois","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Secondary glaucoma","18-39 years","Male","All races","Diabetes","No","%","Crude Prevalence","0.01",,,"0.01","0.02","0","148800","17","TCOND","CDXC5","QDXC5","R5_10","CRDPREV","AGE1839","GM","ALLRACE","RFDM","RFNO","POINT (-88.99771018 40.48501028)"
"2016","2016","MT","Montana","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Low-tension glaucoma","40-64 years","Male","All races","Hypertension","No","%","Crude Prevalence","0.09",,,"0.02","0.23","0","4500","30","TCOND","CDXC5","QDXC5","R5_3","CRDPREV","AGE4064","GM","ALLRACE","RFHT","RFNO","POINT (-109.4244206 47.06652897)"
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","Amblyopia","All ages","Male","All races","Hypertension","Yes","%","Crude Prevalence","0.15",,,"0.07","0.28","0","6000","99","TCOND","CDXC9","QDXC9","R9_2","CRDPREV","AGEALL","GM","ALLRACE","RFHT","RFYES",
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Other/unspecified glaucoma","40-64 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","0.32",,,"0.31","0.33","5700","1767400","59","TCOND","CDXC5","QDXC5","R5_9","CRDPREV","AGE4064","GM","ALLRACE","RFHT","RFYES",
"2016","2016","MI","Michigan","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Senile cataract","18-39 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","0.98",,,"0.66","1.39","0","3100","26","TCOND","CDXC6","QDXC6","R6_1","CRDPREV","AGE1839","GF","ALLRACE","RFDM","RFYES","POINT (-84.71439027 44.66131954)"
"2016","2016","ID","Idaho","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Secondary glaucoma","65-84 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","1.83","0","200","16","TCOND","CDXC5","QDXC5","R5_10","CRDPREV","AGE6584","GF","ALLRACE","RFHT","RFYES","POINT (-114.36373 43.68263001)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Aphakia and disorders of lens","All ages","Female","All races","Diabetes","No","%","Crude Prevalence","0.02",,,"0.02","0.02","2800","14123700","59","TCOND","CDXC6","QDXC6","R6_6","CRDPREV","AGEALL","GF","ALLRACE","RFDM","RFNO",
"2016","2016","AZ","Arizona","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Glaucoma suspect","18-39 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","1.08",,,"0.63","1.72","0","1600","4","TCOND","CDXC5","QDXC5","R5_4","CRDPREV","AGE1839","GM","ALLRACE","RFDM","RFYES","POINT (-111.7638113 34.86597028)"
"2016","2016","VA","Virginia","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","All ages","All genders","All races","Diabetes","No","%","Crude Prevalence","0.16",,,"0.15","0.17","900","550600","51","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGEALL","GALL","ALLRACE","RFDM","RFNO","POINT (-78.45789046 37.54268067)"
"2016","2016","XX","Missing Location","MSCANCC","Service Utilization","Vision Correction","Percentage of people who had a vision correction visit or supplies claim","Eyeglasses","40-64 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0.22",,,"0.09","0.42","0","3700","99","TUTL","CVC","QVC","RGLASS","CRDPREV","AGE4064","GALL","ALLRACE","RFDM","RFYES",
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Senile cataract","0-17 years","All genders","All races","Hypertension","No","%","Crude Prevalence","0.01",,,"0","0.03","0","31200","99","TCOND","CDXC6","QDXC6","R6_1","CRDPREV","AGE017","GALL","ALLRACE","RFHT","RFNO",
"2016","2016","ND","North Dakota","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","18-39 years","Male","All races","Hypertension","No","%","Crude Prevalence","0.02",,,"0","0.13","0","4100","38","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGE1839","GM","ALLRACE","RFHT","RFNO","POINT (-100.118421 47.47531978)"
"2016","2016","MD","Maryland","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Glaucoma suspect","All ages","Female","All races","Hypertension","No","%","Crude Prevalence","1.22",,,"1.16","1.28","1700","141100","24","TCOND","CDXC5","QDXC5","R5_4","CRDPREV","AGEALL","GF","ALLRACE","RFHT","RFNO","POINT (-76.60926011 39.29058096)"
"2016","2016","IA","Iowa","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","All Glaucoma","0-17 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","3.62","0","100","19","TCOND","CDXC5","QDXC5","R5_ALL","CRDPREV","AGE017","GM","ALLRACE","RFDM","RFYES","POINT (-93.81649056 42.46940091)"
"2016","2016","UT","Utah","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Senile cataract","0-17 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","3.62","0","100","49","TCOND","CDXC6","QDXC6","R6_1","CRDPREV","AGE017","GF","ALLRACE","RFHT","RFYES","POINT (-111.5871306 39.36070017)"
"2016","2016","WY","Wyoming","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Secondary glaucoma","18-39 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","3.62","0","100","56","TCOND","CDXC5","QDXC5","R5_10","CRDPREV","AGE1839","GM","ALLRACE","RFDM","RFYES","POINT (-108.1098304 43.23554134)"
"2016","2016","IN","Indiana","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Secondary glaucoma","40-64 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","0.06",,,"0.04","0.09","0","40400","18","TCOND","CDXC5","QDXC5","R5_10","CRDPREV","AGE4064","GM","ALLRACE","RFHT","RFYES","POINT (-86.14996019 39.76691045)"
"2016","2016","UT","Utah","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","All Glaucoma","0-17 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","3.62","0","100","49","TCOND","CDXC5","QDXC5","R5_ALL","CRDPREV","AGE017","GM","ALLRACE","RFHT","RFYES","POINT (-111.5871306 39.36070017)"
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Primary open-angle glaucoma","All ages","Female","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","0.06","0","5700","99","TCOND","CDXC5","QDXC5","R5_2","CRDPREV","AGEALL","GF","ALLRACE","RFHT","RFYES",
"2016","2016","KS","Kansas","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","All ages","Female","All races","Diabetes","No","%","Crude Prevalence","0.23",,,"0.2","0.26","200","107300","20","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGEALL","GF","ALLRACE","RFDM","RFNO","POINT (-98.20078123 38.3477403)"
"2016","2016","NE","Nebraska","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Non-congenital cataract","0-17 years","Female","All races","Diabetes","No","%","Crude Prevalence","0.01",,,"0","0.05","0","13600","31","TCOND","CDXC6","QDXC6","R6_2","CRDPREV","AGE017","GF","ALLRACE","RFDM","RFNO","POINT (-99.36572062 41.64104099)"
"2016","2016","ME","Maine","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","18-39 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","1.22","0","300","23","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGE1839","GF","ALLRACE","RFHT","RFYES","POINT (-68.98503134 45.25422889)"
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Aphakia and disorders of lens","18-39 years","All genders","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","0.37","0","1000","99","TCOND","CDXC6","QDXC6","R6_6","CRDPREV","AGE1839","GALL","ALLRACE","RFHT","RFYES",
"2016","2016","AR","Arkansas","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","65-84 years","Female","All races","Diabetes","No","%","Crude Prevalence","0.81",,,"0.18","2.26","0","400","5","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGE6584","GF","ALLRACE","RFDM","RFNO","POINT (-92.27449074 34.74865012)"
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Secondary glaucoma","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","1.83","0","200","99","TCOND","CDXC5","QDXC5","R5_10","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT",
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Retinopathy of prematurity","40-64 years","Female","All races","Hypertension","No","%","Crude Prevalence","0",,,"0","0","0","4537800","59","TCOND","CDXC4","QDXC4","R4_11","CRDPREV","AGE4064","GF","ALLRACE","RFHT","RFNO",
"2016","2016","ND","North Dakota","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Glaucoma suspect","0-17 years","Female","All races","Diabetes","No","%","Crude Prevalence","0.16",,,"0.05","0.4","0","2600","38","TCOND","CDXC5","QDXC5","R5_4","CRDPREV","AGE017","GF","ALLRACE","RFDM","RFNO","POINT (-100.118421 47.47531978)"
"2016","2016","ME","Maine","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Congenital glaucoma","18-39 years","Female","All races","Hypertension","No","%","Crude Prevalence","0",,,"0","0.04","0","9300","23","TCOND","CDXC5","QDXC5","R5_7","CRDPREV","AGE1839","GF","ALLRACE","RFHT","RFNO","POINT (-68.98503134 45.25422889)"
"2016","2016","SD","South Dakota","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","All ages","Male","All races","Diabetes","No","%","Crude Prevalence","0.16",,,"0.1","0.23","0","16100","46","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGEALL","GM","ALLRACE","RFDM","RFNO","POINT (-100.3735306 44.35313005)"
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Secondary glaucoma","0-17 years","All genders","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.01","0","31300","99","TCOND","CDXC5","QDXC5","R5_10","CRDPREV","AGE017","GALL","ALLRACE","RFALL","RFTOT",
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Posterior capsular opacity","0-17 years","Female","All races","Hypertension","No","%","Crude Prevalence","0",,,"0","0","0","3282800","59","TCOND","CDXC6","QDXC6","R6_4","CRDPREV","AGE017","GF","ALLRACE","RFHT","RFNO",
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Proliferative diabetic retinopathy","18-39 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","0.94",,,"0.88","1","900","96100","59","TCOND","CDXC2","QDXC2","R2_3","CRDPREV","AGE1839","GF","ALLRACE","RFDM","RFYES",
"2016","2016","OH","Ohio","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","0-17 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0.27",,,"0.06","0.79","0","1100","39","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGE017","GALL","ALLRACE","RFDM","RFYES","POINT (-82.40426006 40.06021014)"
"2016","2016","MS","Mississippi","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Glaucoma suspect","All ages","Male","All races","Hypertension","No","%","Crude Prevalence","0.36",,,"0.33","0.39","500","129900","28","TCOND","CDXC5","QDXC5","R5_4","CRDPREV","AGEALL","GM","ALLRACE","RFHT","RFNO","POINT (-89.53803082 32.7455101)"
"2016","2016","MD","Maryland","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","18-39 years","Female","All races","Hypertension","No","%","Crude Prevalence","0.02",,,"0.01","0.04","0","55200","24","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGE1839","GF","ALLRACE","RFHT","RFNO","POINT (-76.60926011 39.29058096)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Non-congenital cataract","65-84 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","1.09",,,"0.95","1.24","200","20100","59","TCOND","CDXC6","QDXC6","R6_2","CRDPREV","AGE6584","GALL","ALLRACE","RFDM","RFYES",
"2016","2016","FL","Florida","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Low-tension glaucoma","18-39 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","0.06","0","6200","12","TCOND","CDXC5","QDXC5","R5_3","CRDPREV","AGE1839","GM","ALLRACE","RFDM","RFYES","POINT (-81.92896054 28.93204038)"
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Secondary glaucoma","18-39 years","Female","All races","Diabetes","No","%","Crude Prevalence","0",,,"0","0.02","0","20300","99","TCOND","CDXC5","QDXC5","R5_10","CRDPREV","AGE1839","GF","ALLRACE","RFDM","RFNO",
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Other corneal disorders","18-39 years","Male","All races","Diabetes","No","%","Crude Prevalence","0.22",,,"0.22","0.22","10500","4765700","59","TCOND","CDXC16","QDXC16","R16_3","CRDPREV","AGE1839","GM","ALLRACE","RFDM","RFNO",
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Macular edema (not diabetic)","0-17 years","Male","All races","Hypertension","No","%","Crude Prevalence","0",,,"0","0","0","3421900","59","TCOND","CDXC4","QDXC4","R4_7","CRDPREV","AGE017","GM","ALLRACE","RFHT","RFNO",
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Posterior capsular opacity","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0","0","3432700","59","TCOND","CDXC6","QDXC6","R6_4","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT",
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Secondary glaucoma","40-64 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0.12",,,"0.11","0.13","1600","1326800","59","TCOND","CDXC5","QDXC5","R5_10","CRDPREV","AGE4064","GALL","ALLRACE","RFDM","RFYES",
"2016","2016","UT","Utah","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Congenital glaucoma","65-84 years","Female","All races","Hypertension","No","%","Crude Prevalence","0",,,"0","0.92","0","400","49","TCOND","CDXC5","QDXC5","R5_7","CRDPREV","AGE6584","GF","ALLRACE","RFHT","RFNO","POINT (-111.5871306 39.36070017)"
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Low-tension glaucoma","18-39 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","1.83","0","200","99","TCOND","CDXC5","QDXC5","R5_3","CRDPREV","AGE1839","GF","ALLRACE","RFDM","RFYES",
"2016","2016","UT","Utah","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Other/unspecified glaucoma","65-84 years","Male","All races","Diabetes","No","%","Crude Prevalence","0",,,"0","0.74","0","500","49","TCOND","CDXC5","QDXC5","R5_9","CRDPREV","AGE6584","GM","ALLRACE","RFDM","RFNO","POINT (-111.5871306 39.36070017)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Other corneal disorders","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","0.07",,,"0.07","0.07","2400","3432700","59","TCOND","CDXC16","QDXC16","R16_3","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT",
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Other corneal disorders","18-39 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0.49",,,"0.46","0.52","900","178900","59","TCOND","CDXC16","QDXC16","R16_3","CRDPREV","AGE1839","GALL","ALLRACE","RFDM","RFYES",
"2016","2016","WY","Wyoming","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","0-17 years","Male","All races","Hypertension","No","%","Crude Prevalence","0.02",,,"0","0.12","0","4700","56","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGE017","GM","ALLRACE","RFHT","RFNO","POINT (-108.1098304 43.23554134)"
"2016","2016","FL","Florida","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Low-tension glaucoma","0-17 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","0.53","0","700","12","TCOND","CDXC5","QDXC5","R5_3","CRDPREV","AGE017","GM","ALLRACE","RFDM","RFYES","POINT (-81.92896054 28.93204038)"
"2016","2016","ND","North Dakota","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Glaucoma suspect","All ages","Male","All races","Diabetes","Yes","%","Crude Prevalence","1.6",,,"0.61","3.37","0","400","38","TCOND","CDXC5","QDXC5","R5_4","CRDPREV","AGEALL","GM","ALLRACE","RFDM","RFYES","POINT (-100.118421 47.47531978)"
"2016","2016","MI","Michigan","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Glaucoma suspect","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","0.15",,,"0.13","0.17","200","125900","26","TCOND","CDXC5","QDXC5","R5_4","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT (-84.71439027 44.66131954)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Glaucoma suspect","All ages","Male","All races","Hypertension","No","%","Crude Prevalence","0.72",,,"0.72","0.72","84900","11794700","59","TCOND","CDXC5","QDXC5","R5_4","CRDPREV","AGEALL","GM","ALLRACE","RFHT","RFNO",
"2016","2016","IL","Illinois","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Primary open-angle glaucoma","All ages","Female","All races","Diabetes","No","%","Crude Prevalence","0",,,"0","0","0","408100","17","TCOND","CDXC5","QDXC5","R5_2","CRDPREV","AGEALL","GF","ALLRACE","RFDM","RFNO","POINT (-88.99771018 40.48501028)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Keratoconus","0-17 years","Male","All races","Hypertension","No","%","Crude Prevalence","0.01",,,"0.01","0.01","300","3421900","59","TCOND","CDXC16","QDXC16","R16_1","CRDPREV","AGE017","GM","ALLRACE","RFHT","RFNO",
"2016","2016","WI","Wisconsin","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Senile cataract","18-39 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","0.19",,,"0.08","0.39","0","3600","55","TCOND","CDXC6","QDXC6","R6_1","CRDPREV","AGE1839","GM","ALLRACE","RFHT","RFYES","POINT (-89.81637074 44.39319117)"
"2016","2016","MT","Montana","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Glaucoma suspect","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0.33",,,"0.2","0.51","0","5800","30","TCOND","CDXC5","QDXC5","R5_4","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT (-109.4244206 47.06652897)"
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Keratoconus","40-64 years","All genders","All races","Hypertension","Yes","%","Crude Prevalence","0.12",,,"0.06","0.21","0","10400","99","TCOND","CDXC16","QDXC16","R16_1","CRDPREV","AGE4064","GALL","ALLRACE","RFHT","RFYES",
"2016","2016","CA","California","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Congenital glaucoma","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.09","0","4200","6","TCOND","CDXC5","QDXC5","R5_7","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT (-120.9999995 37.63864012)"
"2016","2016","NC","North Carolina","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","18-39 years","Male","All races","Diabetes","No","%","Crude Prevalence","0.02",,,"0.01","0.03","0","130600","37","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGE1839","GM","ALLRACE","RFDM","RFNO","POINT (-79.15925046 35.46622098)"
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Congenital glaucoma","All ages","All genders","All races","Hypertension","Yes","%","Crude Prevalence","0.02",,,"0","0.07","0","11600","99","TCOND","CDXC5","QDXC5","R5_7","CRDPREV","AGEALL","GALL","ALLRACE","RFHT","RFYES",
"2016","2016","UT","Utah","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Open-angle glaucoma","40-64 years","Female","All races","Hypertension","No","%","Crude Prevalence","0.24",,,"0.19","0.29","100","37600","49","TCOND","CDXC5","QDXC5","R5_1","CRDPREV","AGE4064","GF","ALLRACE","RFHT","RFNO","POINT (-111.5871306 39.36070017)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Secondary glaucoma","65-84 years","Male","All races","Diabetes","No","%","Crude Prevalence","0.06",,,"0.04","0.08","0","67700","59","TCOND","CDXC5","QDXC5","R5_10","CRDPREV","AGE6584","GM","ALLRACE","RFDM","RFNO",
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","All Glaucoma","65-84 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","7.19",,,"6.68","7.73","700","9500","59","TCOND","CDXC5","QDXC5","R5_ALL","CRDPREV","AGE6584","GF","ALLRACE","RFDM","RFYES",
"2016","2016","MT","Montana","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Secondary glaucoma","All ages","Male","All races","Diabetes","No","%","Crude Prevalence","0.01",,,"0","0.04","0","15000","30","TCOND","CDXC5","QDXC5","R5_10","CRDPREV","AGEALL","GM","ALLRACE","RFDM","RFNO","POINT (-109.4244206 47.06652897)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Open-angle glaucoma","40-64 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","1.51",,,"1.49","1.53","26000","1719900","59","TCOND","CDXC5","QDXC5","R5_1","CRDPREV","AGE4064","GF","ALLRACE","RFHT","RFYES",
"2016","2016","AZ","Arizona","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Low-tension glaucoma","All ages","All genders","All races","Diabetes","No","%","Crude Prevalence","0.02",,,"0.02","0.02","100","492500","4","TCOND","CDXC5","QDXC5","R5_3","CRDPREV","AGEALL","GALL","ALLRACE","RFDM","RFNO","POINT (-111.7638113 34.86597028)"
"2016","2016","NE","Nebraska","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Congenital glaucoma","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.05","0","13600","31","TCOND","CDXC5","QDXC5","R5_7","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT (-99.36572062 41.64104099)"
"2016","2016","OH","Ohio","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Posterior capsular opacity","18-39 years","Female","All races","Diabetes","No","%","Crude Prevalence","0.01",,,"0.01","0.02","0","218800","39","TCOND","CDXC6","QDXC6","R6_4","CRDPREV","AGE1839","GF","ALLRACE","RFDM","RFNO","POINT (-82.40426006 40.06021014)"
"2016","2016","VA","Virginia","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","All ages","Male","All races","All patients","Total","%","Crude Prevalence","0.2",,,"0.18","0.22","600","282500","51","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGEALL","GM","ALLRACE","RFALL","RFTOT","POINT (-78.45789046 37.54268067)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","All Cornea disorders","18-39 years","Female","All races","Diabetes","No","%","Crude Prevalence","0.34",,,"0.33","0.35","17500","5139300","59","TCOND","CDXC16","QDXC16","R16_ALL","CRDPREV","AGE1839","GF","ALLRACE","RFDM","RFNO",
"2016","2016","ID","Idaho","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","All Cataracts","0-17 years","Female","All races","Hypertension","No","%","Crude Prevalence","0.07",,,"0.05","0.1","0","54800","16","TCOND","CDXC6","QDXC6","R6_ALL","CRDPREV","AGE017","GF","ALLRACE","RFHT","RFNO","POINT (-114.36373 43.68263001)"
"2016","2016","DE","Delaware","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","All Glaucoma","0-17 years","All genders","All races","Diabetes","No","%","Crude Prevalence","0.19",,,"0.15","0.24","100","42100","10","TCOND","CDXC5","QDXC5","R5_ALL","CRDPREV","AGE017","GALL","ALLRACE","RFDM","RFNO","POINT (-75.57774117 39.00883067)"
"2016","2016","IA","Iowa","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","All Cataracts","18-39 years","Male","All races","Hypertension","No","%","Crude Prevalence","0.11",,,"0.08","0.15","0","39000","19","TCOND","CDXC6","QDXC6","R6_ALL","CRDPREV","AGE1839","GM","ALLRACE","RFHT","RFNO","POINT (-93.81649056 42.46940091)"
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Keratoconus","40-64 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.1",,,"0.07","0.13","0","42400","99","TCOND","CDXC16","QDXC16","R16_1","CRDPREV","AGE4064","GALL","ALLRACE","RFALL","RFTOT",
"2016","2016","LA","Louisiana","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Secondary glaucoma","All ages","Female","All races","Hypertension","Yes","%","Crude Prevalence","0.09",,,"0.07","0.11","100","119300","22","TCOND","CDXC5","QDXC5","R5_10","CRDPREV","AGEALL","GF","ALLRACE","RFHT","RFYES","POINT (-92.44568007 31.31266064)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","All ages","Male","All races","Diabetes","Yes","%","Crude Prevalence","1.18",,,"1.16","1.2","9400","796400","59","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGEALL","GM","ALLRACE","RFDM","RFYES",
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Low-tension glaucoma","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0.04",,,"0.03","0.06","0","59700","99","TCOND","CDXC5","QDXC5","R5_3","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT",
"2016","2016","WA","Washington","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","All ages","Male","All races","All patients","Total","%","Crude Prevalence","0.23",,,"0.21","0.25","600","279000","53","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGEALL","GM","ALLRACE","RFALL","RFTOT","POINT (-120.4700108 47.52227863)"
"2016","2016","MD","Maryland","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","All Glaucoma","All ages","Male","All races","Hypertension","Yes","%","Crude Prevalence","5.55",,,"5.25","5.86","1200","22300","24","TCOND","CDXC5","QDXC5","R5_ALL","CRDPREV","AGEALL","GM","ALLRACE","RFHT","RFYES","POINT (-76.60926011 39.29058096)"
"2016","2016","IA","Iowa","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","All Cataracts","18-39 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","0.3",,,"0.1","0.69","0","1700","19","TCOND","CDXC6","QDXC6","R6_ALL","CRDPREV","AGE1839","GM","ALLRACE","RFHT","RFYES","POINT (-93.81649056 42.46940091)"
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","All Glaucoma","All ages","Female","All races","Hypertension","No","%","Crude Prevalence","1.29",,,"1.2","1.39","700","54000","99","TCOND","CDXC5","QDXC5","R5_ALL","CRDPREV","AGEALL","GF","ALLRACE","RFHT","RFNO",
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","All Cataracts","65-84 years","Male","All races","Diabetes","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"99","TCOND","CDXC6","QDXC6","R6_ALL","CRDPREV","AGE6584","GM","ALLRACE","RFDM","RFYES",
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Early/mild diabetic retinopathy","0-17 years","Male","All races","Diabetes","No","%","Crude Prevalence","0",,,"0","0.03","0","14500","99","TCOND","CDXC2","QDXC2","R2_1","CRDPREV","AGE017","GM","ALLRACE","RFDM","RFNO",
"2016","2016","AL","Alabama","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Secondary glaucoma","40-64 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","0.08",,,"0.05","0.12","0","34300","1","TCOND","CDXC5","QDXC5","R5_10","CRDPREV","AGE4064","GF","ALLRACE","RFHT","RFYES","POINT (-86.63186076 32.84057112)"
"2016","2016","AR","Arkansas","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Low-tension glaucoma","All ages","Male","All races","Hypertension","Yes","%","Crude Prevalence","0.13",,,"0.08","0.21","0","12700","5","TCOND","CDXC5","QDXC5","R5_3","CRDPREV","AGEALL","GM","ALLRACE","RFHT","RFYES","POINT (-92.27449074 34.74865012)"
"2016","2016","HI","Hawaii","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Secondary glaucoma","All ages","Female","All races","Hypertension","No","%","Crude Prevalence","0",,,"0","0.26","0","1400","15","TCOND","CDXC5","QDXC5","R5_10","CRDPREV","AGEALL","GF","ALLRACE","RFHT","RFNO","POINT (-157.8577494 21.30485044)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Keratoconus","40-64 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","0.12",,,"0.11","0.13","2100","1719900","59","TCOND","CDXC16","QDXC16","R16_1","CRDPREV","AGE4064","GF","ALLRACE","RFHT","RFYES",
"2016","2016","MT","Montana","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","All Cataracts","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0.14",,,"0.06","0.28","0","5700","30","TCOND","CDXC6","QDXC6","R6_ALL","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT (-109.4244206 47.06652897)"
"2016","2016","AR","Arkansas","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","All Glaucoma","0-17 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","3.62","0","100","5","TCOND","CDXC5","QDXC5","R5_ALL","CRDPREV","AGE017","GM","ALLRACE","RFDM","RFYES","POINT (-92.27449074 34.74865012)"
"2016","2016","IN","Indiana","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Secondary glaucoma","18-39 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","0.05",,,"0.01","0.15","0","5500","18","TCOND","CDXC5","QDXC5","R5_10","CRDPREV","AGE1839","GM","ALLRACE","RFHT","RFYES","POINT (-86.14996019 39.76691045)"
"2016","2016","RI","Rhode Island","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Congenital glaucoma","40-64 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","0.25","0","1500","44","TCOND","CDXC5","QDXC5","R5_7","CRDPREV","AGE4064","GM","ALLRACE","RFDM","RFYES","POINT (-71.52247031 41.70828019)"
"2016","2016","MI","Michigan","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Aphakia and disorders of lens","18-39 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","0.12","0","3100","26","TCOND","CDXC6","QDXC6","R6_6","CRDPREV","AGE1839","GF","ALLRACE","RFDM","RFYES","POINT (-84.71439027 44.66131954)"
"2016","2016","VT","Vermont","MSCANCC","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Congenital anomalies","All ages","All genders","All races","Diabetes","No","%","Crude Prevalence","0.11",,,"0.07","0.17","0","16900","50","TCOND","CDXC14","QDXC14","R14_1","CRDPREV","AGEALL","GALL","ALLRACE","RFDM","RFNO","POINT (-72.51764079 43.62538124)"
"2016","2016","LA","Louisiana","MSCANCC","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","All Diabetic eye diseases","18-39 years","Male","All races","Hypertension","No","%","Crude Prevalence","0.05",,,"0.04","0.06","100","208000","22","TCOND","CDXC2","QDXC2","R2_ALL","CRDPREV","AGE1839","GM","ALLRACE","RFHT","RFNO","POINT (-92.44568007 31.31266064)"
"2016","2016","MT","Montana","MSCANCC","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Diabetic macular edema","0-17 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"30","TCOND","CDXC2","QDXC2","R2_4","CRDPREV","AGE017","GALL","ALLRACE","RFDM","RFYES","POINT (-109.4244206 47.06652897)"
"2016","2016","PA","Pennsylvania","MSCANCC","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Other refraction and accommodation disorders","65-84 years","Male","All races","Diabetes","No","%","Crude Prevalence","0.15",,,"0.03","0.45","0","1900","42","TCOND","CDXC7","QDXC7","R7_5","CRDPREV","AGE6584","GM","ALLRACE","RFDM","RFNO","POINT (-77.86070029 40.79373015)"
"2016","2016","WA","Washington","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Posterior capsular opacity","65-84 years","Female","All races","Hypertension","No","%","Crude Prevalence","0.5",,,"0.2","1.03","0","1400","53","TCOND","CDXC6","QDXC6","R6_4","CRDPREV","AGE6584","GF","ALLRACE","RFHT","RFNO","POINT (-120.4700108 47.52227863)"
"2016","2016","PA","Pennsylvania","MSCANCC","Eye Health Conditions","Disorders of Optic Nerve and Visual Pathways","Annual prevalence of treated disorders of optic nerve and visual pathways","Visual pathway disorders","65-84 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","0.74","0","500","42","TCOND","CDXC11","QDXC11","R11_2","CRDPREV","AGE6584","GALL","ALLRACE","RFDM","RFYES","POINT (-77.86070029 40.79373015)"
"2016","2016","NJ","New Jersey","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Central retinal vein occlusion","0-17 years","Male","All races","Diabetes","No","%","Crude Prevalence","0",,,"0","0","0","93000","34","TCOND","CDXC4","QDXC4","R4_2","CRDPREV","AGE017","GM","ALLRACE","RFDM","RFNO","POINT (-74.27369129 40.13057005)"
"2016","2016","MI","Michigan","MSCANCC","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Early stage age-related macular degeneration","65-84 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0.57",,,"0.25","1.12","0","1400","26","TCOND","CDXC3","QDXC3","R3_2","CRDPREV","AGE6584","GALL","ALLRACE","RFDM","RFYES","POINT (-84.71439027 44.66131954)"
"2016","2016","RI","Rhode Island","MSCANCC","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Presbyopia","18-39 years","Female","All races","Diabetes","No","%","Crude Prevalence","0.14",,,"0.08","0.23","0","10300","44","TCOND","CDXC7","QDXC7","R7_4","CRDPREV","AGE1839","GF","ALLRACE","RFDM","RFNO","POINT (-71.52247031 41.70828019)"
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Posterior capsular opacity","0-17 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","3.62","0","100","99","TCOND","CDXC6","QDXC6","R6_4","CRDPREV","AGE017","GALL","ALLRACE","RFDM","RFYES",
"2016","2016","TN","Tennessee","MSCANCC","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Eyelid disorders","All ages","All genders","All races","Diabetes","Yes","%","Crude Prevalence","1.51",,,"1.41","1.62","800","50700","47","TCOND","CDXC14","QDXC14","R14_4","CRDPREV","AGEALL","GALL","ALLRACE","RFDM","RFYES","POINT (-85.77449091 35.68094058)"
"2016","2016","GA","Georgia","MSCANCC","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Lacrimal diseases","65-84 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","0.14",,,"0.02","0.49","0","1500","13","TCOND","CDXC14","QDXC14","R14_3","CRDPREV","AGE6584","GF","ALLRACE","RFHT","RFYES","POINT (-83.62758035 32.83968109)"
"2016","2016","RI","Rhode Island","MSCANCC","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","All Refraction and accommodation disorders","65-84 years","Female","All races","Hypertension","No","%","Crude Prevalence","1.34",,,"0.08","6","0","100","44","TCOND","CDXC7","QDXC7","R7_ALL","CRDPREV","AGE6584","GF","ALLRACE","RFHT","RFNO","POINT (-71.52247031 41.70828019)"
"2016","2016","OH","Ohio","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Primary angle-closure glaucoma","All ages","Female","All races","Hypertension","Yes","%","Crude Prevalence","0.49",,,"0.44","0.54","400","87000","39","TCOND","CDXC5","QDXC5","R5_5","CRDPREV","AGEALL","GF","ALLRACE","RFHT","RFYES","POINT (-82.40426006 40.06021014)"
"2016","2016","WV","West Virginia","MSCANCC","Eye Health Conditions","Retinal Detachment and Defects","Annual prevalence of treated retinal detachment and defects","All Retinal detachment and defects","40-64 years","All genders","All races","Hypertension","No","%","Crude Prevalence","0.27",,,"0.2","0.35","100","19100","54","TCOND","CDXC1","QDXC1","R1_ALL","CRDPREV","AGE4064","GALL","ALLRACE","RFHT","RFNO","POINT (-80.71264013 38.6655102)"
"2016","2016","CA","California","MSCANCC","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Other refraction and accommodation disorders","65-84 years","Male","All races","Diabetes","No","%","Crude Prevalence","0.22",,,"0.1","0.43","0","3700","6","TCOND","CDXC7","QDXC7","R7_5","CRDPREV","AGE6584","GM","ALLRACE","RFDM","RFNO","POINT (-120.9999995 37.63864012)"
"2016","2016","SD","South Dakota","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Senile cataract","All ages","Female","All races","Hypertension","Yes","%","Crude Prevalence","6.15",,,"4.95","7.54","100","1400","46","TCOND","CDXC6","QDXC6","R6_1","CRDPREV","AGEALL","GF","ALLRACE","RFHT","RFYES","POINT (-100.3735306 44.35313005)"
"2016","2016","WV","West Virginia","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","All Glaucoma","40-64 years","Male","All races","Diabetes","No","%","Crude Prevalence","2.39",,,"2.13","2.67","300","12900","54","TCOND","CDXC5","QDXC5","R5_ALL","CRDPREV","AGE4064","GM","ALLRACE","RFDM","RFNO","POINT (-80.71264013 38.6655102)"
"2016","2016","RI","Rhode Island","MSCANCC","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","All Diabetic eye diseases","0-17 years","All genders","All races","Hypertension","No","%","Crude Prevalence","0.01",,,"0","0.05","0","13000","44","TCOND","CDXC2","QDXC2","R2_ALL","CRDPREV","AGE017","GALL","ALLRACE","RFHT","RFNO","POINT (-71.52247031 41.70828019)"
"2016","2016","NM","New Mexico","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Branch retinal artery occlusion","40-64 years","Male","All races","Diabetes","No","%","Crude Prevalence","0.02",,,"0","0.07","0","11600","35","TCOND","CDXC4","QDXC4","R4_5","CRDPREV","AGE4064","GM","ALLRACE","RFDM","RFNO","POINT (-106.240581 34.52088095)"
"2016","2016","CT","Connecticut","MSCANCC","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Myopia","All ages","All genders","All races","Hypertension","Yes","%","Crude Prevalence","4.06",,,"3.86","4.27","1400","35100","9","TCOND","CDXC7","QDXC7","R7_1","CRDPREV","AGEALL","GALL","ALLRACE","RFHT","RFYES","POINT (-72.64984095 41.56266102)"
"2016","2016","NE","Nebraska","MSCANCC","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Profound bilateral imp., legal blindness","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","0",,,"0","1.83","0","200","31","TCOND","CDXC8","QDXC8","R8_6","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT","POINT (-99.36572062 41.64104099)"
"2016","2016","US","National","MSCANCC","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Tonometry?test","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0.01","0.01","1400","14874100","59","TUTL","CTEST","QTEST","RTONO","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT",
"2016","2016","ME","Maine","MSCANCC","Eye Health Conditions","Cancer and Neoplasms of the Eye","Annual prevalence of treated cancer and neoplasms of the eye","All Cancer and neoplasms of the eye diseases","65-84 years","All genders","All races","Diabetes","No","%","Crude Prevalence","0.26",,,"0.01","1.4","0","400","23","TCOND","CDXC15","QDXC15","R15_ALL","CRDPREV","AGE6584","GALL","ALLRACE","RFDM","RFNO","POINT (-68.98503134 45.25422889)"
"2016","2016","TN","Tennessee","MSCANCC","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Infectious diseases","18-39 years","Female","All races","Hypertension","No","%","Crude Prevalence","0.22",,,"0.2","0.25","300","139800","47","TCOND","CDXC13","QDXC13","R13_1","CRDPREV","AGE1839","GF","ALLRACE","RFHT","RFNO","POINT (-85.77449091 35.68094058)"
"2016","2016","DE","Delaware","MSCANCC","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Eyelid infection and inflammation","40-64 years","All genders","All races","Diabetes","No","%","Crude Prevalence","2.02",,,"1.91","2.14","1200","59900","10","TCOND","CDXC13","QDXC13","R13_4","CRDPREV","AGE4064","GALL","ALLRACE","RFDM","RFNO","POINT (-75.57774117 39.00883067)"
"2016","2016","NJ","New Jersey","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Central retinal vein occlusion","40-64 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","0.09",,,"0.06","0.12","0","43400","34","TCOND","CDXC4","QDXC4","R4_2","CRDPREV","AGE4064","GM","ALLRACE","RFHT","RFYES","POINT (-74.27369129 40.13057005)"
"2016","2016","UT","Utah","MSCANCC","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Color blindness","0-17 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","0.92","0","400","49","TCOND","CDXC12","QDXC12","R12_2","CRDPREV","AGE017","GALL","ALLRACE","RFDM","RFYES","POINT (-111.5871306 39.36070017)"
"2016","2016","MS","Mississippi","MSCANCC","Service Utilization","Cataract Surgery","Percentage of people with diagnosed cataract who had a treatment claim","Any cataract treatment","0-17 years","Male","All races","Cataract","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"28","TUTL","CCATS","QCATS","RCATANY","CRDPREV","AGE017","GM","ALLRACE","RFCAT","RFYES","POINT (-89.53803082 32.7455101)"
"2016","2016","NM","New Mexico","MSCANCC","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Moderate imp. better eye, profound imp. lesser eye","40-64 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","0.31","0","1200","35","TCOND","CDXC8","QDXC8","R8_4","CRDPREV","AGE4064","GF","ALLRACE","RFDM","RFYES","POINT (-106.240581 34.52088095)"
"2016","2016","IL","Illinois","MSCANCC","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Unspecified-age related macular degeneration","All ages","All genders","All races","Hypertension","Yes","%","Crude Prevalence","0.09",,,"0.07","0.11","100","101800","17","TCOND","CDXC3","QDXC3","R3_1","CRDPREV","AGEALL","GALL","ALLRACE","RFHT","RFYES","POINT (-88.99771018 40.48501028)"
"2016","2016","SD","South Dakota","MSCANCC","Eye Health Conditions","Cancer and Neoplasms of the Eye","Annual prevalence of treated cancer and neoplasms of the eye","All Cancer and neoplasms of the eye diseases","18-39 years","Female","All races","Hypertension","No","%","Crude Prevalence","0.06",,,"0.02","0.16","0","6300","46","TCOND","CDXC15","QDXC15","R15_ALL","CRDPREV","AGE1839","GF","ALLRACE","RFHT","RFNO","POINT (-100.3735306 44.35313005)"
"2016","2016","FL","Florida","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Glaucoma suspect","18-39 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","1.56",,,"1.36","1.78","200","14100","12","TCOND","CDXC5","QDXC5","R5_4","CRDPREV","AGE1839","GALL","ALLRACE","RFDM","RFYES","POINT (-81.92896054 28.93204038)"
"2016","2016","AZ","Arizona","MSCANCC","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Endothelial dystrophy (Fuchs)","0-17 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","1.83","0","200","4","TCOND","CDXC16","QDXC16","R16_2","CRDPREV","AGE017","GM","ALLRACE","RFDM","RFYES","POINT (-111.7638113 34.86597028)"
"2016","2016","UT","Utah","MSCANCC","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Glaucoma surgery","65-84 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","3.08","0","100","49","TUTL","CGLAUTX","QGLAU","RGLASUR","CRDPREV","AGE6584","GALL","ALLRACE","RFDM","RFYES","POINT (-111.5871306 39.36070017)"
"2016","2016","CT","Connecticut","MSCANCC","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Hypermetropia","0-17 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","3.62","0","100","9","TCOND","CDXC7","QDXC7","R7_2","CRDPREV","AGE017","GF","ALLRACE","RFHT","RFYES","POINT (-72.64984095 41.56266102)"
"2016","2016","PA","Pennsylvania","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","All Other retinal disorders","18-39 years","All genders","All races","Hypertension","No","%","Crude Prevalence","0.38",,,"0.36","0.4","1100","284300","42","TCOND","CDXC4","QDXC4","R4_ALL","CRDPREV","AGE1839","GALL","ALLRACE","RFHT","RFNO","POINT (-77.86070029 40.79373015)"
"2016","2016","TX","Texas","MSCANCC","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","Amblyopia","65-84 years","Male","All races","Diabetes","No","%","Crude Prevalence","0.02",,,"0","0.13","0","4000","48","TCOND","CDXC9","QDXC9","R9_2","CRDPREV","AGE6584","GM","ALLRACE","RFDM","RFNO","POINT (-99.42677021 31.82724041)"
"2016","2016","TN","Tennessee","MSCANCC","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Photodynamic therapy","0-17 years","All genders","All races","Age-related macular degeneration","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"47","TUTL","CAMDTX","QAMD","RPHOTO","CRDPREV","AGE017","GALL","ALLRACE","RFAMD","RFYES","POINT (-85.77449091 35.68094058)"
"2016","2016","IL","Illinois","MSCANCC","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Vision impairment one eye","0-17 years","Male","All races","Hypertension","No","%","Crude Prevalence","0.01",,,"0","0.02","0","105600","17","TCOND","CDXC8","QDXC8","R8_3","CRDPREV","AGE017","GM","ALLRACE","RFHT","RFNO","POINT (-88.99771018 40.48501028)"
"2016","2016","AL","Alabama","MSCANCC","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Proliferative diabetic retinopathy","All ages","Female","All races","Hypertension","Yes","%","Crude Prevalence","0.35",,,"0.29","0.41","100","40700","1","TCOND","CDXC2","QDXC2","R2_3","CRDPREV","AGEALL","GF","ALLRACE","RFHT","RFYES","POINT (-86.63186076 32.84057112)"
"2016","2016","WI","Wisconsin","MSCANCC","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Glaucoma surgery","65-84 years","All genders","All races","Diabetes and glaucoma","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"55","TUTL","CGLAUTX","QGLAU","RGLASUR","CRDPREV","AGE6584","GALL","ALLRACE","RFDMGLC","RFYES","POINT (-89.81637074 44.39319117)"
"2016","2016","FL","Florida","MSCANCC","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Retinal detachment repair","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0.08",,,"0.02","0.21","0","5000","12","TUTL","CDRTX","QDRTX","RDRRET","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT (-81.92896054 28.93204038)"
"2016","2016","MN","Minnesota","MSCANCC","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Diabetic macular edema","65-84 years","Female","All races","Diabetes","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"27","TCOND","CDXC2","QDXC2","R2_4","CRDPREV","AGE6584","GF","ALLRACE","RFDM","RFYES","POINT (-94.7942005 46.35564874)"
"2016","2016","MT","Montana","MSCANCC","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Laser surgery","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.05",,,"0.01","0.15","0","5900","30","TUTL","CGLAUTX","QGLAU","RLASER","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT (-109.4244206 47.06652897)"
"2016","2016","AZ","Arizona","MSCANCC","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","Surgical complication of the eye","All ages","Female","All races","Hypertension","No","%","Crude Prevalence","0.02",,,"0.01","0.03","0","237200","4","TCOND","CDXC10","QDXC10","R10_3","CRDPREV","AGEALL","GF","ALLRACE","RFHT","RFNO","POINT (-111.7638113 34.86597028)"
"2016","2016","AK","Alaska","MSCANCC","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Astigmatism","18-39 years","All genders","All races","Diabetes","No","%","Crude Prevalence","1.85",,,"1.6","2.12","200","10800","2","TCOND","CDXC7","QDXC7","R7_3","CRDPREV","AGE1839","GALL","ALLRACE","RFDM","RFNO","POINT (-147.722059 64.84507996)"
"2016","2016","DE","Delaware","MSCANCC","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Visual field defect","18-39 years","Female","All races","Hypertension","No","%","Crude Prevalence","0.09",,,"0.06","0.13","0","28500","10","TCOND","CDXC12","QDXC12","R12_1","CRDPREV","AGE1839","GF","ALLRACE","RFHT","RFNO","POINT (-75.57774117 39.00883067)"
"2016","2016","AZ","Arizona","MSCANCC","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Vision impairment one eye","40-64 years","All genders","All races","Diabetes","No","%","Crude Prevalence","0.02",,,"0.01","0.03","0","168700","4","TCOND","CDXC8","QDXC8","R8_3","CRDPREV","AGE4064","GALL","ALLRACE","RFDM","RFNO","POINT (-111.7638113 34.86597028)"
"2016","2016","NY","New York","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Myopic degeneration","65-84 years","Male","All races","Diabetes","No","%","Crude Prevalence","0.06",,,"0.02","0.16","0","6200","36","TCOND","CDXC4","QDXC4","R4_9","CRDPREV","AGE6584","GM","ALLRACE","RFDM","RFNO","POINT (-75.54397043 42.82700103)"
"2016","2016","CA","California","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Aphakia and disorders of lens","40-64 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0.06",,,"0.04","0.08","0","63300","6","TCOND","CDXC6","QDXC6","R6_6","CRDPREV","AGE4064","GALL","ALLRACE","RFDM","RFYES","POINT (-120.9999995 37.63864012)"
"2016","2016","SD","South Dakota","MSCANCC","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Hypermetropia","65-84 years","All genders","All races","Hypertension","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"46","TCOND","CDXC7","QDXC7","R7_2","CRDPREV","AGE6584","GALL","ALLRACE","RFHT","RFYES","POINT (-100.3735306 44.35313005)"
"2016","2016","RI","Rhode Island","MSCANCC","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Other corneal disorders","All ages","Female","All races","Hypertension","No","%","Crude Prevalence","0.49",,,"0.41","0.58","100","25900","44","TCOND","CDXC16","QDXC16","R16_3","CRDPREV","AGEALL","GF","ALLRACE","RFHT","RFNO","POINT (-71.52247031 41.70828019)"
"2016","2016","HI","Hawaii","MSCANCC","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Wet-form age-related macular degeneration","0-17 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"15","TCOND","CDXC3","QDXC3","R3_4","CRDPREV","AGE017","GALL","ALLRACE","RFDM","RFYES","POINT (-157.8577494 21.30485044)"
"2016","2016","RI","Rhode Island","MSCANCC","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Unqualified impairment in one eye, or unspecified","0-17 years","Male","All races","Hypertension","No","%","Crude Prevalence","0.21",,,"0.11","0.35","0","6600","44","TCOND","CDXC8","QDXC8","R8_2","CRDPREV","AGE017","GM","ALLRACE","RFHT","RFNO","POINT (-71.52247031 41.70828019)"
"2016","2016","OR","Oregon","MSCANCC","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Proliferative diabetic retinopathy","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.02",,,"0.01","0.03","0","108800","41","TCOND","CDXC2","QDXC2","R2_3","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT","POINT (-120.1550313 44.56744942)"
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","All Other visual disturbances","65-84 years","Male","All races","Hypertension","No","%","Crude Prevalence","1.06",,,"0.14","3.66","0","200","99","TCOND","CDXC12","QDXC12","R12_ALL","CRDPREV","AGE6584","GM","ALLRACE","RFHT","RFNO",
"2016","2016","ME","Maine","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","All Cataracts","All ages","All genders","All races","Diabetes","No","%","Crude Prevalence","1.7",,,"1.6","1.81","1000","58300","23","TCOND","CDXC6","QDXC6","R6_ALL","CRDPREV","AGEALL","GALL","ALLRACE","RFDM","RFNO","POINT (-68.98503134 45.25422889)"
"2016","2016","MO","Missouri","MSCANCC","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Hypermetropia","65-84 years","Female","All races","Hypertension","No","%","Crude Prevalence","0.32",,,"0.09","0.8","0","1300","29","TCOND","CDXC7","QDXC7","R7_2","CRDPREV","AGE6584","GF","ALLRACE","RFHT","RFNO","POINT (-92.56630005 38.63579078)"
"2016","2016","CT","Connecticut","MSCANCC","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Other/unspecified infectious and inflammatory diseases","All ages","Male","All races","All patients","Total","%","Crude Prevalence","0.19",,,"0.17","0.21","300","153900","9","TCOND","CDXC13","QDXC13","R13_5","CRDPREV","AGEALL","GM","ALLRACE","RFALL","RFTOT","POINT (-72.64984095 41.56266102)"
"2016","2016","ME","Maine","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Branch retinal artery occlusion","0-17 years","All genders","All races","Diabetes","No","%","Crude Prevalence","0",,,"0","0.03","0","13200","23","TCOND","CDXC4","QDXC4","R4_5","CRDPREV","AGE017","GALL","ALLRACE","RFDM","RFNO","POINT (-68.98503134 45.25422889)"
"2016","2016","HI","Hawaii","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Central retinal vein occlusion","0-17 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"15","TCOND","CDXC4","QDXC4","R4_2","CRDPREV","AGE017","GALL","ALLRACE","RFDM","RFYES","POINT (-157.8577494 21.30485044)"
"2016","2016","NE","Nebraska","MSCANCC","Service Utilization","Vision Correction","Percentage of people who had a vision correction visit or supplies claim","Any vision correction","65-84 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","2.5",,,"0.06","13.16","0","0","31","TUTL","CVC","QVC","RVCANY","CRDPREV","AGE6584","GALL","ALLRACE","RFDM","RFYES","POINT (-99.36572062 41.64104099)"
"2016","2016","CT","Connecticut","MSCANCC","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Disorders of the globe","40-64 years","Female","All races","Diabetes","No","%","Crude Prevalence","0.01",,,"0","0.02","0","59800","9","TCOND","CDXC14","QDXC14","R14_6","CRDPREV","AGE4064","GF","ALLRACE","RFDM","RFNO","POINT (-72.64984095 41.56266102)"
"2016","2016","NC","North Carolina","MSCANCC","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Endophthalmitis","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0.01","0.02","0","132800","37","TCOND","CDXC13","QDXC13","R13_7","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT (-79.15925046 35.46622098)"
"2016","2016","ND","North Dakota","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Hereditary chorioretinal dystrophy","65-84 years","Female","All races","Diabetes","No","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"38","TCOND","CDXC4","QDXC4","R4_8","CRDPREV","AGE6584","GF","ALLRACE","RFDM","RFNO","POINT (-100.118421 47.47531978)"
"2016","2016","NC","North Carolina","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Primary angle-closure glaucoma","All ages","Male","All races","Hypertension","Yes","%","Crude Prevalence","0.21",,,"0.17","0.25","100","56800","37","TCOND","CDXC5","QDXC5","R5_5","CRDPREV","AGEALL","GM","ALLRACE","RFHT","RFYES","POINT (-79.15925046 35.46622098)"
"2016","2016","OR","Oregon","MSCANCC","Service Utilization","Vision Correction","Percentage of people who had a vision correction visit or supplies claim","Any vision correction","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","2.29",,,"2.16","2.41","1300","56800","41","TUTL","CVC","QVC","RVCANY","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT (-120.1550313 44.56744942)"
"2016","2016","DE","Delaware","MSCANCC","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Early stage age-related macular degeneration","40-64 years","Female","All races","Hypertension","No","%","Crude Prevalence","0.45",,,"0.37","0.54","100","26000","10","TCOND","CDXC3","QDXC3","R3_2","CRDPREV","AGE4064","GF","ALLRACE","RFHT","RFNO","POINT (-75.57774117 39.00883067)"
"2016","2016","MS","Mississippi","MSCANCC","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Myopia","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.44",,,"0.41","0.48","600","133000","28","TCOND","CDXC7","QDXC7","R7_1","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT","POINT (-89.53803082 32.7455101)"
"2016","2016","NM","New Mexico","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Primary angle-closure glaucoma","65-84 years","All genders","All races","Diabetes","No","%","Crude Prevalence","0.34",,,"0.01","1.85","0","300","35","TCOND","CDXC5","QDXC5","R5_5","CRDPREV","AGE6584","GALL","ALLRACE","RFDM","RFNO","POINT (-106.240581 34.52088095)"
"2016","2016","MI","Michigan","MSCANCC","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Other diabetes related eye disorders","40-64 years","Female","All races","Hypertension","No","%","Crude Prevalence","0.08",,,"0.07","0.09","100","184000","26","TCOND","CDXC2","QDXC2","R2_5","CRDPREV","AGE4064","GF","ALLRACE","RFHT","RFNO","POINT (-84.71439027 44.66131954)"
"2016","2016","WI","Wisconsin","MSCANCC","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","Amblyopia","40-64 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","0.32",,,"0.22","0.45","0","9700","55","TCOND","CDXC9","QDXC9","R9_2","CRDPREV","AGE4064","GF","ALLRACE","RFDM","RFYES","POINT (-89.81637074 44.39319117)"
"2016","2016","IA","Iowa","MSCANCC","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Any vision screening","All ages","Male","All races","Diabetes","Yes","%","Crude Prevalence","0.02",,,"0","0.12","0","4600","19","TUTL","CSCRN","QSCRN","RSCNANY","CRDPREV","AGEALL","GM","ALLRACE","RFDM","RFYES","POINT (-93.81649056 42.46940091)"
"2016","2016","MT","Montana","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Congenital glaucoma","65-84 years","Male","All races","Diabetes","No","%","Crude Prevalence","0",,,"0","3.62","0","100","30","TCOND","CDXC5","QDXC5","R5_7","CRDPREV","AGE6584","GM","ALLRACE","RFDM","RFNO","POINT (-109.4244206 47.06652897)"
"2016","2016","CT","Connecticut","MSCANCC","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Hypermetropia","0-17 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","3.62","0","100","9","TCOND","CDXC7","QDXC7","R7_2","CRDPREV","AGE017","GM","ALLRACE","RFHT","RFYES","POINT (-72.64984095 41.56266102)"
"2016","2016","KY","Kentucky","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Branch retinal vein occlusion","All ages","Male","All races","Hypertension","Yes","%","Crude Prevalence","0.1",,,"0.08","0.13","100","55700","21","TCOND","CDXC4","QDXC4","R4_3","CRDPREV","AGEALL","GM","ALLRACE","RFHT","RFYES","POINT (-84.77497105 37.64597027)"
"2016","2016","OR","Oregon","MSCANCC","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","Strabismus","All ages","All genders","All races","Hypertension","No","%","Crude Prevalence","0.49",,,"0.46","0.52","1400","291100","41","TCOND","CDXC9","QDXC9","R9_1","CRDPREV","AGEALL","GALL","ALLRACE","RFHT","RFNO","POINT (-120.1550313 44.56744942)"
"2016","2016","UT","Utah","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Macular edema (not diabetic)","65-84 years","All genders","All races","Diabetes","No","%","Crude Prevalence","0.22",,,"0.03","0.8","0","900","49","TCOND","CDXC4","QDXC4","R4_7","CRDPREV","AGE6584","GALL","ALLRACE","RFDM","RFNO","POINT (-111.5871306 39.36070017)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Low-tension glaucoma","18-39 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0.02",,,"0.01","0.03","0","178900","59","TCOND","CDXC5","QDXC5","R5_3","CRDPREV","AGE1839","GALL","ALLRACE","RFDM","RFYES",
"2016","2016","KY","Kentucky","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Retinopathy of prematurity","40-64 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","0.01","0","47700","21","TCOND","CDXC4","QDXC4","R4_11","CRDPREV","AGE4064","GM","ALLRACE","RFHT","RFYES","POINT (-84.77497105 37.64597027)"
"2016","2016","RI","Rhode Island","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Open-angle glaucoma","65-84 years","Female","All races","Hypertension","No","%","Crude Prevalence","0.67",,,"0","4.88","0","100","44","TCOND","CDXC5","QDXC5","R5_1","CRDPREV","AGE6584","GF","ALLRACE","RFHT","RFNO","POINT (-71.52247031 41.70828019)"
"2016","2016","MI","Michigan","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Low-tension glaucoma","65-84 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","0.21",,,"0.04","0.62","0","1400","26","TCOND","CDXC5","QDXC5","R5_3","CRDPREV","AGE6584","GM","ALLRACE","RFHT","RFYES","POINT (-84.71439027 44.66131954)"
"2016","2016","HI","Hawaii","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Aphakia and disorders of lens","18-39 years","Male","All races","Hypertension","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"15","TCOND","CDXC6","QDXC6","R6_6","CRDPREV","AGE1839","GM","ALLRACE","RFHT","RFYES","POINT (-157.8577494 21.30485044)"
"2016","2016","RI","Rhode Island","MSCANCC","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Moderate/Severe non-proliferative diabetic retinopathy","40-64 years","All genders","All races","Hypertension","Yes","%","Crude Prevalence","0.3",,,"0.19","0.45","0","7600","44","TCOND","CDXC2","QDXC2","R2_2","CRDPREV","AGE4064","GALL","ALLRACE","RFHT","RFYES","POINT (-71.52247031 41.70828019)"
"2016","2016","TX","Texas","MSCANCC","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Hypermetropia","18-39 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","0.4",,,"0.28","0.55","0","9200","48","TCOND","CDXC7","QDXC7","R7_2","CRDPREV","AGE1839","GF","ALLRACE","RFDM","RFYES","POINT (-99.42677021 31.82724041)"
"2016","2016","AK","Alaska","MSCANCC","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Color blindness","40-64 years","All genders","All races","Hypertension","No","%","Crude Prevalence","0",,,"0","0.05","0","7600","2","TCOND","CDXC12","QDXC12","R12_2","CRDPREV","AGE4064","GALL","ALLRACE","RFHT","RFNO","POINT (-147.722059 64.84507996)"
"2016","2016","IA","Iowa","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","All Glaucoma","65-84 years","All genders","All races","All patients","Total","%","Crude Prevalence","3.18",,,"2.08","4.64","0","800","19","TCOND","CDXC5","QDXC5","R5_ALL","CRDPREV","AGE6584","GALL","ALLRACE","RFALL","RFTOT","POINT (-93.81649056 42.46940091)"
"2016","2016","KY","Kentucky","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Primary open-angle glaucoma","65-84 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","1.22","0","300","21","TCOND","CDXC5","QDXC5","R5_2","CRDPREV","AGE6584","GM","ALLRACE","RFDM","RFYES","POINT (-84.77497105 37.64597027)"
"2016","2016","OR","Oregon","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Aphakia and disorders of lens","65-84 years","All genders","All races","Diabetes","No","%","Crude Prevalence","0",,,"0","0.2","0","1800","41","TCOND","CDXC6","QDXC6","R6_6","CRDPREV","AGE6584","GALL","ALLRACE","RFDM","RFNO","POINT (-120.1550313 44.56744942)"
"2016","2016","MA","Massachusetts","MSCANCC","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Profound bilateral imp., legal blindness","65-84 years","All genders","All races","Diabetes","No","%","Crude Prevalence","0",,,"0","0.17","0","2200","25","TCOND","CDXC8","QDXC8","R8_6","CRDPREV","AGE6584","GALL","ALLRACE","RFDM","RFNO","POINT (-72.08269067 42.27687047)"
"2016","2016","PR","Puerto Rico","MSCANCC","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Retinal detachment repair","18-39 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","2.82","0","100","72","TUTL","CDRTX","QDRTX","RDRRET","CRDPREV","AGE1839","GALL","ALLRACE","RFDM","RFYES","POINT (-66.590149 18.220833)"
"2016","2016","OK","Oklahoma","MSCANCC","Service Utilization","Cataract Surgery","Percentage of people with diagnosed cataract who had a treatment claim","Cataract surgery","0-17 years","Female","All races","Diabetes and cataract","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"40","TUTL","CCATS","QCATS","RCATSUR","CRDPREV","AGE017","GF","ALLRACE","RFDMCAT","RFYES","POINT (-97.52107021 35.47203136)"
"2016","2016","CO","Colorado","MSCANCC","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Endophthalmitis","40-64 years","Female","All races","Hypertension","No","%","Crude Prevalence","0.02",,,"0.01","0.03","0","70300","8","TCOND","CDXC13","QDXC13","R13_7","CRDPREV","AGE4064","GF","ALLRACE","RFHT","RFNO","POINT (-106.1336109 38.84384076)"
"2016","2016","MI","Michigan","MSCANCC","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Unqualified impairment in one eye, or unspecified","0-17 years","All genders","All races","Hypertension","No","%","Crude Prevalence","0.14",,,"0.13","0.16","300","245300","26","TCOND","CDXC8","QDXC8","R8_2","CRDPREV","AGE017","GALL","ALLRACE","RFHT","RFNO","POINT (-84.71439027 44.66131954)"
"2016","2016","WA","Washington","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Primary open-angle glaucoma","18-39 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","0.15","0","2500","53","TCOND","CDXC5","QDXC5","R5_2","CRDPREV","AGE1839","GF","ALLRACE","RFHT","RFYES","POINT (-120.4700108 47.52227863)"
"2016","2016","KS","Kansas","MSCANCC","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Laser surgery","40-64 years","All genders","All races","Diabetes","No","%","Crude Prevalence","0.08",,,"0.06","0.1","100","74200","20","TUTL","CGLAUTX","QGLAU","RLASER","CRDPREV","AGE4064","GALL","ALLRACE","RFDM","RFNO","POINT (-98.20078123 38.3477403)"
"2016","2016","NH","New Hampshire","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Senile cataract","18-39 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","1.83","0","200","33","TCOND","CDXC6","QDXC6","R6_1","CRDPREV","AGE1839","GF","ALLRACE","RFDM","RFYES","POINT (-71.50036092 43.65595011)"
"2016","2016","SD","South Dakota","MSCANCC","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Any age related macular degeneration treatment","All ages","All genders","All races","Diabetes","Yes","%","Crude Prevalence","5.08",,,"3.89","6.5","100","1200","46","TUTL","CAMDTX","QAMD","RAMDANY","CRDPREV","AGEALL","GALL","ALLRACE","RFDM","RFYES","POINT (-100.3735306 44.35313005)"
"2016","2016","US","National","MSCANCC","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Anti-VEGF injections","65-84 years","Male","All races","Diabetes","No","%","Crude Prevalence","0.58",,,"0.52","0.64","400","67700","59","TUTL","CDRTX","QDRTX","RVEGF","CRDPREV","AGE6584","GM","ALLRACE","RFDM","RFNO",
"2016","2016","ID","Idaho","MSCANCC","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Anti-VEGF injections","All ages","Female","All races","Diabetes","No","%","Crude Prevalence","0.57",,,"0.54","0.6","1300","222800","16","TUTL","CDRTX","QDRTX","RVEGF","CRDPREV","AGEALL","GF","ALLRACE","RFDM","RFNO","POINT (-114.36373 43.68263001)"
"2016","2016","IN","Indiana","MSCANCC","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Laser surgery","40-64 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","0.14",,,"0.1","0.18","100","37800","18","TUTL","CGLAUTX","QGLAU","RLASER","CRDPREV","AGE4064","GF","ALLRACE","RFHT","RFYES","POINT (-86.14996019 39.76691045)"
"2016","2016","MO","Missouri","MSCANCC","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Lacrimal and orbit inflammation","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.26","0","1400","29","TCOND","CDXC13","QDXC13","R13_6","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT (-92.56630005 38.63579078)"
"2016","2016","WY","Wyoming","MSCANCC","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Wet-form age-related macular degeneration","65-84 years","All genders","All races","Diabetes","No","%","Crude Prevalence","0.8",,,"0.01","5.11","0","100","56","TCOND","CDXC3","QDXC3","R3_4","CRDPREV","AGE6584","GALL","ALLRACE","RFDM","RFNO","POINT (-108.1098304 43.23554134)"
"2016","2016","MT","Montana","MSCANCC","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Astigmatism","40-64 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","4.23",,,"2.64","6.38","0","500","30","TCOND","CDXC7","QDXC7","R7_3","CRDPREV","AGE4064","GM","ALLRACE","RFDM","RFYES","POINT (-109.4244206 47.06652897)"
"2016","2016","MS","Mississippi","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Branch retinal artery occlusion","18-39 years","All genders","All races","Hypertension","No","%","Crude Prevalence","0",,,"0","0","0","121300","28","TCOND","CDXC4","QDXC4","R4_5","CRDPREV","AGE1839","GALL","ALLRACE","RFHT","RFNO","POINT (-89.53803082 32.7455101)"
"2016","2016","WA","Washington","MSCANCC","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","Amblyopia","40-64 years","All genders","All races","Diabetes","No","%","Crude Prevalence","0.1",,,"0.09","0.11","200","223900","53","TCOND","CDXC9","QDXC9","R9_2","CRDPREV","AGE4064","GALL","ALLRACE","RFDM","RFNO","POINT (-120.4700108 47.52227863)"
"2016","2016","MN","Minnesota","MSCANCC","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Disorders of the globe","All ages","Male","All races","Diabetes","Yes","%","Crude Prevalence","0.04",,,"0.01","0.14","0","5500","27","TCOND","CDXC14","QDXC14","R14_6","CRDPREV","AGEALL","GM","ALLRACE","RFDM","RFYES","POINT (-94.7942005 46.35564874)"
"2016","2016","NJ","New Jersey","MSCANCC","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Any diabetic retinopathy treatment","All ages","Female","All races","Diabetes","No","%","Crude Prevalence","0.92",,,"0.89","0.95","3200","348700","34","TUTL","CDRTX","QDRTX","RDRANY","CRDPREV","AGEALL","GF","ALLRACE","RFDM","RFNO","POINT (-74.27369129 40.13057005)"
"2016","2016","TN","Tennessee","MSCANCC","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Laser surgery","0-17 years","Male","All races","Hypertension and glaucoma","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"47","TUTL","CGLAUTX","QGLAU","RLASER","CRDPREV","AGE017","GM","ALLRACE","RFHTGLC","RFYES","POINT (-85.77449091 35.68094058)"
"2016","2016","LA","Louisiana","MSCANCC","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Unspecified-age related macular degeneration","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0.01","0.01","0","466600","22","TCOND","CDXC3","QDXC3","R3_1","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT","POINT (-92.44568007 31.31266064)"
"2016","2016","PR","Puerto Rico","MSCANCC","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","All Refraction and accommodation disorders","18-39 years","All genders","All races","Hypertension","No","%","Crude Prevalence","5.79",,,"5.02","6.64","200","3300","72","TCOND","CDXC7","QDXC7","R7_ALL","CRDPREV","AGE1839","GALL","ALLRACE","RFHT","RFNO","POINT (-66.590149 18.220833)"
"2016","2016","VT","Vermont","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Primary angle-closure glaucoma","18-39 years","Male","All races","Hypertension","No","%","Crude Prevalence","0",,,"0","0.13","0","2800","50","TCOND","CDXC5","QDXC5","R5_5","CRDPREV","AGE1839","GM","ALLRACE","RFHT","RFNO","POINT (-72.51764079 43.62538124)"
"2016","2016","WY","Wyoming","MSCANCC","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Any glaucoma treatment","All ages","Female","All races","Diabetes","No","%","Crude Prevalence","0.03",,,"0.01","0.08","0","15500","56","TUTL","CGLAUTX","QGLAU","RGLAANY","CRDPREV","AGEALL","GF","ALLRACE","RFDM","RFNO","POINT (-108.1098304 43.23554134)"
"2016","2016","KS","Kansas","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Posterior capsular opacity","18-39 years","All genders","All races","Hypertension","No","%","Crude Prevalence","0.01",,,"0","0.02","0","75500","20","TCOND","CDXC6","QDXC6","R6_4","CRDPREV","AGE1839","GALL","ALLRACE","RFHT","RFNO","POINT (-98.20078123 38.3477403)"
"2016","2016","TX","Texas","MSCANCC","Eye Health Conditions","Other Eye Disorders","Annual prevalence of treated other eye disorders","All Other eye disorders","40-64 years","Female","All races","Diabetes","No","%","Crude Prevalence","2.39",,,"2.34","2.44","10100","421800","48","TCOND","CDXC17","QDXC17","R17_ALL","CRDPREV","AGE4064","GF","ALLRACE","RFDM","RFNO","POINT (-99.42677021 31.82724041)"
"2016","2016","TN","Tennessee","MSCANCC","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Eyelid infection and inflammation","All ages","Male","All races","Diabetes","No","%","Crude Prevalence","0.7",,,"0.67","0.73","2600","364400","47","TCOND","CDXC13","QDXC13","R13_4","CRDPREV","AGEALL","GM","ALLRACE","RFDM","RFNO","POINT (-85.77449091 35.68094058)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Non-congenital cataract","65-84 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","1.06",,,"0.87","1.27","100","10500","59","TCOND","CDXC6","QDXC6","R6_2","CRDPREV","AGE6584","GM","ALLRACE","RFDM","RFYES",
"2016","2016","MO","Missouri","MSCANCC","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Diabetic Retinopathy Telemedicine Screening","40-64 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","0.02","0","35000","29","TUTL","CSCRN","QSCRN","RSCNDR","CRDPREV","AGE4064","GF","ALLRACE","RFHT","RFYES","POINT (-92.56630005 38.63579078)"
"2016","2016","AR","Arkansas","MSCANCC","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Laser surgery","0-17 years","Male","All races","Hypertension","No","%","Crude Prevalence","0",,,"0","0.02","0","19900","5","TUTL","CGLAUTX","QGLAU","RLASER","CRDPREV","AGE017","GM","ALLRACE","RFHT","RFNO","POINT (-92.27449074 34.74865012)"
"2016","2016","KS","Kansas","MSCANCC","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Vision screening","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.73","0","500","20","TUTL","CSCRN","QSCRN","RSCNVIS","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT (-98.20078123 38.3477403)"
"2016","2016","CT","Connecticut","MSCANCC","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Profound bilateral imp., legal blindness","40-64 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","0.03",,,"0.01","0.07","0","18400","9","TCOND","CDXC8","QDXC8","R8_6","CRDPREV","AGE4064","GM","ALLRACE","RFHT","RFYES","POINT (-72.64984095 41.56266102)"
"2016","2016","NH","New Hampshire","MSCANCC","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Glaucoma screening","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","1.56","0","200","33","TUTL","CSCRN","QSCRN","RSCNGLA","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT (-71.50036092 43.65595011)"
"2016","2016","PR","Puerto Rico","MSCANCC","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Presbyopia","0-17 years","Male","All races","Diabetes","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"72","TCOND","CDXC7","QDXC7","R7_4","CRDPREV","AGE017","GM","ALLRACE","RFDM","RFYES","POINT (-66.590149 18.220833)"
"2016","2016","KY","Kentucky","MSCANCC","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Infectious diseases","0-17 years","All genders","All races","Diabetes","No","%","Crude Prevalence","0.2",,,"0.18","0.22","300","145800","21","TCOND","CDXC13","QDXC13","R13_1","CRDPREV","AGE017","GALL","ALLRACE","RFDM","RFNO","POINT (-84.77497105 37.64597027)"
"2016","2016","OK","Oklahoma","MSCANCC","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Any age related macular degeneration treatment","18-39 years","All genders","All races","Hypertension","Yes","%","Crude Prevalence","2.12",,,"1.82","2.45","200","8500","40","TUTL","CAMDTX","QAMD","RAMDANY","CRDPREV","AGE1839","GALL","ALLRACE","RFHT","RFYES","POINT (-97.52107021 35.47203136)"
"2016","2016","NV","Nevada","MSCANCC","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Vision impairment one eye","65-84 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","3.62","0","100","32","TCOND","CDXC8","QDXC8","R8_3","CRDPREV","AGE6584","GF","ALLRACE","RFHT","RFYES","POINT (-117.0718406 39.49324039)"
"2016","2016","IA","Iowa","MSCANCC","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","All Strabismus and amblyopia","65-84 years","Male","All races","Diabetes","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"19","TCOND","CDXC9","QDXC9","R9_ALL","CRDPREV","AGE6584","GM","ALLRACE","RFDM","RFYES","POINT (-93.81649056 42.46940091)"
"2016","2016","WI","Wisconsin","MSCANCC","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Other corneal disorders","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.28",,,"0.26","0.3","600","214400","55","TCOND","CDXC16","QDXC16","R16_3","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT","POINT (-89.81637074 44.39319117)"
"2016","2016","MI","Michigan","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","All ages","Female","All races","Hypertension","Yes","%","Crude Prevalence","1.57",,,"1.49","1.66","1300","81600","26","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGEALL","GF","ALLRACE","RFHT","RFYES","POINT (-84.71439027 44.66131954)"
"2016","2016","WI","Wisconsin","MSCANCC","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Any glaucoma treatment","65-84 years","Male","All races","Diabetes and glaucoma","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"55","TUTL","CGLAUTX","QGLAU","RGLAANY","CRDPREV","AGE6584","GM","ALLRACE","RFDMGLC","RFYES","POINT (-89.81637074 44.39319117)"
"2016","2016","IL","Illinois","MSCANCC","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Unspecified-age related macular degeneration","All ages","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0.08",,,"0.05","0.11","0","39300","17","TCOND","CDXC3","QDXC3","R3_1","CRDPREV","AGEALL","GALL","ALLRACE","RFDM","RFYES","POINT (-88.99771018 40.48501028)"
"2016","2016","AL","Alabama","MSCANCC","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Other/unspecified orbital and external disease","All ages","All genders","All races","Hypertension","Yes","%","Crude Prevalence","0.09",,,"0.07","0.11","100","82100","1","TCOND","CDXC14","QDXC14","R14_2","CRDPREV","AGEALL","GALL","ALLRACE","RFHT","RFYES","POINT (-86.63186076 32.84057112)"
"2016","2016","UT","Utah","MSCANCC","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Unspecified-age related macular degeneration","0-17 years","All genders","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0","0","103400","49","TCOND","CDXC3","QDXC3","R3_1","CRDPREV","AGE017","GALL","ALLRACE","RFALL","RFTOT","POINT (-111.5871306 39.36070017)"
"2016","2016","KY","Kentucky","MSCANCC","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Profound bilateral imp., legal blindness","0-17 years","Female","All races","Diabetes","No","%","Crude Prevalence","0.01",,,"0","0.02","0","71400","21","TCOND","CDXC8","QDXC8","R8_6","CRDPREV","AGE017","GF","ALLRACE","RFDM","RFNO","POINT (-84.77497105 37.64597027)"
"2016","2016","NC","North Carolina","MSCANCC","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Night blindness","40-64 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0.01",,,"0","0.03","0","35600","37","TCOND","CDXC12","QDXC12","R12_3","CRDPREV","AGE4064","GALL","ALLRACE","RFDM","RFYES","POINT (-79.15925046 35.46622098)"
"2016","2016","GA","Georgia","MSCANCC","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Eyelid disorders","18-39 years","Male","All races","Diabetes","No","%","Crude Prevalence","0.1",,,"0.09","0.12","200","194800","13","TCOND","CDXC14","QDXC14","R14_4","CRDPREV","AGE1839","GM","ALLRACE","RFDM","RFNO","POINT (-83.62758035 32.83968109)"
"2016","2016","CA","California","MSCANCC","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Profound bilateral imp., legal blindness","All ages","Male","All races","Hypertension","No","%","Crude Prevalence","0.01",,,"0.01","0.01","100","835500","6","TCOND","CDXC8","QDXC8","R8_6","CRDPREV","AGEALL","GM","ALLRACE","RFHT","RFNO","POINT (-120.9999995 37.63864012)"
"2016","2016","RI","Rhode Island","MSCANCC","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","Ocular injury","18-39 years","Female","All races","Diabetes","No","%","Crude Prevalence","0.53",,,"0.4","0.69","100","10300","44","TCOND","CDXC10","QDXC10","R10_1","CRDPREV","AGE1839","GF","ALLRACE","RFDM","RFNO","POINT (-71.52247031 41.70828019)"
"2016","2016","VA","Virginia","MSCANCC","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Other/unspecified visual disturbances","0-17 years","Male","All races","Hypertension","No","%","Crude Prevalence","0.73",,,"0.67","0.79","500","72000","51","TCOND","CDXC12","QDXC12","R12_4","CRDPREV","AGE017","GM","ALLRACE","RFHT","RFNO","POINT (-78.45789046 37.54268067)"
"2016","2016","NV","Nevada","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Aphakia and disorders of lens","65-84 years","All genders","All races","Hypertension","No","%","Crude Prevalence","0",,,"0","0.53","0","700","32","TCOND","CDXC6","QDXC6","R6_6","CRDPREV","AGE6584","GALL","ALLRACE","RFHT","RFNO","POINT (-117.0718406 39.49324039)"
"2016","2016","WV","West Virginia","MSCANCC","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","All Age-related macular degeneration (AMD)","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","0.78",,,"0.12","2.56","0","300","54","TCOND","CDXC3","QDXC3","R3_ALL","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT","POINT (-80.71264013 38.6655102)"
"2016","2016","NH","New Hampshire","MSCANCC","Eye Health Conditions","Cancer and Neoplasms of the Eye","Annual prevalence of treated cancer and neoplasms of the eye","Benign neoplasm","18-39 years","All genders","All races","Hypertension","Yes","%","Crude Prevalence","0.26",,,"0.03","0.92","0","800","33","TCOND","CDXC15","QDXC15","R15_2","CRDPREV","AGE1839","GALL","ALLRACE","RFHT","RFYES","POINT (-71.50036092 43.65595011)"
"2016","2016","OR","Oregon","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","All Other retinal disorders","65-84 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","1.28",,,"0.22","3.99","0","200","41","TCOND","CDXC4","QDXC4","R4_ALL","CRDPREV","AGE6584","GF","ALLRACE","RFHT","RFYES","POINT (-120.1550313 44.56744942)"
"2016","2016","KS","Kansas","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","All Other retinal disorders","65-84 years","Female","All races","Hypertension","No","%","Crude Prevalence","1.23",,,"0.4","2.87","0","400","20","TCOND","CDXC4","QDXC4","R4_ALL","CRDPREV","AGE6584","GF","ALLRACE","RFHT","RFNO","POINT (-98.20078123 38.3477403)"
"2016","2016","OK","Oklahoma","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Posterior capsular opacity","All ages","All genders","All races","Hypertension","No","%","Crude Prevalence","0.11",,,"0.1","0.12","400","322500","40","TCOND","CDXC6","QDXC6","R6_4","CRDPREV","AGEALL","GALL","ALLRACE","RFHT","RFNO","POINT (-97.52107021 35.47203136)"
"2016","2016","OK","Oklahoma","MSCANCC","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Profound bilateral imp., legal blindness","All ages","All genders","All races","Diabetes","No","%","Crude Prevalence","0.01",,,"0.01","0.01","0","363700","40","TCOND","CDXC8","QDXC8","R8_6","CRDPREV","AGEALL","GALL","ALLRACE","RFDM","RFNO","POINT (-97.52107021 35.47203136)"
"2016","2016","IA","Iowa","MSCANCC","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Other/unspecified visual disturbances","0-17 years","Male","All races","Diabetes","No","%","Crude Prevalence","0.47",,,"0.39","0.56","100","27400","19","TCOND","CDXC12","QDXC12","R12_4","CRDPREV","AGE017","GM","ALLRACE","RFDM","RFNO","POINT (-93.81649056 42.46940091)"
"2016","2016","WV","West Virginia","MSCANCC","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","All Strabismus and amblyopia","0-17 years","Female","All races","Hypertension","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"54","TCOND","CDXC9","QDXC9","R9_ALL","CRDPREV","AGE017","GF","ALLRACE","RFHT","RFYES","POINT (-80.71264013 38.6655102)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Disorders of Optic Nerve and Visual Pathways","Annual prevalence of treated disorders of optic nerve and visual pathways","Optic nerve disorders","40-64 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","0.66",,,"0.65","0.67","11400","1719900","59","TCOND","CDXC11","QDXC11","R11_1","CRDPREV","AGE4064","GF","ALLRACE","RFHT","RFYES",
"2016","2016","VA","Virginia","MSCANCC","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","All Strabismus and amblyopia","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0.22",,,"0.19","0.25","200","107500","51","TCOND","CDXC9","QDXC9","R9_ALL","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT (-78.45789046 37.54268067)"
"2016","2016","MS","Mississippi","MSCANCC","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","Ocular burns","0-17 years","Female","All races","Diabetes","No","%","Crude Prevalence","0.01",,,"0","0.03","0","35000","28","TCOND","CDXC10","QDXC10","R10_2","CRDPREV","AGE017","GF","ALLRACE","RFDM","RFNO","POINT (-89.53803082 32.7455101)"
"2016","2016","AK","Alaska","MSCANCC","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Presbyopia","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.05",,,"0.02","0.11","0","11000","2","TCOND","CDXC7","QDXC7","R7_4","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT","POINT (-147.722059 64.84507996)"
"2016","2016","AZ","Arizona","MSCANCC","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Unqualified impairment, both eyes","All ages","Female","All races","Hypertension","Yes","%","Crude Prevalence","0.02",,,"0.01","0.05","0","24800","4","TCOND","CDXC8","QDXC8","R8_1","CRDPREV","AGEALL","GF","ALLRACE","RFHT","RFYES","POINT (-111.7638113 34.86597028)"
"2016","2016","WA","Washington","MSCANCC","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","Surgical complication of the eye","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.02","0","62700","53","TCOND","CDXC10","QDXC10","R10_3","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT (-120.4700108 47.52227863)"
"2016","2016","MS","Mississippi","MSCANCC","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Any age related macular degeneration treatment","18-39 years","Female","All races","Hypertension","No","%","Crude Prevalence","0.48",,,"0.43","0.53","300","69100","28","TUTL","CAMDTX","QAMD","RAMDANY","CRDPREV","AGE1839","GF","ALLRACE","RFHT","RFNO","POINT (-89.53803082 32.7455101)"
"2016","2016","IA","Iowa","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Senile cataract","0-17 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","3.62","0","100","19","TCOND","CDXC6","QDXC6","R6_1","CRDPREV","AGE017","GM","ALLRACE","RFHT","RFYES","POINT (-93.81649056 42.46940091)"
"2016","2016","MN","Minnesota","MSCANCC","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","All Diabetic eye diseases","65-84 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.63",,,"0.28","1.23","0","1300","27","TCOND","CDXC2","QDXC2","R2_ALL","CRDPREV","AGE6584","GALL","ALLRACE","RFALL","RFTOT","POINT (-94.7942005 46.35564874)"
"2016","2016","IA","Iowa","MSCANCC","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","Ocular burns","All ages","Male","All races","Diabetes","No","%","Crude Prevalence","0.02",,,"0.01","0.03","0","100200","19","TCOND","CDXC10","QDXC10","R10_2","CRDPREV","AGEALL","GM","ALLRACE","RFDM","RFNO","POINT (-93.81649056 42.46940091)"
"2016","2016","FL","Florida","MSCANCC","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","All Strabismus and amblyopia","65-84 years","All genders","All races","Hypertension","Yes","%","Crude Prevalence","0.2",,,"0.07","0.43","0","3000","12","TCOND","CDXC9","QDXC9","R9_ALL","CRDPREV","AGE6584","GALL","ALLRACE","RFHT","RFYES","POINT (-81.92896054 28.93204038)"
"2016","2016","MN","Minnesota","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Branch retinal vein occlusion","All ages","All genders","All races","Diabetes","No","%","Crude Prevalence","0.02",,,"0.02","0.03","100","291800","27","TCOND","CDXC4","QDXC4","R4_3","CRDPREV","AGEALL","GALL","ALLRACE","RFDM","RFNO","POINT (-94.7942005 46.35564874)"
"2016","2016","ID","Idaho","MSCANCC","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Proliferative diabetic retinopathy","40-64 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","1.2",,,"1.03","1.4","200","13800","16","TCOND","CDXC2","QDXC2","R2_3","CRDPREV","AGE4064","GALL","ALLRACE","RFDM","RFYES","POINT (-114.36373 43.68263001)"
"2016","2016","GA","Georgia","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Open-angle glaucoma","18-39 years","Female","All races","Hypertension","No","%","Crude Prevalence","0.06",,,"0.05","0.07","100","227800","13","TCOND","CDXC5","QDXC5","R5_1","CRDPREV","AGE1839","GF","ALLRACE","RFHT","RFNO","POINT (-83.62758035 32.83968109)"
"2016","2016","ND","North Dakota","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","All Cataracts","0-17 years","Female","All races","Hypertension","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"38","TCOND","CDXC6","QDXC6","R6_ALL","CRDPREV","AGE017","GF","ALLRACE","RFHT","RFYES","POINT (-100.118421 47.47531978)"
"2016","2016","NY","New York","MSCANCC","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Other diabetes related eye disorders","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0.01","0.02","0","226000","36","TCOND","CDXC2","QDXC2","R2_5","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT (-75.54397043 42.82700103)"
"2016","2016","WV","West Virginia","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","All Cataracts","65-84 years","All genders","All races","All patients","Total","%","Crude Prevalence","7",,,"4.92","9.6","0","500","54","TCOND","CDXC6","QDXC6","R6_ALL","CRDPREV","AGE6584","GALL","ALLRACE","RFALL","RFTOT","POINT (-80.71264013 38.6655102)"
"2016","2016","HI","Hawaii","MSCANCC","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Photodynamic therapy","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.12","0","3100","15","TUTL","CAMDTX","QAMD","RPHOTO","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT (-157.8577494 21.30485044)"
"2016","2016","FL","Florida","MSCANCC","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Moderate bilateral impairment","65-84 years","Male","All races","Diabetes","No","%","Crude Prevalence","0",,,"0","0.09","0","4300","12","TCOND","CDXC8","QDXC8","R8_5","CRDPREV","AGE6584","GM","ALLRACE","RFDM","RFNO","POINT (-81.92896054 28.93204038)"
"2016","2016","MD","Maryland","MSCANCC","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Any diabetic retinopathy treatment","All ages","All genders","All races","Diabetes","Yes","%","Crude Prevalence","3.14",,,"2.88","3.42","500","16500","24","TUTL","CDRTX","QDRTX","RDRANY","CRDPREV","AGEALL","GALL","ALLRACE","RFDM","RFYES","POINT (-76.60926011 39.29058096)"
"2016","2016","AL","Alabama","MSCANCC","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Other/unspecified infectious and inflammatory diseases","40-64 years","All genders","All races","Hypertension","Yes","%","Crude Prevalence","0.46",,,"0.41","0.51","300","69300","1","TCOND","CDXC13","QDXC13","R13_5","CRDPREV","AGE4064","GALL","ALLRACE","RFHT","RFYES","POINT (-86.63186076 32.84057112)"
"2016","2016","OR","Oregon","MSCANCC","Service Utilization","Eye Exams","Proportion of patients who had an eye exam in selected year","By any provider type","40-64 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","96.15",,,"95.79","96.48","11600","12100","41","TUTL","CUTLEX","QUTLEX","REXANY","CRDPREV","AGE4064","GF","ALLRACE","RFHT","RFYES","POINT (-120.1550313 44.56744942)"
"2016","2016","VT","Vermont","MSCANCC","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Other refraction and accommodation disorders","0-17 years","Female","All races","Diabetes","No","%","Crude Prevalence","0.13",,,"0.02","0.48","0","1500","50","TCOND","CDXC7","QDXC7","R7_5","CRDPREV","AGE017","GF","ALLRACE","RFDM","RFNO","POINT (-72.51764079 43.62538124)"
"2016","2016","ME","Maine","MSCANCC","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Choroidal neovascularization","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.01","0","61200","23","TCOND","CDXC3","QDXC3","R3_4CNV","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT (-68.98503134 45.25422889)"
"2016","2016","CA","California","MSCANCC","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","All Other visual disturbances","18-39 years","All genders","All races","Hypertension","No","%","Crude Prevalence","0.45",,,"0.43","0.47","3100","684300","6","TCOND","CDXC12","QDXC12","R12_ALL","CRDPREV","AGE1839","GALL","ALLRACE","RFHT","RFNO","POINT (-120.9999995 37.63864012)"
"2016","2016","HI","Hawaii","MSCANCC","Eye Health Conditions","Retinal Detachment and Defects","Annual prevalence of treated retinal detachment and defects","All Retinal detachment and defects","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0.43",,,"0.17","0.89","0","1600","15","TCOND","CDXC1","QDXC1","R1_ALL","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT","POINT (-157.8577494 21.30485044)"
"2016","2016","WI","Wisconsin","MSCANCC","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Retinal detachment repair","All ages","Male","All races","Diabetic retinopathy","Yes","%","Crude Prevalence","0.53",,,"0.19","1.15","0","1100","55","TUTL","CDRTX","QDRTX","RDRRET","CRDPREV","AGEALL","GM","ALLRACE","RFDR","RFYES","POINT (-89.81637074 44.39319117)"
"2016","2016","VA","Virginia","MSCANCC","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Laser/photocoagulation","0-17 years","Male","All races","Diabetes and diabetic retinopathy","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"51","TUTL","CDRTX","QDRTX","RLASPH","CRDPREV","AGE017","GM","ALLRACE","RFDMDR","RFYES","POINT (-78.45789046 37.54268067)"
"2016","2016","UT","Utah","MSCANCC","Eye Health Conditions","Retinal Detachment and Defects","Annual prevalence of treated retinal detachment and defects","All Retinal detachment and defects","All ages","Male","All races","All patients","Total","%","Crude Prevalence","0.13",,,"0.11","0.15","200","153800","49","TCOND","CDXC1","QDXC1","R1_ALL","CRDPREV","AGEALL","GM","ALLRACE","RFALL","RFTOT","POINT (-111.5871306 39.36070017)"
"2016","2016","GA","Georgia","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Glaucoma suspect","All ages","Male","All races","Diabetes","No","%","Crude Prevalence","0.77",,,"0.75","0.79","4300","563600","13","TCOND","CDXC5","QDXC5","R5_4","CRDPREV","AGEALL","GM","ALLRACE","RFDM","RFNO","POINT (-83.62758035 32.83968109)"
"2016","2016","NM","New Mexico","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Posterior capsular opacity","65-84 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"35","TCOND","CDXC6","QDXC6","R6_4","CRDPREV","AGE6584","GALL","ALLRACE","RFDM","RFYES","POINT (-106.240581 34.52088095)"
"2016","2016","NH","New Hampshire","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Open-angle glaucoma","All ages","All genders","All races","Diabetes","Yes","%","Crude Prevalence","1.69",,,"1.28","2.18","100","3400","33","TCOND","CDXC5","QDXC5","R5_1","CRDPREV","AGEALL","GALL","ALLRACE","RFDM","RFYES","POINT (-71.50036092 43.65595011)"
"2016","2016","FL","Florida","MSCANCC","Eye Health Conditions","Cancer and Neoplasms of the Eye","Annual prevalence of treated cancer and neoplasms of the eye","Malignant neoplasm","0-17 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","0.21",,,"0.01","1.13","0","500","12","TCOND","CDXC15","QDXC15","R15_1","CRDPREV","AGE017","GF","ALLRACE","RFHT","RFYES","POINT (-81.92896054 28.93204038)"
"2016","2016","WY","Wyoming","MSCANCC","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Laser/photocoagulation","0-17 years","Female","All races","Hypertension","No","%","Crude Prevalence","0",,,"0","0.08","0","4400","56","TUTL","CDRTX","QDRTX","RLASPH","CRDPREV","AGE017","GF","ALLRACE","RFHT","RFNO","POINT (-108.1098304 43.23554134)"
"2016","2016","CA","California","MSCANCC","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Lacrimal diseases","40-64 years","All genders","All races","Diabetes","No","%","Crude Prevalence","0.11",,,"0.1","0.12","700","657700","6","TCOND","CDXC14","QDXC14","R14_3","CRDPREV","AGE4064","GALL","ALLRACE","RFDM","RFNO","POINT (-120.9999995 37.63864012)"
"2016","2016","MT","Montana","MSCANCC","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","All Strabismus and amblyopia","40-64 years","Female","All races","Hypertension","No","%","Crude Prevalence","0.12",,,"0.04","0.26","0","4900","30","TCOND","CDXC9","QDXC9","R9_ALL","CRDPREV","AGE4064","GF","ALLRACE","RFHT","RFNO","POINT (-109.4244206 47.06652897)"
"2016","2016","MI","Michigan","MSCANCC","Service Utilization","Eye Exams","Proportion of patients who had an eye exam in selected year","By any provider type","40-64 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","96.4",,,"96.18","96.61","29000","30100","26","TUTL","CUTLEX","QUTLEX","REXANY","CRDPREV","AGE4064","GM","ALLRACE","RFDM","RFYES","POINT (-84.71439027 44.66131954)"
"2016","2016","IN","Indiana","MSCANCC","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Vision screening","0-17 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","2.79",,,"1.13","5.66","0","300","18","TUTL","CSCRN","QSCRN","RSCNVIS","CRDPREV","AGE017","GF","ALLRACE","RFDM","RFYES","POINT (-86.14996019 39.76691045)"
"2016","2016","WV","West Virginia","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","All Other retinal disorders","65-84 years","Female","All races","Hypertension","No","%","Crude Prevalence","2.29",,,"0.7","5.45","0","200","54","TCOND","CDXC4","QDXC4","R4_ALL","CRDPREV","AGE6584","GF","ALLRACE","RFHT","RFNO","POINT (-80.71264013 38.6655102)"
"2016","2016","IL","Illinois","MSCANCC","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Unspecified-age related macular degeneration","0-17 years","All genders","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0","0","206400","17","TCOND","CDXC3","QDXC3","R3_1","CRDPREV","AGE017","GALL","ALLRACE","RFALL","RFTOT","POINT (-88.99771018 40.48501028)"
"2016","2016","NM","New Mexico","MSCANCC","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Victrectomy","40-64 years","Male","All races","Diabetes and diabetic retinopathy","Yes","%","Crude Prevalence","1.06",,,"0.03","5.79","0","100","35","TUTL","CDRTX","QDRTX","RDRVIC","CRDPREV","AGE4064","GM","ALLRACE","RFDMDR","RFYES","POINT (-106.240581 34.52088095)"
"2016","2016","ME","Maine","MSCANCC","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Other/unspecified visual disturbances","0-17 years","Female","All races","Hypertension","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"23","TCOND","CDXC12","QDXC12","R12_4","CRDPREV","AGE017","GF","ALLRACE","RFHT","RFYES","POINT (-68.98503134 45.25422889)"
"2016","2016","NV","Nevada","MSCANCC","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Diabetic macular edema","All ages","All genders","All races","Hypertension","Yes","%","Crude Prevalence","0.53",,,"0.45","0.62","100","26700","32","TCOND","CDXC2","QDXC2","R2_4","CRDPREV","AGEALL","GALL","ALLRACE","RFHT","RFYES","POINT (-117.0718406 39.49324039)"
"2016","2016","CO","Colorado","MSCANCC","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","Surgical complication of the eye","18-39 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","0.19",,,"0.04","0.55","0","1600","8","TCOND","CDXC10","QDXC10","R10_3","CRDPREV","AGE1839","GF","ALLRACE","RFHT","RFYES","POINT (-106.1336109 38.84384076)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Other/unspecified other retinal disorders","0-17 years","All genders","All races","Diabetes","No","%","Crude Prevalence","0.13",,,"0.13","0.13","8700","6701600","59","TCOND","CDXC4","QDXC4","R4_10","CRDPREV","AGE017","GALL","ALLRACE","RFDM","RFNO",
"2016","2016","UT","Utah","MSCANCC","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Myopia","0-17 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","4.42",,,"2.02","8.27","0","200","49","TCOND","CDXC7","QDXC7","R7_1","CRDPREV","AGE017","GM","ALLRACE","RFDM","RFYES","POINT (-111.5871306 39.36070017)"
"2016","2016","XX","Missing Location","MSCANCC","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Anti-VEGF injections","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.76",,,"0.68","0.85","300","38500","99","TUTL","CDRTX","QDRTX","RVEGF","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT",
"2016","2016","VA","Virginia","MSCANCC","Service Utilization","Cataract Surgery","Percentage of people with diagnosed cataract who had a treatment claim","Any cataract treatment","65-84 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","2.48",,,"1.08","4.84","0","300","51","TUTL","CCATS","QCATS","RCATANY","CRDPREV","AGE6584","GALL","ALLRACE","RFDM","RFYES","POINT (-78.45789046 37.54268067)"
"2016","2016","FL","Florida","MSCANCC","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Diabetic macular edema","65-84 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","2.02",,,"1.11","3.36","0","700","12","TCOND","CDXC2","QDXC2","R2_4","CRDPREV","AGE6584","GM","ALLRACE","RFDM","RFYES","POINT (-81.92896054 28.93204038)"
"2016","2016","DE","Delaware","MSCANCC","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Moderate/Severe non-proliferative diabetic retinopathy","18-39 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","0.18",,,"0.04","0.54","0","1600","10","TCOND","CDXC2","QDXC2","R2_2","CRDPREV","AGE1839","GM","ALLRACE","RFHT","RFYES","POINT (-75.57774117 39.00883067)"
"2016","2016","NJ","New Jersey","MSCANCC","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Conjunctivitis","40-64 years","Male","All races","All patients","Total","%","Crude Prevalence","3.19",,,"3.1","3.28","4600","145000","34","TCOND","CDXC13","QDXC13","R13_3","CRDPREV","AGE4064","GM","ALLRACE","RFALL","RFTOT","POINT (-74.27369129 40.13057005)"
"2016","2016","OK","Oklahoma","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Other/unspecified other retinal disorders","All ages","All genders","All races","Hypertension","No","%","Crude Prevalence","0.38",,,"0.36","0.4","1200","322500","40","TCOND","CDXC4","QDXC4","R4_10","CRDPREV","AGEALL","GALL","ALLRACE","RFHT","RFNO","POINT (-97.52107021 35.47203136)"
"2016","2016","KS","Kansas","MSCANCC","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Infectious diseases","18-39 years","All genders","All races","Hypertension","No","%","Crude Prevalence","0.21",,,"0.18","0.25","200","75500","20","TCOND","CDXC13","QDXC13","R13_1","CRDPREV","AGE1839","GALL","ALLRACE","RFHT","RFNO","POINT (-98.20078123 38.3477403)"
"2016","2016","IL","Illinois","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Central retinal vein occlusion","0-17 years","All genders","All races","Diabetes","No","%","Crude Prevalence","0",,,"0","0","0","205700","17","TCOND","CDXC4","QDXC4","R4_2","CRDPREV","AGE017","GALL","ALLRACE","RFDM","RFNO","POINT (-88.99771018 40.48501028)"
"2016","2016","MD","Maryland","MSCANCC","Eye Health Conditions","Disorders of Optic Nerve and Visual Pathways","Annual prevalence of treated disorders of optic nerve and visual pathways","Visual pathway disorders","40-64 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","0.01",,,"0","0.04","0","19300","24","TCOND","CDXC11","QDXC11","R11_2","CRDPREV","AGE4064","GM","ALLRACE","RFHT","RFYES","POINT (-76.60926011 39.29058096)"
"2016","2016","CO","Colorado","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Macular edema (not diabetic)","65-84 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","3.62","0","100","8","TCOND","CDXC4","QDXC4","R4_7","CRDPREV","AGE6584","GM","ALLRACE","RFDM","RFYES","POINT (-106.1336109 38.84384076)"
"2016","2016","IA","Iowa","MSCANCC","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","Ocular injury","65-84 years","All genders","All races","Hypertension","Yes","%","Crude Prevalence","1.81",,,"0.45","4.77","0","200","19","TCOND","CDXC10","QDXC10","R10_1","CRDPREV","AGE6584","GALL","ALLRACE","RFHT","RFYES","POINT (-93.81649056 42.46940091)"
"2016","2016","SD","South Dakota","MSCANCC","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Visual field defect","All ages","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0.52",,,"0.2","1.11","0","1200","46","TCOND","CDXC12","QDXC12","R12_1","CRDPREV","AGEALL","GALL","ALLRACE","RFDM","RFYES","POINT (-100.3735306 44.35313005)"
"2016","2016","OK","Oklahoma","MSCANCC","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","All Blindness and low vision","40-64 years","Female","All races","Hypertension","No","%","Crude Prevalence","0.08",,,"0.06","0.11","100","62900","40","TCOND","CDXC8","QDXC8","R8_ALL","CRDPREV","AGE4064","GF","ALLRACE","RFHT","RFNO","POINT (-97.52107021 35.47203136)"
"2016","2016","CA","California","MSCANCC","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Astigmatism","40-64 years","Male","All races","Hypertension","No","%","Crude Prevalence","1.07",,,"1.03","1.11","2900","268300","6","TCOND","CDXC7","QDXC7","R7_3","CRDPREV","AGE4064","GM","ALLRACE","RFHT","RFNO","POINT (-120.9999995 37.63864012)"
"2016","2016","WY","Wyoming","MSCANCC","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Drain","65-84 years","Male","All races","Diabetes","No","%","Crude Prevalence","0",,,"0","4.86","0","100","56","TUTL","CGLAUTX","QGLAU","RGLADRN","CRDPREV","AGE6584","GM","ALLRACE","RFDM","RFNO","POINT (-108.1098304 43.23554134)"
"2016","2016","NV","Nevada","MSCANCC","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Eyelid infection and inflammation","65-84 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","2.34",,,"0.36","7.55","0","100","32","TCOND","CDXC13","QDXC13","R13_4","CRDPREV","AGE6584","GF","ALLRACE","RFHT","RFYES","POINT (-117.0718406 39.49324039)"
"2016","2016","OK","Oklahoma","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Other/unspecified other retinal disorders","65-84 years","Male","All races","Hypertension","No","%","Crude Prevalence","0.67",,,"0.21","1.6","0","700","40","TCOND","CDXC4","QDXC4","R4_10","CRDPREV","AGE6584","GM","ALLRACE","RFHT","RFNO","POINT (-97.52107021 35.47203136)"
"2016","2016","ME","Maine","MSCANCC","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Laser/photocoagulation","0-17 years","All genders","All races","Diabetes and diabetic retinopathy","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"23","TUTL","CDRTX","QDRTX","RLASPH","CRDPREV","AGE017","GALL","ALLRACE","RFDMDR","RFYES","POINT (-68.98503134 45.25422889)"
"2016","2016","ND","North Dakota","MSCANCC","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Unspecified-age related macular degeneration","18-39 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","1.83","0","200","38","TCOND","CDXC3","QDXC3","R3_1","CRDPREV","AGE1839","GM","ALLRACE","RFHT","RFYES","POINT (-100.118421 47.47531978)"
"2016","2016","GA","Georgia","MSCANCC","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Color blindness","All ages","Male","All races","Hypertension","No","%","Crude Prevalence","0.01",,,"0.01","0.01","0","496200","13","TCOND","CDXC12","QDXC12","R12_2","CRDPREV","AGEALL","GM","ALLRACE","RFHT","RFNO","POINT (-83.62758035 32.83968109)"
"2016","2016","NJ","New Jersey","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Non-congenital cataract","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0.28",,,"0.09","0.65","0","1800","34","TCOND","CDXC6","QDXC6","R6_2","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT (-74.27369129 40.13057005)"
"2016","2016","FL","Florida","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Senile cataract","18-39 years","All genders","All races","Diabetes","No","%","Crude Prevalence","0.06",,,"0.05","0.07","400","664400","12","TCOND","CDXC6","QDXC6","R6_1","CRDPREV","AGE1839","GALL","ALLRACE","RFDM","RFNO","POINT (-81.92896054 28.93204038)"
"2016","2016","WV","West Virginia","MSCANCC","Service Utilization","Cataract Surgery","Percentage of people with diagnosed cataract who had a treatment claim","Any cataract treatment","65-84 years","Female","All races","Hypertension and cataract","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"54","TUTL","CCATS","QCATS","RCATANY","CRDPREV","AGE6584","GF","ALLRACE","RFHTCAT","RFYES","POINT (-80.71264013 38.6655102)"
"2016","2016","OK","Oklahoma","MSCANCC","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Endophthalmitis","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.01","0","44200","40","TCOND","CDXC13","QDXC13","R13_7","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT (-97.52107021 35.47203136)"
"2016","2016","XX","Missing Location","MSCANCC","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Glaucoma surgery","40-64 years","Female","All races","Hypertension","No","%","Crude Prevalence","0.01",,,"0","0.04","0","16900","99","TUTL","CGLAUTX","QGLAU","RGLASUR","CRDPREV","AGE4064","GF","ALLRACE","RFHT","RFNO",
"2016","2016","IA","Iowa","MSCANCC","Eye Health Conditions","Retinal Detachment and Defects","Annual prevalence of treated retinal detachment and defects","All Retinal detachment and defects","18-39 years","Male","All races","Diabetes","No","%","Crude Prevalence","0.07",,,"0.05","0.1","0","40100","19","TCOND","CDXC1","QDXC1","R1_ALL","CRDPREV","AGE1839","GM","ALLRACE","RFDM","RFNO","POINT (-93.81649056 42.46940091)"
"2016","2016","DE","Delaware","MSCANCC","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Any vision screening","65-84 years","All genders","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","1.19","0","300","10","TUTL","CSCRN","QSCRN","RSCNANY","CRDPREV","AGE6584","GALL","ALLRACE","RFHT","RFYES","POINT (-75.57774117 39.00883067)"
"2016","2016","MN","Minnesota","MSCANCC","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Tonometry?test","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","0.15",,,"0","0.82","0","700","27","TUTL","CTEST","QTEST","RTONO","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT","POINT (-94.7942005 46.35564874)"
"2016","2016","GA","Georgia","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Low-tension glaucoma","40-64 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.07",,,"0.06","0.08","400","571100","13","TCOND","CDXC5","QDXC5","R5_3","CRDPREV","AGE4064","GALL","ALLRACE","RFALL","RFTOT","POINT (-83.62758035 32.83968109)"
"2016","2016","NJ","New Jersey","MSCANCC","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Any diabetic retinopathy treatment","All ages","Male","All races","Diabetic retinopathy","Yes","%","Crude Prevalence","21.11",,,"19.1","23.24","300","1500","34","TUTL","CDRTX","QDRTX","RDRANY","CRDPREV","AGEALL","GM","ALLRACE","RFDR","RFYES","POINT (-74.27369129 40.13057005)"
"2016","2016","VA","Virginia","MSCANCC","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Any age related macular degeneration treatment","0-17 years","Male","All races","Diabetes and AMD","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"51","TUTL","CAMDTX","QAMD","RAMDANY","CRDPREV","AGE017","GM","ALLRACE","RFDMAMD","RFYES","POINT (-78.45789046 37.54268067)"
"2016","2016","CO","Colorado","MSCANCC","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Stereo fundus exam","65-84 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","2.48",,,"0.51","7.07","0","100","8","TUTL","CTEST","QTEST","RFUN","CRDPREV","AGE6584","GALL","ALLRACE","RFDM","RFYES","POINT (-106.1336109 38.84384076)"
"2016","2016","MO","Missouri","MSCANCC","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Astigmatism","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.74",,,"0.7","0.78","1500","203100","29","TCOND","CDXC7","QDXC7","R7_3","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT","POINT (-92.56630005 38.63579078)"
"2016","2016","AL","Alabama","MSCANCC","Eye Health Conditions","Cancer and Neoplasms of the Eye","Annual prevalence of treated cancer and neoplasms of the eye","Benign neoplasm","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0.44",,,"0.14","1.04","0","1100","1","TCOND","CDXC15","QDXC15","R15_2","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT (-86.63186076 32.84057112)"
"2016","2016","WI","Wisconsin","MSCANCC","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Tonometry?test","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.21","0","1700","55","TUTL","CTEST","QTEST","RTONO","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT (-89.81637074 44.39319117)"
"2016","2016","MO","Missouri","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Macular edema (not diabetic)","18-39 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","0.05",,,"0","0.29","0","1900","29","TCOND","CDXC4","QDXC4","R4_7","CRDPREV","AGE1839","GF","ALLRACE","RFDM","RFYES","POINT (-92.56630005 38.63579078)"
"2016","2016","PA","Pennsylvania","MSCANCC","Service Utilization","Cataract Surgery","Percentage of people with diagnosed cataract who had a treatment claim","Any cataract treatment","40-64 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.6",,,"0.58","0.63","2100","346100","42","TUTL","CCATS","QCATS","RCATANY","CRDPREV","AGE4064","GALL","ALLRACE","RFALL","RFTOT","POINT (-77.86070029 40.79373015)"
"2016","2016","NY","New York","MSCANCC","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Early/mild diabetic retinopathy","65-84 years","All genders","All races","Hypertension","Yes","%","Crude Prevalence","1.45",,,"1.11","1.86","100","4200","36","TCOND","CDXC2","QDXC2","R2_1","CRDPREV","AGE6584","GALL","ALLRACE","RFHT","RFYES","POINT (-75.54397043 42.82700103)"
"2016","2016","CA","California","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Primary angle-closure glaucoma","0-17 years","All genders","All races","Diabetes","No","%","Crude Prevalence","0",,,"0","0","0","451100","6","TCOND","CDXC5","QDXC5","R5_5","CRDPREV","AGE017","GALL","ALLRACE","RFDM","RFNO","POINT (-120.9999995 37.63864012)"
"2016","2016","TN","Tennessee","MSCANCC","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Vision impairment one eye","All ages","Female","All races","Hypertension","No","%","Crude Prevalence","0.01",,,"0.01","0.01","0","365400","47","TCOND","CDXC8","QDXC8","R8_3","CRDPREV","AGEALL","GF","ALLRACE","RFHT","RFNO","POINT (-85.77449091 35.68094058)"
"2016","2016","KS","Kansas","MSCANCC","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Endothelial dystrophy (Fuchs)","40-64 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","0.14",,,"0.08","0.23","0","11900","20","TCOND","CDXC16","QDXC16","R16_2","CRDPREV","AGE4064","GM","ALLRACE","RFHT","RFYES","POINT (-98.20078123 38.3477403)"
"2016","2016","TN","Tennessee","MSCANCC","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","All Cornea disorders","0-17 years","All genders","All races","Hypertension","No","%","Crude Prevalence","0.08",,,"0.07","0.09","200","189200","47","TCOND","CDXC16","QDXC16","R16_ALL","CRDPREV","AGE017","GALL","ALLRACE","RFHT","RFNO","POINT (-85.77449091 35.68094058)"
"2016","2016","PR","Puerto Rico","MSCANCC","Service Utilization","Cataract Surgery","Percentage of people with diagnosed cataract who had a treatment claim","Any cataract treatment","65-84 years","All genders","All races","All patients","Total","%","Crude Prevalence","0",,,"0","7.4","0","0","72","TUTL","CCATS","QCATS","RCATANY","CRDPREV","AGE6584","GALL","ALLRACE","RFALL","RFTOT","POINT (-66.590149 18.220833)"
"2016","2016","IL","Illinois","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Other/unspecified glaucoma","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0.01","0.01","0","296800","17","TCOND","CDXC5","QDXC5","R5_9","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT","POINT (-88.99771018 40.48501028)"
"2016","2016","AK","Alaska","MSCANCC","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Unspecified-age related macular degeneration","65-84 years","All genders","All races","Diabetes","No","%","Crude Prevalence","1.1",,,"0.04","5.61","0","100","2","TCOND","CDXC3","QDXC3","R3_1","CRDPREV","AGE6584","GALL","ALLRACE","RFDM","RFNO","POINT (-147.722059 64.84507996)"
"2016","2016","IL","Illinois","MSCANCC","Service Utilization","Vision Correction","Percentage of people who had a vision correction visit or supplies claim","Any vision correction","18-39 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","0.88",,,"0.63","1.21","0","4300","17","TUTL","CVC","QVC","RVCANY","CRDPREV","AGE1839","GF","ALLRACE","RFHT","RFYES","POINT (-88.99771018 40.48501028)"
"2016","2016","AZ","Arizona","MSCANCC","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Night blindness","18-39 years","Male","All races","Hypertension","No","%","Crude Prevalence","0",,,"0","0","0","86500","4","TCOND","CDXC12","QDXC12","R12_3","CRDPREV","AGE1839","GM","ALLRACE","RFHT","RFNO","POINT (-111.7638113 34.86597028)"
"2016","2016","MA","Massachusetts","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Non-congenital cataract","40-64 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","2.44",,,"2.05","2.88","100","5600","25","TCOND","CDXC6","QDXC6","R6_2","CRDPREV","AGE4064","GF","ALLRACE","RFDM","RFYES","POINT (-72.08269067 42.27687047)"
"2016","2016","MN","Minnesota","MSCANCC","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Unqualified impairment in one eye, or unspecified","65-84 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","3.62","0","100","27","TCOND","CDXC8","QDXC8","R8_2","CRDPREV","AGE6584","GALL","ALLRACE","RFDM","RFYES","POINT (-94.7942005 46.35564874)"
"2016","2016","MI","Michigan","MSCANCC","Eye Health Conditions","Cancer and Neoplasms of the Eye","Annual prevalence of treated cancer and neoplasms of the eye","Benign neoplasm","18-39 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","0.12",,,"0.05","0.24","0","6500","26","TCOND","CDXC15","QDXC15","R15_2","CRDPREV","AGE1839","GF","ALLRACE","RFHT","RFYES","POINT (-84.71439027 44.66131954)"
"2016","2016","VT","Vermont","MSCANCC","Service Utilization","Cataract Surgery","Percentage of people with diagnosed cataract who had a treatment claim","Cataract surgery","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0.25",,,"0.18","0.33","0","17800","50","TUTL","CCATS","QCATS","RCATSUR","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT (-72.51764079 43.62538124)"
"2016","2016","IA","Iowa","MSCANCC","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Glaucoma surgery","0-17 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","5.96","0","100","19","TUTL","CGLAUTX","QGLAU","RGLASUR","CRDPREV","AGE017","GF","ALLRACE","RFDM","RFYES","POINT (-93.81649056 42.46940091)"
"2016","2016","WA","Washington","MSCANCC","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","All Cornea disorders","0-17 years","Female","All races","Hypertension","No","%","Crude Prevalence","0.1",,,"0.08","0.13","100","62600","53","TCOND","CDXC16","QDXC16","R16_ALL","CRDPREV","AGE017","GF","ALLRACE","RFHT","RFNO","POINT (-120.4700108 47.52227863)"
"2016","2016","TN","Tennessee","MSCANCC","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Glaucoma screening","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0","0","279900","47","TUTL","CSCRN","QSCRN","RSCNGLA","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT","POINT (-85.77449091 35.68094058)"
"2016","2016","FL","Florida","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Other/unspecified other retinal disorders","65-84 years","Female","All races","Hypertension","No","%","Crude Prevalence","1.05",,,"0.78","1.38","100","4800","12","TCOND","CDXC4","QDXC4","R4_10","CRDPREV","AGE6584","GF","ALLRACE","RFHT","RFNO","POINT (-81.92896054 28.93204038)"
"2016","2016","AK","Alaska","MSCANCC","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Keratitis","40-64 years","Male","All races","Diabetes","No","%","Crude Prevalence","0.85",,,"0.6","1.17","0","4400","2","TCOND","CDXC13","QDXC13","R13_2","CRDPREV","AGE4064","GM","ALLRACE","RFDM","RFNO","POINT (-147.722059 64.84507996)"
"2016","2016","AR","Arkansas","MSCANCC","Eye Health Conditions","Cancer and Neoplasms of the Eye","Annual prevalence of treated cancer and neoplasms of the eye","Malignant neoplasm","0-17 years","Female","All races","Diabetes","No","%","Crude Prevalence","0",,,"0","0.02","0","19200","5","TCOND","CDXC15","QDXC15","R15_1","CRDPREV","AGE017","GF","ALLRACE","RFDM","RFNO","POINT (-92.27449074 34.74865012)"
"2016","2016","NY","New York","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Branch retinal vein occlusion","18-39 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","0.03",,,"0.01","0.08","0","12700","36","TCOND","CDXC4","QDXC4","R4_3","CRDPREV","AGE1839","GF","ALLRACE","RFHT","RFYES","POINT (-75.54397043 42.82700103)"
"2016","2016","IA","Iowa","MSCANCC","Service Utilization","Eye Exams","Proportion of patients who had an eye exam in selected year","By any provider type","All ages","Male","All races","Hypertension","Yes","%","Crude Prevalence","93.73",,,"93.29","94.15","11600","12400","19","TUTL","CUTLEX","QUTLEX","REXANY","CRDPREV","AGEALL","GM","ALLRACE","RFHT","RFYES","POINT (-93.81649056 42.46940091)"
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Dry eye syndrome","40-64 years","All genders","All races","Diabetes","No","%","Crude Prevalence","2.57",,,"2.41","2.73","1000","38700","99","TCOND","CDXC14","QDXC14","R14_5","CRDPREV","AGE4064","GALL","ALLRACE","RFDM","RFNO",
"2016","2016","OR","Oregon","MSCANCC","Eye Health Conditions","Retinal Detachment and Defects","Annual prevalence of treated retinal detachment and defects","All Retinal detachment and defects","18-39 years","All genders","All races","Diabetes","No","%","Crude Prevalence","0.07",,,"0.06","0.09","100","107500","41","TCOND","CDXC1","QDXC1","R1_ALL","CRDPREV","AGE1839","GALL","ALLRACE","RFDM","RFNO","POINT (-120.1550313 44.56744942)"
"2016","2016","SD","South Dakota","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Other/unspecified glaucoma","65-84 years","All genders","All races","Hypertension","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"46","TCOND","CDXC5","QDXC5","R5_9","CRDPREV","AGE6584","GALL","ALLRACE","RFHT","RFYES","POINT (-100.3735306 44.35313005)"
"2016","2016","US","National","MSCANCC","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Laser surgery","65-84 years","All genders","All races","Hypertension","Yes","%","Crude Prevalence","0.16",,,"0.12","0.2","100","41700","59","TUTL","CGLAUTX","QGLAU","RLASER","CRDPREV","AGE6584","GALL","ALLRACE","RFHT","RFYES",
"2016","2016","CT","Connecticut","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.59",,,"0.53","0.65","400","64300","9","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT (-72.64984095 41.56266102)"
"2016","2016","PR","Puerto Rico","MSCANCC","Service Utilization","Vision Correction","Percentage of people who had a vision correction visit or supplies claim","Any vision correction","0-17 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.04",,,"0","0.23","0","2400","72","TUTL","CVC","QVC","RVCANY","CRDPREV","AGE017","GALL","ALLRACE","RFALL","RFTOT","POINT (-66.590149 18.220833)"
"2016","2016","PA","Pennsylvania","MSCANCC","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Vision screening","65-84 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","0.59","0","600","42","TUTL","CSCRN","QSCRN","RSCNVIS","CRDPREV","AGE6584","GM","ALLRACE","RFHT","RFYES","POINT (-77.86070029 40.79373015)"
"2016","2016","ME","Maine","MSCANCC","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Infectious diseases","0-17 years","Female","All races","Hypertension","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"23","TCOND","CDXC13","QDXC13","R13_1","CRDPREV","AGE017","GF","ALLRACE","RFHT","RFYES","POINT (-68.98503134 45.25422889)"
"2016","2016","GA","Georgia","MSCANCC","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","All Age-related macular degeneration (AMD)","65-84 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","1.17",,,"0.64","1.95","0","1200","13","TCOND","CDXC3","QDXC3","R3_ALL","CRDPREV","AGE6584","GALL","ALLRACE","RFDM","RFYES","POINT (-83.62758035 32.83968109)"
"2016","2016","VA","Virginia","MSCANCC","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Disorders of the globe","0-17 years","Male","All races","Hypertension","No","%","Crude Prevalence","0.01",,,"0","0.02","0","72000","51","TCOND","CDXC14","QDXC14","R14_6","CRDPREV","AGE017","GM","ALLRACE","RFHT","RFNO","POINT (-78.45789046 37.54268067)"
"2016","2016","KS","Kansas","MSCANCC","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Astigmatism","All ages","Female","All races","Diabetes","Yes","%","Crude Prevalence","5.03",,,"4.41","5.71","200","4500","20","TCOND","CDXC7","QDXC7","R7_3","CRDPREV","AGEALL","GF","ALLRACE","RFDM","RFYES","POINT (-98.20078123 38.3477403)"
"2016","2016","IL","Illinois","MSCANCC","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Keratoconus","0-17 years","All genders","All races","Diabetes","No","%","Crude Prevalence","0.01",,,"0.01","0.02","0","205700","17","TCOND","CDXC16","QDXC16","R16_1","CRDPREV","AGE017","GALL","ALLRACE","RFDM","RFNO","POINT (-88.99771018 40.48501028)"
"2016","2016","NV","Nevada","MSCANCC","Service Utilization","Cataract Surgery","Percentage of people with diagnosed cataract who had a treatment claim","Cataract surgery","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.02","0","27800","32","TUTL","CCATS","QCATS","RCATSUR","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT (-117.0718406 39.49324039)"
"2016","2016","MO","Missouri","MSCANCC","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Lacrimal and orbit inflammation","0-17 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","1.83","0","200","29","TCOND","CDXC13","QDXC13","R13_6","CRDPREV","AGE017","GM","ALLRACE","RFDM","RFYES","POINT (-92.56630005 38.63579078)"
"2016","2016","NH","New Hampshire","MSCANCC","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Optical coherence tomography","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","3.96",,,"3.67","4.25","700","17700","33","TUTL","CTEST","QTEST","ROCT","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT (-71.50036092 43.65595011)"
"2016","2016","AK","Alaska","MSCANCC","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Vision screening","0-17 years","Male","All races","Hypertension","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"2","TUTL","CSCRN","QSCRN","RSCNVIS","CRDPREV","AGE017","GM","ALLRACE","RFHT","RFYES","POINT (-147.722059 64.84507996)"
"2016","2016","NY","New York","MSCANCC","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Geographic atrophy","40-64 years","All genders","All races","Hypertension","No","%","Crude Prevalence","0",,,"0","0","0","617100","36","TCOND","CDXC3","QDXC3","R3_3GA","CRDPREV","AGE4064","GALL","ALLRACE","RFHT","RFNO","POINT (-75.54397043 42.82700103)"
"2016","2016","AK","Alaska","MSCANCC","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Laser/photocoagulation","0-17 years","Male","All races","Hypertension","No","%","Crude Prevalence","0",,,"0","0.1","0","3700","2","TUTL","CDRTX","QDRTX","RLASPH","CRDPREV","AGE017","GM","ALLRACE","RFHT","RFNO","POINT (-147.722059 64.84507996)"
"2016","2016","MS","Mississippi","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Non-Occlusive retinal vascular disease","65-84 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","0.79",,,"0.01","5.09","0","100","28","TCOND","CDXC4","QDXC4","R4_6","CRDPREV","AGE6584","GM","ALLRACE","RFDM","RFYES","POINT (-89.53803082 32.7455101)"
"2016","2016","TN","Tennessee","MSCANCC","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","All Diabetic eye diseases","0-17 years","Female","All races","Hypertension","No","%","Crude Prevalence","0",,,"0","0","0","92200","47","TCOND","CDXC2","QDXC2","R2_ALL","CRDPREV","AGE017","GF","ALLRACE","RFHT","RFNO","POINT (-85.77449091 35.68094058)"
"2016","2016","AK","Alaska","MSCANCC","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Conjunctivitis","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","3.62","0","100","2","TCOND","CDXC13","QDXC13","R13_3","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT (-147.722059 64.84507996)"
"2016","2016","RI","Rhode Island","MSCANCC","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Myopia","All ages","Male","All races","Hypertension","No","%","Crude Prevalence","2.45",,,"2.26","2.65","600","24900","44","TCOND","CDXC7","QDXC7","R7_1","CRDPREV","AGEALL","GM","ALLRACE","RFHT","RFNO","POINT (-71.52247031 41.70828019)"
"2016","2016","MD","Maryland","MSCANCC","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Disorders of the globe","18-39 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","0.14","0","2700","24","TCOND","CDXC14","QDXC14","R14_6","CRDPREV","AGE1839","GM","ALLRACE","RFHT","RFYES","POINT (-76.60926011 39.29058096)"
"2016","2016","NC","North Carolina","MSCANCC","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Any diabetic retinopathy treatment","18-39 years","Male","All races","Diabetes","No","%","Crude Prevalence","2.01",,,"1.93","2.08","2600","130600","37","TUTL","CDRTX","QDRTX","RDRANY","CRDPREV","AGE1839","GM","ALLRACE","RFDM","RFNO","POINT (-79.15925046 35.46622098)"
"2016","2016","FL","Florida","MSCANCC","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Myopia","All ages","All genders","All races","Hypertension","No","%","Crude Prevalence","0.55",,,"0.54","0.56","8900","1620100","12","TCOND","CDXC7","QDXC7","R7_1","CRDPREV","AGEALL","GALL","ALLRACE","RFHT","RFNO","POINT (-81.92896054 28.93204038)"
"2016","2016","RI","Rhode Island","MSCANCC","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","All Orbital and external disease","All ages","All genders","All races","Hypertension","No","%","Crude Prevalence","2.85",,,"2.71","3","1400","50800","44","TCOND","CDXC14","QDXC14","R14_ALL","CRDPREV","AGEALL","GALL","ALLRACE","RFHT","RFNO","POINT (-71.52247031 41.70828019)"
"2016","2016","FL","Florida","MSCANCC","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Any glaucoma treatment","18-39 years","Male","All races","Glaucoma","Yes","%","Crude Prevalence","1.18",,,"0.69","1.88","0","1400","12","TUTL","CGLAUTX","QGLAU","RGLAANY","CRDPREV","AGE1839","GM","ALLRACE","RFGLC","RFYES","POINT (-81.92896054 28.93204038)"
"2016","2016","NC","North Carolina","MSCANCC","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Flourescein angiography","65-84 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","1.01",,,"0.12","3.6","0","200","37","TUTL","CTEST","QTEST","RANGIO","CRDPREV","AGE6584","GF","ALLRACE","RFDM","RFYES","POINT (-79.15925046 35.46622098)"
"2016","2016","NH","New Hampshire","MSCANCC","Service Utilization","Eye Exams","Proportion of patients who had an eye exam in selected year","By any provider type","18-39 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","92.06",,,"89.3","94.29","500","500","33","TUTL","CUTLEX","QUTLEX","REXANY","CRDPREV","AGE1839","GM","ALLRACE","RFHT","RFYES","POINT (-71.50036092 43.65595011)"
"2016","2016","FL","Florida","MSCANCC","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Geographic atrophy","All ages","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0","0","904400","12","TCOND","CDXC3","QDXC3","R3_3GA","CRDPREV","AGEALL","GM","ALLRACE","RFALL","RFTOT","POINT (-81.92896054 28.93204038)"
"2016","2016","ND","North Dakota","MSCANCC","Service Utilization","Cataract Surgery","Percentage of people with diagnosed cataract who had a treatment claim","Cataract surgery","0-17 years","Male","All races","Hypertension","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"38","TUTL","CCATS","QCATS","RCATSUR","CRDPREV","AGE017","GM","ALLRACE","RFHT","RFYES","POINT (-100.118421 47.47531978)"
"2016","2016","MO","Missouri","MSCANCC","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Vision impairment one eye","40-64 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0.09",,,"0.06","0.13","0","26100","29","TCOND","CDXC8","QDXC8","R8_3","CRDPREV","AGE4064","GALL","ALLRACE","RFDM","RFYES","POINT (-92.56630005 38.63579078)"
"2016","2016","FL","Florida","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Senile cataract","0-17 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0.01","0.01","0","401800","12","TCOND","CDXC6","QDXC6","R6_1","CRDPREV","AGE017","GALL","ALLRACE","RFALL","RFTOT","POINT (-81.92896054 28.93204038)"
"2016","2016","PR","Puerto Rico","MSCANCC","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Eyelid disorders","40-64 years","All genders","All races","Diabetes","No","%","Crude Prevalence","0.28",,,"0.13","0.52","0","3500","72","TCOND","CDXC14","QDXC14","R14_4","CRDPREV","AGE4064","GALL","ALLRACE","RFDM","RFNO","POINT (-66.590149 18.220833)"
"2016","2016","VA","Virginia","MSCANCC","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","All Diabetic eye diseases","All ages","Female","All races","Hypertension","No","%","Crude Prevalence","0.1",,,"0.09","0.11","300","259900","51","TCOND","CDXC2","QDXC2","R2_ALL","CRDPREV","AGEALL","GF","ALLRACE","RFHT","RFNO","POINT (-78.45789046 37.54268067)"
"2016","2016","MN","Minnesota","MSCANCC","Eye Health Conditions","Disorders of Optic Nerve and Visual Pathways","Annual prevalence of treated disorders of optic nerve and visual pathways","Optic nerve disorders","All ages","Male","All races","Hypertension","No","%","Crude Prevalence","0.12",,,"0.1","0.14","200","137800","27","TCOND","CDXC11","QDXC11","R11_1","CRDPREV","AGEALL","GM","ALLRACE","RFHT","RFNO","POINT (-94.7942005 46.35564874)"
"2016","2016","WY","Wyoming","MSCANCC","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","All Age-related macular degeneration (AMD)","40-64 years","All genders","All races","Hypertension","No","%","Crude Prevalence","0.42",,,"0.29","0.58","0","8500","56","TCOND","CDXC3","QDXC3","R3_ALL","CRDPREV","AGE4064","GALL","ALLRACE","RFHT","RFNO","POINT (-108.1098304 43.23554134)"
"2016","2016","VT","Vermont","MSCANCC","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Wet-form age-related macular degeneration","40-64 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.04",,,"0.01","0.11","0","8900","50","TCOND","CDXC3","QDXC3","R3_4","CRDPREV","AGE4064","GALL","ALLRACE","RFALL","RFTOT","POINT (-72.51764079 43.62538124)"
"2016","2016","NC","North Carolina","MSCANCC","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","All Other visual disturbances","65-84 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","0.51",,,"0.01","2.77","0","200","37","TCOND","CDXC12","QDXC12","R12_ALL","CRDPREV","AGE6584","GF","ALLRACE","RFDM","RFYES","POINT (-79.15925046 35.46622098)"
"2016","2016","NC","North Carolina","MSCANCC","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Geographic atrophy","0-17 years","All genders","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","0.74","0","500","37","TCOND","CDXC3","QDXC3","R3_3GA","CRDPREV","AGE017","GALL","ALLRACE","RFHT","RFYES","POINT (-79.15925046 35.46622098)"
"2016","2016","PA","Pennsylvania","MSCANCC","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Vision screening","0-17 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","10.69",,,"7.52","14.62","0","300","42","TUTL","CSCRN","QSCRN","RSCNVIS","CRDPREV","AGE017","GM","ALLRACE","RFDM","RFYES","POINT (-77.86070029 40.79373015)"
"2016","2016","MD","Maryland","MSCANCC","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Other/unspecified orbital and external disease","65-84 years","All genders","All races","Diabetes","No","%","Crude Prevalence","0",,,"0","0.26","0","1400","24","TCOND","CDXC14","QDXC14","R14_2","CRDPREV","AGE6584","GALL","ALLRACE","RFDM","RFNO","POINT (-76.60926011 39.29058096)"
"2016","2016","ME","Maine","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Secondary glaucoma","40-64 years","Male","All races","All patients","Total","%","Crude Prevalence","0.06",,,"0.03","0.12","0","14000","23","TCOND","CDXC5","QDXC5","R5_10","CRDPREV","AGE4064","GM","ALLRACE","RFALL","RFTOT","POINT (-68.98503134 45.25422889)"
"2016","2016","IN","Indiana","MSCANCC","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Endothelial dystrophy (Fuchs)","40-64 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.09",,,"0.08","0.1","200","249500","18","TCOND","CDXC16","QDXC16","R16_2","CRDPREV","AGE4064","GALL","ALLRACE","RFALL","RFTOT","POINT (-86.14996019 39.76691045)"
"2016","2016","MN","Minnesota","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","All Other retinal disorders","40-64 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","3.11",,,"2.54","3.77","100","3200","27","TCOND","CDXC4","QDXC4","R4_ALL","CRDPREV","AGE4064","GF","ALLRACE","RFDM","RFYES","POINT (-94.7942005 46.35564874)"
"2016","2016","ID","Idaho","MSCANCC","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Moderate imp. better eye, profound imp. lesser eye","All ages","Male","All races","Hypertension","No","%","Crude Prevalence","0",,,"0","0","0","197500","16","TCOND","CDXC8","QDXC8","R8_4","CRDPREV","AGEALL","GM","ALLRACE","RFHT","RFNO","POINT (-114.36373 43.68263001)"
"2016","2016","MT","Montana","MSCANCC","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Other/unspecified infectious and inflammatory diseases","18-39 years","All genders","All races","Diabetes","No","%","Crude Prevalence","0.13",,,"0.07","0.22","0","11300","30","TCOND","CDXC13","QDXC13","R13_5","CRDPREV","AGE1839","GALL","ALLRACE","RFDM","RFNO","POINT (-109.4244206 47.06652897)"
"2016","2016","VT","Vermont","MSCANCC","Eye Health Conditions","Cancer and Neoplasms of the Eye","Annual prevalence of treated cancer and neoplasms of the eye","Benign neoplasm","40-64 years","All genders","All races","Diabetes","No","%","Crude Prevalence","0.96",,,"0.76","1.2","100","8100","50","TCOND","CDXC15","QDXC15","R15_2","CRDPREV","AGE4064","GALL","ALLRACE","RFDM","RFNO","POINT (-72.51764079 43.62538124)"
"2016","2016","WV","West Virginia","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","All Glaucoma","All ages","Female","All races","Diabetes","No","%","Crude Prevalence","1.42",,,"1.29","1.56","400","31500","54","TCOND","CDXC5","QDXC5","R5_ALL","CRDPREV","AGEALL","GF","ALLRACE","RFDM","RFNO","POINT (-80.71264013 38.6655102)"
"2016","2016","NH","New Hampshire","MSCANCC","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Anti-VEGF injections","65-84 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","7.87","0","0","33","TUTL","CDRTX","QDRTX","RVEGF","CRDPREV","AGE6584","GF","ALLRACE","RFHT","RFYES","POINT (-71.50036092 43.65595011)"
"2016","2016","NE","Nebraska","MSCANCC","Service Utilization","Cataract Surgery","Percentage of people with diagnosed cataract who had a treatment claim","Cataract surgery","40-64 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.63",,,"0.55","0.72","200","34100","31","TUTL","CCATS","QCATS","RCATSUR","CRDPREV","AGE4064","GALL","ALLRACE","RFALL","RFTOT","POINT (-99.36572062 41.64104099)"
"2016","2016","AK","Alaska","MSCANCC","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Color blindness","0-17 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.04",,,"0.01","0.12","0","7200","2","TCOND","CDXC12","QDXC12","R12_2","CRDPREV","AGE017","GALL","ALLRACE","RFALL","RFTOT","POINT (-147.722059 64.84507996)"
"2016","2016","AR","Arkansas","MSCANCC","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Visual field defect","All ages","Female","All races","Hypertension","No","%","Crude Prevalence","0.1",,,"0.08","0.13","100","71500","5","TCOND","CDXC12","QDXC12","R12_1","CRDPREV","AGEALL","GF","ALLRACE","RFHT","RFNO","POINT (-92.27449074 34.74865012)"
"2016","2016","OH","Ohio","MSCANCC","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Retinal detachment repair","0-17 years","Male","All races","Diabetic retinopathy","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"39","TUTL","CDRTX","QDRTX","RDRRET","CRDPREV","AGE017","GM","ALLRACE","RFDR","RFYES","POINT (-82.40426006 40.06021014)"
"2016","2016","MO","Missouri","MSCANCC","Eye Health Conditions","Cancer and Neoplasms of the Eye","Annual prevalence of treated cancer and neoplasms of the eye","Benign neoplasm","40-64 years","All genders","All races","Hypertension","No","%","Crude Prevalence","0.38",,,"0.35","0.41","600","158100","29","TCOND","CDXC15","QDXC15","R15_2","CRDPREV","AGE4064","GALL","ALLRACE","RFHT","RFNO","POINT (-92.56630005 38.63579078)"
"2016","2016","AL","Alabama","MSCANCC","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Color blindness","All ages","Male","All races","Diabetes","No","%","Crude Prevalence","0.01",,,"0.01","0.02","0","171900","1","TCOND","CDXC12","QDXC12","R12_2","CRDPREV","AGEALL","GM","ALLRACE","RFDM","RFNO","POINT (-86.63186076 32.84057112)"
"2016","2016","OK","Oklahoma","MSCANCC","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Anti-VEGF injections","0-17 years","Male","All races","Diabetes and diabetic retinopathy","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"40","TUTL","CDRTX","QDRTX","RVEGF","CRDPREV","AGE017","GM","ALLRACE","RFDMDR","RFYES","POINT (-97.52107021 35.47203136)"
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Aphakia and disorders of lens","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.04","0","20600","99","TCOND","CDXC6","QDXC6","R6_6","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT",
"2016","2016","AR","Arkansas","MSCANCC","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Dry-form age-related macular degeneration","40-64 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","0.39",,,"0.28","0.53","0","10500","5","TCOND","CDXC3","QDXC3","R3_3","CRDPREV","AGE4064","GM","ALLRACE","RFHT","RFYES","POINT (-92.27449074 34.74865012)"
"2016","2016","PA","Pennsylvania","MSCANCC","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Tonometry?test","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.01","0","144600","42","TUTL","CTEST","QTEST","RTONO","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT (-77.86070029 40.79373015)"
"2016","2016","IL","Illinois","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Other/unspecified other retinal disorders","0-17 years","Male","All races","Diabetes","No","%","Crude Prevalence","0.1",,,"0.08","0.12","100","105500","17","TCOND","CDXC4","QDXC4","R4_10","CRDPREV","AGE017","GM","ALLRACE","RFDM","RFNO","POINT (-88.99771018 40.48501028)"
"2016","2016","MT","Montana","MSCANCC","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Retinal detachment repair","18-39 years","All genders","All races","Hypertension and diabetic retinopathy","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"30","TUTL","CDRTX","QDRTX","RDRRET","CRDPREV","AGE1839","GALL","ALLRACE","RFHTDR","RFYES","POINT (-109.4244206 47.06652897)"
"2016","2016","NV","Nevada","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Branch retinal artery occlusion","40-64 years","All genders","All races","Hypertension","No","%","Crude Prevalence","0.01",,,"0","0.02","0","61400","32","TCOND","CDXC4","QDXC4","R4_5","CRDPREV","AGE4064","GALL","ALLRACE","RFHT","RFNO","POINT (-117.0718406 39.49324039)"
"2016","2016","TX","Texas","MSCANCC","Eye Health Conditions","Disorders of Optic Nerve and Visual Pathways","Annual prevalence of treated disorders of optic nerve and visual pathways","Visual pathway disorders","40-64 years","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0","0","424400","48","TCOND","CDXC11","QDXC11","R11_2","CRDPREV","AGE4064","GM","ALLRACE","RFALL","RFTOT","POINT (-99.42677021 31.82724041)"
"2016","2016","NE","Nebraska","MSCANCC","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Congenital anomalies","18-39 years","Female","All races","Diabetes","No","%","Crude Prevalence","0.04",,,"0.02","0.08","0","17800","31","TCOND","CDXC14","QDXC14","R14_1","CRDPREV","AGE1839","GF","ALLRACE","RFDM","RFNO","POINT (-99.36572062 41.64104099)"
"2016","2016","TN","Tennessee","MSCANCC","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Photodynamic therapy","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0","0","827400","47","TUTL","CAMDTX","QAMD","RPHOTO","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT (-85.77449091 35.68094058)"
"2016","2016","WV","West Virginia","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Central retinal arterial occlusion","All ages","Male","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","0.15","0","2500","54","TCOND","CDXC4","QDXC4","R4_4","CRDPREV","AGEALL","GM","ALLRACE","RFDM","RFYES","POINT (-80.71264013 38.6655102)"
"2016","2016","MS","Mississippi","MSCANCC","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Other/unspecified infectious and inflammatory diseases","40-64 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","0.44",,,"0.33","0.57","100","12500","28","TCOND","CDXC13","QDXC13","R13_5","CRDPREV","AGE4064","GF","ALLRACE","RFDM","RFYES","POINT (-89.53803082 32.7455101)"
"2016","2016","WA","Washington","MSCANCC","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Any glaucoma treatment","18-39 years","All genders","All races","Hypertension","Yes","%","Crude Prevalence","0.02",,,"0","0.09","0","6200","53","TUTL","CGLAUTX","QGLAU","RGLAANY","CRDPREV","AGE1839","GALL","ALLRACE","RFHT","RFYES","POINT (-120.4700108 47.52227863)"
"2016","2016","WI","Wisconsin","MSCANCC","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","All Other visual disturbances","18-39 years","Female","All races","Diabetes","No","%","Crude Prevalence","0.94",,,"0.88","1","1000","111200","55","TCOND","CDXC12","QDXC12","R12_ALL","CRDPREV","AGE1839","GF","ALLRACE","RFDM","RFNO","POINT (-89.81637074 44.39319117)"
"2016","2016","UT","Utah","MSCANCC","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Any age related macular degeneration treatment","65-84 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","6.25",,,"1.31","17.2","0","0","49","TUTL","CAMDTX","QAMD","RAMDANY","CRDPREV","AGE6584","GF","ALLRACE","RFDM","RFYES","POINT (-111.5871306 39.36070017)"
"2016","2016","MS","Mississippi","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Open-angle glaucoma","65-84 years","Male","All races","Diabetes","No","%","Crude Prevalence","0.77",,,"0.29","1.65","0","800","28","TCOND","CDXC5","QDXC5","R5_1","CRDPREV","AGE6584","GM","ALLRACE","RFDM","RFNO","POINT (-89.53803082 32.7455101)"
"2016","2016","AK","Alaska","MSCANCC","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Keratoconus","18-39 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","1.83","0","200","2","TCOND","CDXC16","QDXC16","R16_1","CRDPREV","AGE1839","GALL","ALLRACE","RFDM","RFYES","POINT (-147.722059 64.84507996)"
"2016","2016","TN","Tennessee","MSCANCC","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","All Infectious and inflammatory diseases","40-64 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","7.92",,,"7.57","8.28","1800","22100","47","TCOND","CDXC13","QDXC13","R13_ALL","CRDPREV","AGE4064","GF","ALLRACE","RFDM","RFYES","POINT (-85.77449091 35.68094058)"
"2016","2016","MT","Montana","MSCANCC","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Moderate/Severe non-proliferative diabetic retinopathy","18-39 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","3.62","0","100","30","TCOND","CDXC2","QDXC2","R2_2","CRDPREV","AGE1839","GF","ALLRACE","RFDM","RFYES","POINT (-109.4244206 47.06652897)"
"2016","2016","IA","Iowa","MSCANCC","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","Ocular injury","0-17 years","Female","All races","Hypertension","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"19","TCOND","CDXC10","QDXC10","R10_1","CRDPREV","AGE017","GF","ALLRACE","RFHT","RFYES","POINT (-93.81649056 42.46940091)"
"2016","2016","PA","Pennsylvania","MSCANCC","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Keratitis","0-17 years","All genders","All races","Diabetes","No","%","Crude Prevalence","0.15",,,"0.13","0.17","300","191300","42","TCOND","CDXC13","QDXC13","R13_2","CRDPREV","AGE017","GALL","ALLRACE","RFDM","RFNO","POINT (-77.86070029 40.79373015)"
"2016","2016","OR","Oregon","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Non-congenital cataract","40-64 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","1.2",,,"0.91","1.56","100","4600","41","TCOND","CDXC6","QDXC6","R6_2","CRDPREV","AGE4064","GF","ALLRACE","RFDM","RFYES","POINT (-120.1550313 44.56744942)"
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Other diabetes related eye disorders","0-17 years","All genders","All races","Hypertension","No","%","Crude Prevalence","0",,,"0","0.01","0","31200","99","TCOND","CDXC2","QDXC2","R2_5","CRDPREV","AGE017","GALL","ALLRACE","RFHT","RFNO",
"2016","2016","PR","Puerto Rico","MSCANCC","Eye Health Conditions","Disorders of Optic Nerve and Visual Pathways","Annual prevalence of treated disorders of optic nerve and visual pathways","Visual pathway disorders","40-64 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","0.61","0","600","72","TCOND","CDXC11","QDXC11","R11_2","CRDPREV","AGE4064","GF","ALLRACE","RFHT","RFYES","POINT (-66.590149 18.220833)"
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","Ocular burns","65-84 years","Female","All races","Diabetes","No","%","Crude Prevalence","0",,,"0","1.22","0","300","99","TCOND","CDXC10","QDXC10","R10_2","CRDPREV","AGE6584","GF","ALLRACE","RFDM","RFNO",
"2016","2016","AK","Alaska","MSCANCC","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Choroidal neovascularization","0-17 years","Female","All races","Diabetes","No","%","Crude Prevalence","0",,,"0","0.11","0","3500","2","TCOND","CDXC3","QDXC3","R3_4CNV","CRDPREV","AGE017","GF","ALLRACE","RFDM","RFNO","POINT (-147.722059 64.84507996)"
"2016","2016","NV","Nevada","MSCANCC","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Profound bilateral imp., legal blindness","40-64 years","Male","All races","Hypertension","No","%","Crude Prevalence","0",,,"0","0.01","0","28900","32","TCOND","CDXC8","QDXC8","R8_6","CRDPREV","AGE4064","GM","ALLRACE","RFHT","RFNO","POINT (-117.0718406 39.49324039)"
"2016","2016","OH","Ohio","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Retinopathy of prematurity","65-84 years","Male","All races","Hypertension","No","%","Crude Prevalence","0",,,"0","0.14","0","2700","39","TCOND","CDXC4","QDXC4","R4_11","CRDPREV","AGE6584","GM","ALLRACE","RFHT","RFNO","POINT (-82.40426006 40.06021014)"
"2016","2016","WI","Wisconsin","MSCANCC","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Diabetic Retinopathy Telemedicine Screening","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0","0","101700","55","TUTL","CSCRN","QSCRN","RSCNDR","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT (-89.81637074 44.39319117)"
"2016","2016","TX","Texas","MSCANCC","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Stereo fundus exam","65-84 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","2.5",,,"1.7","3.56","0","1200","48","TUTL","CTEST","QTEST","RFUN","CRDPREV","AGE6584","GF","ALLRACE","RFHT","RFYES","POINT (-99.42677021 31.82724041)"
"2016","2016","MI","Michigan","MSCANCC","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Eyelid infection and inflammation","All ages","Female","All races","All patients","Total","%","Crude Prevalence","1.38",,,"1.35","1.41","7700","555700","26","TCOND","CDXC13","QDXC13","R13_4","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT","POINT (-84.71439027 44.66131954)"
"2016","2016","PA","Pennsylvania","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","All Other retinal disorders","0-17 years","All genders","All races","Hypertension","No","%","Crude Prevalence","0.24",,,"0.22","0.26","500","191400","42","TCOND","CDXC4","QDXC4","R4_ALL","CRDPREV","AGE017","GALL","ALLRACE","RFHT","RFNO","POINT (-77.86070029 40.79373015)"
"2016","2016","MT","Montana","MSCANCC","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","Ocular burns","65-84 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"30","TCOND","CDXC10","QDXC10","R10_2","CRDPREV","AGE6584","GALL","ALLRACE","RFDM","RFYES","POINT (-109.4244206 47.06652897)"
"2016","2016","MD","Maryland","MSCANCC","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Diabetic Retinopathy Telemedicine Screening","All ages","All genders","All races","Hypertension","Yes","%","Crude Prevalence","0.02",,,"0.01","0.04","0","43100","24","TUTL","CSCRN","QSCRN","RSCNDR","CRDPREV","AGEALL","GALL","ALLRACE","RFHT","RFYES","POINT (-76.60926011 39.29058096)"
"2016","2016","MD","Maryland","MSCANCC","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Keratoconus","All ages","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0.14",,,"0.09","0.21","0","16500","24","TCOND","CDXC16","QDXC16","R16_1","CRDPREV","AGEALL","GALL","ALLRACE","RFDM","RFYES","POINT (-76.60926011 39.29058096)"
"2016","2016","MI","Michigan","MSCANCC","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Gonioscopy","65-84 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0.72",,,"0.34","1.31","0","1400","26","TUTL","CTEST","QTEST","RGONIO","CRDPREV","AGE6584","GALL","ALLRACE","RFDM","RFYES","POINT (-84.71439027 44.66131954)"
"2016","2016","AL","Alabama","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Central retinal arterial occlusion","65-84 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","0.92","0","400","1","TCOND","CDXC4","QDXC4","R4_4","CRDPREV","AGE6584","GM","ALLRACE","RFHT","RFYES","POINT (-86.63186076 32.84057112)"
"2016","2016","HI","Hawaii","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Primary angle-closure glaucoma","40-64 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.67",,,"0.34","1.18","0","1700","15","TCOND","CDXC5","QDXC5","R5_5","CRDPREV","AGE4064","GALL","ALLRACE","RFALL","RFTOT","POINT (-157.8577494 21.30485044)"
"2016","2016","WA","Washington","MSCANCC","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Glaucoma surgery","18-39 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","0.3","0","1200","53","TUTL","CGLAUTX","QGLAU","RGLASUR","CRDPREV","AGE1839","GM","ALLRACE","RFDM","RFYES","POINT (-120.4700108 47.52227863)"
"2016","2016","MO","Missouri","MSCANCC","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Early stage age-related macular degeneration","All ages","Female","All races","Diabetes","No","%","Crude Prevalence","0.13",,,"0.12","0.14","400","289600","29","TCOND","CDXC3","QDXC3","R3_2","CRDPREV","AGEALL","GF","ALLRACE","RFDM","RFNO","POINT (-92.56630005 38.63579078)"
"2016","2016","SD","South Dakota","MSCANCC","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Laser/photocoagulation","40-64 years","All genders","All races","Diabetes and diabetic retinopathy","Yes","%","Crude Prevalence","4.94",,,"1.36","12.16","0","100","46","TUTL","CDRTX","QDRTX","RLASPH","CRDPREV","AGE4064","GALL","ALLRACE","RFDMDR","RFYES","POINT (-100.3735306 44.35313005)"
"2016","2016","WA","Washington","MSCANCC","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Photodynamic therapy","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0","0","95700","53","TUTL","CAMDTX","QAMD","RPHOTO","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT (-120.4700108 47.52227863)"
"2016","2016","VT","Vermont","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","All Glaucoma","18-39 years","All genders","All races","Hypertension","Yes","%","Crude Prevalence","2.29",,,"0.7","5.45","0","200","50","TCOND","CDXC5","QDXC5","R5_ALL","CRDPREV","AGE1839","GALL","ALLRACE","RFHT","RFYES","POINT (-72.51764079 43.62538124)"
"2016","2016","SD","South Dakota","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Other/unspecified other retinal disorders","40-64 years","Female","All races","Diabetes","No","%","Crude Prevalence","1.02",,,"0.78","1.31","100","5800","46","TCOND","CDXC4","QDXC4","R4_10","CRDPREV","AGE4064","GF","ALLRACE","RFDM","RFNO","POINT (-100.3735306 44.35313005)"
"2016","2016","ID","Idaho","MSCANCC","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Eyelid disorders","0-17 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","1.83","0","200","16","TCOND","CDXC14","QDXC14","R14_4","CRDPREV","AGE017","GF","ALLRACE","RFDM","RFYES","POINT (-114.36373 43.68263001)"
"2016","2016","NM","New Mexico","MSCANCC","Eye Health Conditions","Cancer and Neoplasms of the Eye","Annual prevalence of treated cancer and neoplasms of the eye","Benign neoplasm","All ages","All genders","All races","Hypertension","No","%","Crude Prevalence","0.09",,,"0.07","0.12","100","60600","35","TCOND","CDXC15","QDXC15","R15_2","CRDPREV","AGEALL","GALL","ALLRACE","RFHT","RFNO","POINT (-106.240581 34.52088095)"
"2016","2016","KS","Kansas","MSCANCC","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Visual field defect","All ages","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0.32",,,"0.22","0.45","0","9800","20","TCOND","CDXC12","QDXC12","R12_1","CRDPREV","AGEALL","GALL","ALLRACE","RFDM","RFYES","POINT (-98.20078123 38.3477403)"
"2016","2016","PA","Pennsylvania","MSCANCC","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Flourescein angiography","All ages","All genders","All races","Hypertension","Yes","%","Crude Prevalence","0.39",,,"0.35","0.43","400","106600","42","TUTL","CTEST","QTEST","RANGIO","CRDPREV","AGEALL","GALL","ALLRACE","RFHT","RFYES","POINT (-77.86070029 40.79373015)"
"2016","2016","LA","Louisiana","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Non-congenital cataract","40-64 years","Male","All races","Diabetes","No","%","Crude Prevalence","0.31",,,"0.29","0.33","700","217200","22","TCOND","CDXC6","QDXC6","R6_2","CRDPREV","AGE4064","GM","ALLRACE","RFDM","RFNO","POINT (-92.44568007 31.31266064)"
"2016","2016","HI","Hawaii","MSCANCC","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Dry eye syndrome","All ages","Male","All races","Diabetes","No","%","Crude Prevalence","1.3",,,"0.77","2.04","0","1400","15","TCOND","CDXC14","QDXC14","R14_5","CRDPREV","AGEALL","GM","ALLRACE","RFDM","RFNO","POINT (-157.8577494 21.30485044)"
"2016","2016","KY","Kentucky","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Retinopathy of prematurity","All ages","All genders","All races","Hypertension","No","%","Crude Prevalence","0.02",,,"0.02","0.02","100","496900","21","TCOND","CDXC4","QDXC4","R4_11","CRDPREV","AGEALL","GALL","ALLRACE","RFHT","RFNO","POINT (-84.77497105 37.64597027)"
"2016","2016","AL","Alabama","MSCANCC","Service Utilization","Cataract Surgery","Percentage of people with diagnosed cataract who had a treatment claim","Cataract surgery","All ages","Male","All races","Cataract","Yes","%","Crude Prevalence","13.05",,,"12.08","14.06","600","4500","1","TUTL","CCATS","QCATS","RCATSUR","CRDPREV","AGEALL","GM","ALLRACE","RFCAT","RFYES","POINT (-86.63186076 32.84057112)"
"2016","2016","NE","Nebraska","MSCANCC","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Any diabetic retinopathy treatment","40-64 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","3.17",,,"2.6","3.81","100","3400","31","TUTL","CDRTX","QDRTX","RDRANY","CRDPREV","AGE4064","GF","ALLRACE","RFHT","RFYES","POINT (-99.36572062 41.64104099)"
"2016","2016","MT","Montana","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Primary angle-closure glaucoma","40-64 years","Male","All races","Diabetes","No","%","Crude Prevalence","0.04",,,"0.01","0.14","0","5400","30","TCOND","CDXC5","QDXC5","R5_5","CRDPREV","AGE4064","GM","ALLRACE","RFDM","RFNO","POINT (-109.4244206 47.06652897)"
"2016","2016","OK","Oklahoma","MSCANCC","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Keratitis","0-17 years","Female","All races","Hypertension","No","%","Crude Prevalence","0.14",,,"0.11","0.18","100","42200","40","TCOND","CDXC13","QDXC13","R13_2","CRDPREV","AGE017","GF","ALLRACE","RFHT","RFNO","POINT (-97.52107021 35.47203136)"
"2016","2016","NJ","New Jersey","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Glaucoma suspect","All ages","Male","All races","Hypertension","Yes","%","Crude Prevalence","4.47",,,"4.29","4.66","2200","49500","34","TCOND","CDXC5","QDXC5","R5_4","CRDPREV","AGEALL","GM","ALLRACE","RFHT","RFYES","POINT (-74.27369129 40.13057005)"
"2016","2016","CT","Connecticut","MSCANCC","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Any diabetic retinopathy treatment","18-39 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","7.06",,,"5.2","9.34","0","600","9","TUTL","CDRTX","QDRTX","RDRANY","CRDPREV","AGE1839","GF","ALLRACE","RFDM","RFYES","POINT (-72.64984095 41.56266102)"
"2016","2016","RI","Rhode Island","MSCANCC","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Moderate/Severe non-proliferative diabetic retinopathy","40-64 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","1.35",,,"0.83","2.07","0","1500","44","TCOND","CDXC2","QDXC2","R2_2","CRDPREV","AGE4064","GM","ALLRACE","RFDM","RFYES","POINT (-71.52247031 41.70828019)"
"2016","2016","WI","Wisconsin","MSCANCC","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Moderate bilateral impairment","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0","0","214400","55","TCOND","CDXC8","QDXC8","R8_5","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT","POINT (-89.81637074 44.39319117)"
"2016","2016","LA","Louisiana","MSCANCC","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Other diabetes related eye disorders","0-17 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","0.25",,,"0.01","1.38","0","400","22","TCOND","CDXC2","QDXC2","R2_5","CRDPREV","AGE017","GF","ALLRACE","RFHT","RFYES","POINT (-92.44568007 31.31266064)"
"2016","2016","PR","Puerto Rico","MSCANCC","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Other corneal disorders","0-17 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.04",,,"0","0.23","0","2400","72","TCOND","CDXC16","QDXC16","R16_3","CRDPREV","AGE017","GALL","ALLRACE","RFALL","RFTOT","POINT (-66.590149 18.220833)"
"2016","2016","KY","Kentucky","MSCANCC","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Eyelid infection and inflammation","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","1",,,"0.65","1.46","0","2600","21","TCOND","CDXC13","QDXC13","R13_4","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT","POINT (-84.77497105 37.64597027)"
"2016","2016","PR","Puerto Rico","MSCANCC","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Drain","All ages","Male","All races","Diabetes","No","%","Crude Prevalence","0",,,"0","0.08","0","4700","72","TUTL","CGLAUTX","QGLAU","RGLADRN","CRDPREV","AGEALL","GM","ALLRACE","RFDM","RFNO","POINT (-66.590149 18.220833)"
"2016","2016","MD","Maryland","MSCANCC","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","Ocular burns","All ages","All genders","All races","Hypertension","Yes","%","Crude Prevalence","0.01",,,"0","0.02","0","43100","24","TCOND","CDXC10","QDXC10","R10_2","CRDPREV","AGEALL","GALL","ALLRACE","RFHT","RFYES","POINT (-76.60926011 39.29058096)"
"2016","2016","AK","Alaska","MSCANCC","Service Utilization","Eye Exams","Proportion of patients who had an eye exam in selected year","By any provider type","All ages","Female","All races","Hypertension","Yes","%","Crude Prevalence","95.55",,,"94.14","96.7","1000","1100","2","TUTL","CUTLEX","QUTLEX","REXANY","CRDPREV","AGEALL","GF","ALLRACE","RFHT","RFYES","POINT (-147.722059 64.84507996)"
"2016","2016","UT","Utah","MSCANCC","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Glaucoma surgery","All ages","Male","All races","Glaucoma","Yes","%","Crude Prevalence","0.79",,,"0.29","1.71","0","800","49","TUTL","CGLAUTX","QGLAU","RGLASUR","CRDPREV","AGEALL","GM","ALLRACE","RFGLC","RFYES","POINT (-111.5871306 39.36070017)"
"2016","2016","ND","North Dakota","MSCANCC","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Any diabetic retinopathy treatment","All ages","Female","All races","Diabetic retinopathy","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"38","TUTL","CDRTX","QDRTX","RDRANY","CRDPREV","AGEALL","GF","ALLRACE","RFDR","RFYES","POINT (-100.118421 47.47531978)"
"2016","2016","ID","Idaho","MSCANCC","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Infectious diseases","All ages","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0.31",,,"0.23","0.41","100","16600","16","TCOND","CDXC13","QDXC13","R13_1","CRDPREV","AGEALL","GALL","ALLRACE","RFDM","RFYES","POINT (-114.36373 43.68263001)"
"2016","2016","AR","Arkansas","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Macular edema (not diabetic)","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.04","0","19300","5","TCOND","CDXC4","QDXC4","R4_7","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT (-92.27449074 34.74865012)"
"2016","2016","ID","Idaho","MSCANCC","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Other corneal disorders","0-17 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","3.62","0","100","16","TCOND","CDXC16","QDXC16","R16_3","CRDPREV","AGE017","GM","ALLRACE","RFHT","RFYES","POINT (-114.36373 43.68263001)"
"2016","2016","CO","Colorado","MSCANCC","Eye Health Conditions","Cancer and Neoplasms of the Eye","Annual prevalence of treated cancer and neoplasms of the eye","All Cancer and neoplasms of the eye diseases","40-64 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","0.32",,,"0.24","0.42","100","16100","8","TCOND","CDXC15","QDXC15","R15_ALL","CRDPREV","AGE4064","GM","ALLRACE","RFHT","RFYES","POINT (-106.1336109 38.84384076)"
"2016","2016","OH","Ohio","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Macular edema (not diabetic)","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0.01","0.02","0","208900","39","TCOND","CDXC4","QDXC4","R4_7","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT (-82.40426006 40.06021014)"
"2016","2016","LA","Louisiana","MSCANCC","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Victrectomy","All ages","All genders","All races","Hypertension and diabetic retinopathy","Yes","%","Crude Prevalence","1.61",,,"1.28","2","100","5000","22","TUTL","CDRTX","QDRTX","RDRVIC","CRDPREV","AGEALL","GALL","ALLRACE","RFHTDR","RFYES","POINT (-92.44568007 31.31266064)"
"2016","2016","MN","Minnesota","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","All Glaucoma","18-39 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","1.58",,,"0.95","2.46","0","1200","27","TCOND","CDXC5","QDXC5","R5_ALL","CRDPREV","AGE1839","GALL","ALLRACE","RFDM","RFYES","POINT (-94.7942005 46.35564874)"
"2016","2016","CO","Colorado","MSCANCC","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Lacrimal diseases","40-64 years","All genders","All races","Diabetes","No","%","Crude Prevalence","0.12",,,"0.1","0.14","200","152600","8","TCOND","CDXC14","QDXC14","R14_3","CRDPREV","AGE4064","GALL","ALLRACE","RFDM","RFNO","POINT (-106.1336109 38.84384076)"
"2016","2016","WY","Wyoming","MSCANCC","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Night blindness","65-84 years","All genders","All races","Hypertension","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"56","TCOND","CDXC12","QDXC12","R12_3","CRDPREV","AGE6584","GALL","ALLRACE","RFHT","RFYES","POINT (-108.1098304 43.23554134)"
"2016","2016","MN","Minnesota","MSCANCC","Service Utilization","Eye Exams","Proportion of patients who had an eye exam in selected year","By any provider type","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","69.7",,,"69.3","70.09","37300","53500","27","TUTL","CUTLEX","QUTLEX","REXANY","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT (-94.7942005 46.35564874)"
"2016","2016","IN","Indiana","MSCANCC","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Laser/photocoagulation","18-39 years","All genders","All races","Diabetic retinopathy","Yes","%","Crude Prevalence","16.89",,,"11.24","23.92","0","100","18","TUTL","CDRTX","QDRTX","RLASPH","CRDPREV","AGE1839","GALL","ALLRACE","RFDR","RFYES","POINT (-86.14996019 39.76691045)"
"2016","2016","NV","Nevada","MSCANCC","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Any diabetic retinopathy treatment","0-17 years","Female","All races","Diabetic retinopathy","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"32","TUTL","CDRTX","QDRTX","RDRANY","CRDPREV","AGE017","GF","ALLRACE","RFDR","RFYES","POINT (-117.0718406 39.49324039)"
"2016","2016","NJ","New Jersey","MSCANCC","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Anti-VEGF injections","65-84 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","0.49",,,"0.01","2.71","0","200","34","TUTL","CDRTX","QDRTX","RVEGF","CRDPREV","AGE6584","GF","ALLRACE","RFDM","RFYES","POINT (-74.27369129 40.13057005)"
"2016","2016","RI","Rhode Island","MSCANCC","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","All Strabismus and amblyopia","40-64 years","Female","All races","Diabetes","No","%","Crude Prevalence","0.39",,,"0.28","0.52","0","11500","44","TCOND","CDXC9","QDXC9","R9_ALL","CRDPREV","AGE4064","GF","ALLRACE","RFDM","RFNO","POINT (-71.52247031 41.70828019)"
"2016","2016","XX","Missing Location","MSCANCC","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Any vision screening","18-39 years","All genders","All races","Hypertension","Yes","%","Crude Prevalence","0.8",,,"0.35","1.57","0","1000","99","TUTL","CSCRN","QSCRN","RSCNANY","CRDPREV","AGE1839","GALL","ALLRACE","RFHT","RFYES",
"2016","2016","VA","Virginia","MSCANCC","Service Utilization","Cataract Surgery","Percentage of people with diagnosed cataract who had a treatment claim","Any cataract treatment","40-64 years","Female","All races","Cataract","Yes","%","Crude Prevalence","10.76",,,"10.03","11.53","700","6700","51","TUTL","CCATS","QCATS","RCATANY","CRDPREV","AGE4064","GF","ALLRACE","RFCAT","RFYES","POINT (-78.45789046 37.54268067)"
"2016","2016","OK","Oklahoma","MSCANCC","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","All Orbital and external disease","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0.36",,,"0.31","0.41","200","62800","40","TCOND","CDXC14","QDXC14","R14_ALL","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT (-97.52107021 35.47203136)"
"2016","2016","IN","Indiana","MSCANCC","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Choroidal neovascularization","All ages","Female","All races","Diabetes","No","%","Crude Prevalence","0",,,"0","0","0","296500","18","TCOND","CDXC3","QDXC3","R3_4CNV","CRDPREV","AGEALL","GF","ALLRACE","RFDM","RFNO","POINT (-86.14996019 39.76691045)"
"2016","2016","NC","North Carolina","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Central retinal vein occlusion","65-84 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","1.83","0","200","37","TCOND","CDXC4","QDXC4","R4_2","CRDPREV","AGE6584","GF","ALLRACE","RFDM","RFYES","POINT (-79.15925046 35.46622098)"
"2016","2016","AR","Arkansas","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Myopic degeneration","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0.03",,,"0.01","0.06","0","29800","5","TCOND","CDXC4","QDXC4","R4_9","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT (-92.27449074 34.74865012)"
"2016","2016","MI","Michigan","MSCANCC","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Glaucoma surgery","40-64 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","0.01",,,"0","0.02","0","73400","26","TUTL","CGLAUTX","QGLAU","RGLASUR","CRDPREV","AGE4064","GF","ALLRACE","RFHT","RFYES","POINT (-84.71439027 44.66131954)"
"2016","2016","MS","Mississippi","MSCANCC","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Endothelial dystrophy (Fuchs)","65-84 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","1.22","0","300","28","TCOND","CDXC16","QDXC16","R16_2","CRDPREV","AGE6584","GM","ALLRACE","RFHT","RFYES","POINT (-89.53803082 32.7455101)"
"2016","2016","KS","Kansas","MSCANCC","Service Utilization","Vision Correction","Percentage of people who had a vision correction visit or supplies claim","Contact lens or fitting","18-39 years","All genders","All races","Hypertension","Yes","%","Crude Prevalence","0.6",,,"0.36","0.93","0","3200","20","TUTL","CVC","QVC","RCONTAC","CRDPREV","AGE1839","GALL","ALLRACE","RFHT","RFYES","POINT (-98.20078123 38.3477403)"
"2016","2016","MA","Massachusetts","MSCANCC","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Unqualified impairment in one eye, or unspecified","18-39 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","0.46","0","800","25","TCOND","CDXC8","QDXC8","R8_2","CRDPREV","AGE1839","GM","ALLRACE","RFDM","RFYES","POINT (-72.08269067 42.27687047)"
"2016","2016","MS","Mississippi","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Branch retinal artery occlusion","65-84 years","Female","All races","Hypertension","No","%","Crude Prevalence","0",,,"0","0.37","0","1000","28","TCOND","CDXC4","QDXC4","R4_5","CRDPREV","AGE6584","GF","ALLRACE","RFHT","RFNO","POINT (-89.53803082 32.7455101)"
"2016","2016","NJ","New Jersey","MSCANCC","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Any diabetic retinopathy treatment","65-84 years","All genders","All races","Diabetes","No","%","Crude Prevalence","0.96",,,"0.66","1.37","0","3200","34","TUTL","CDRTX","QDRTX","RDRANY","CRDPREV","AGE6584","GALL","ALLRACE","RFDM","RFNO","POINT (-74.27369129 40.13057005)"
"2016","2016","WA","Washington","MSCANCC","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Photodynamic therapy","40-64 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","0.01","0","25900","53","TUTL","CAMDTX","QAMD","RPHOTO","CRDPREV","AGE4064","GF","ALLRACE","RFHT","RFYES","POINT (-120.4700108 47.52227863)"
"2016","2016","NM","New Mexico","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Macular edema (not diabetic)","18-39 years","All genders","All races","Diabetes","No","%","Crude Prevalence","0",,,"0","0.01","0","25000","35","TCOND","CDXC4","QDXC4","R4_7","CRDPREV","AGE1839","GALL","ALLRACE","RFDM","RFNO","POINT (-106.240581 34.52088095)"
"2016","2016","OR","Oregon","MSCANCC","Eye Health Conditions","Cancer and Neoplasms of the Eye","Annual prevalence of treated cancer and neoplasms of the eye","Benign neoplasm","18-39 years","Female","All races","Diabetes","No","%","Crude Prevalence","0.1",,,"0.08","0.13","100","56100","41","TCOND","CDXC15","QDXC15","R15_2","CRDPREV","AGE1839","GF","ALLRACE","RFDM","RFNO","POINT (-120.1550313 44.56744942)"
"2016","2016","VA","Virginia","MSCANCC","Service Utilization","Cataract Surgery","Percentage of people with diagnosed cataract who had a treatment claim","Any cataract treatment","18-39 years","All genders","All races","Diabetes","No","%","Crude Prevalence","0.02",,,"0.01","0.02","0","202700","51","TUTL","CCATS","QCATS","RCATANY","CRDPREV","AGE1839","GALL","ALLRACE","RFDM","RFNO","POINT (-78.45789046 37.54268067)"
"2016","2016","MA","Massachusetts","MSCANCC","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Drain","All ages","Male","All races","Diabetes and glaucoma","Yes","%","Crude Prevalence","0.81",,,"0.3","1.75","0","700","25","TUTL","CGLAUTX","QGLAU","RGLADRN","CRDPREV","AGEALL","GM","ALLRACE","RFDMGLC","RFYES","POINT (-72.08269067 42.27687047)"
"2016","2016","IL","Illinois","MSCANCC","Eye Health Conditions","Disorders of Optic Nerve and Visual Pathways","Annual prevalence of treated disorders of optic nerve and visual pathways","All Disorders of optic nerve and visual pathways","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0.23",,,"0.21","0.26","300","145700","17","TCOND","CDXC11","QDXC11","R11_ALL","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT (-88.99771018 40.48501028)"
"2016","2016","ID","Idaho","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Central retinal vein occlusion","18-39 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0.14",,,"0.03","0.4","0","2200","16","TCOND","CDXC4","QDXC4","R4_2","CRDPREV","AGE1839","GALL","ALLRACE","RFDM","RFYES","POINT (-114.36373 43.68263001)"
"2016","2016","AZ","Arizona","MSCANCC","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","All Cornea disorders","0-17 years","Male","All races","Hypertension","No","%","Crude Prevalence","0.04",,,"0.03","0.06","0","71400","4","TCOND","CDXC16","QDXC16","R16_ALL","CRDPREV","AGE017","GM","ALLRACE","RFHT","RFNO","POINT (-111.7638113 34.86597028)"
"2016","2016","SD","South Dakota","MSCANCC","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","All Orbital and external disease","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0.99",,,"0.76","1.26","100","6500","46","TCOND","CDXC14","QDXC14","R14_ALL","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT (-100.3735306 44.35313005)"
"2016","2016","NC","North Carolina","MSCANCC","Eye Health Conditions","Disorders of Optic Nerve and Visual Pathways","Annual prevalence of treated disorders of optic nerve and visual pathways","Visual pathway disorders","0-17 years","Male","All races","Hypertension","No","%","Crude Prevalence","0",,,"0","0","0","95300","37","TCOND","CDXC11","QDXC11","R11_2","CRDPREV","AGE017","GM","ALLRACE","RFHT","RFNO","POINT (-79.15925046 35.46622098)"
"2016","2016","MS","Mississippi","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","All Glaucoma","18-39 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","0.89",,,"0.64","1.21","0","4600","28","TCOND","CDXC5","QDXC5","R5_ALL","CRDPREV","AGE1839","GM","ALLRACE","RFHT","RFYES","POINT (-89.53803082 32.7455101)"
"2016","2016","CT","Connecticut","MSCANCC","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Endophthalmitis","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.02","0","100400","9","TCOND","CDXC13","QDXC13","R13_7","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT","POINT (-72.64984095 41.56266102)"
"2016","2016","RI","Rhode Island","MSCANCC","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","Strabismus","All ages","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0.37",,,"0.19","0.66","0","3000","44","TCOND","CDXC9","QDXC9","R9_1","CRDPREV","AGEALL","GALL","ALLRACE","RFDM","RFYES","POINT (-71.52247031 41.70828019)"
"2016","2016","MA","Massachusetts","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Posterior capsular opacity","18-39 years","Male","All races","Hypertension","No","%","Crude Prevalence","0.01",,,"0","0.02","0","75700","25","TCOND","CDXC6","QDXC6","R6_4","CRDPREV","AGE1839","GM","ALLRACE","RFHT","RFNO","POINT (-72.08269067 42.27687047)"
"2016","2016","AL","Alabama","MSCANCC","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Visual field testing","All ages","Male","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","0.01","0","41400","1","TUTL","CTEST","QTEST","RVISFLD","CRDPREV","AGEALL","GM","ALLRACE","RFHT","RFYES","POINT (-86.63186076 32.84057112)"
"2016","2016","MS","Mississippi","MSCANCC","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Other/unspecified visual disturbances","All ages","Male","All races","Diabetes","Yes","%","Crude Prevalence","1.13",,,"0.94","1.35","100","10600","28","TCOND","CDXC12","QDXC12","R12_4","CRDPREV","AGEALL","GM","ALLRACE","RFDM","RFYES","POINT (-89.53803082 32.7455101)"
"2016","2016","IN","Indiana","MSCANCC","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Other corneal disorders","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.45",,,"0.41","0.49","600","131600","18","TCOND","CDXC16","QDXC16","R16_3","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT (-86.14996019 39.76691045)"
"2016","2016","AK","Alaska","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Posterior capsular opacity","65-84 years","All genders","All races","Hypertension","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"2","TCOND","CDXC6","QDXC6","R6_4","CRDPREV","AGE6584","GALL","ALLRACE","RFHT","RFYES","POINT (-147.722059 64.84507996)"
"2016","2016","MN","Minnesota","MSCANCC","Eye Health Conditions","Disorders of Optic Nerve and Visual Pathways","Annual prevalence of treated disorders of optic nerve and visual pathways","Optic nerve disorders","0-17 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","3.62","0","100","27","TCOND","CDXC11","QDXC11","R11_1","CRDPREV","AGE017","GF","ALLRACE","RFDM","RFYES","POINT (-94.7942005 46.35564874)"
"2016","2016","UT","Utah","MSCANCC","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","All Age-related macular degeneration (AMD)","All ages","Female","All races","Hypertension","Yes","%","Crude Prevalence","0.93",,,"0.74","1.15","100","9100","49","TCOND","CDXC3","QDXC3","R3_ALL","CRDPREV","AGEALL","GF","ALLRACE","RFHT","RFYES","POINT (-111.5871306 39.36070017)"
"2016","2016","MA","Massachusetts","MSCANCC","Eye Health Conditions","Cancer and Neoplasms of the Eye","Annual prevalence of treated cancer and neoplasms of the eye","Malignant neoplasm","40-64 years","Female","All races","Diabetes","No","%","Crude Prevalence","0.03",,,"0.02","0.04","0","90600","25","TCOND","CDXC15","QDXC15","R15_1","CRDPREV","AGE4064","GF","ALLRACE","RFDM","RFNO","POINT (-72.08269067 42.27687047)"
"2016","2016","NY","New York","MSCANCC","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Lacrimal diseases","0-17 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","0.42",,,"0.08","1.23","0","700","36","TCOND","CDXC14","QDXC14","R14_3","CRDPREV","AGE017","GM","ALLRACE","RFHT","RFYES","POINT (-75.54397043 42.82700103)"
"2016","2016","KS","Kansas","MSCANCC","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","Ocular injury","All ages","Female","All races","Diabetes","Yes","%","Crude Prevalence","0.64",,,"0.43","0.92","0","4500","20","TCOND","CDXC10","QDXC10","R10_1","CRDPREV","AGEALL","GF","ALLRACE","RFDM","RFYES","POINT (-98.20078123 38.3477403)"
"2016","2016","WY","Wyoming","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Low-tension glaucoma","18-39 years","Female","All races","Hypertension","No","%","Crude Prevalence","0",,,"0","0.06","0","5900","56","TCOND","CDXC5","QDXC5","R5_3","CRDPREV","AGE1839","GF","ALLRACE","RFHT","RFNO","POINT (-108.1098304 43.23554134)"
"2016","2016","NC","North Carolina","MSCANCC","Eye Health Conditions","Cancer and Neoplasms of the Eye","Annual prevalence of treated cancer and neoplasms of the eye","Benign neoplasm","40-64 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","0.63",,,"0.52","0.75","100","18800","37","TCOND","CDXC15","QDXC15","R15_2","CRDPREV","AGE4064","GM","ALLRACE","RFDM","RFYES","POINT (-79.15925046 35.46622098)"
"2016","2016","PR","Puerto Rico","MSCANCC","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Hypermetropia","40-64 years","All genders","All races","Hypertension","No","%","Crude Prevalence","3.21",,,"2.61","3.9","100","3000","72","TCOND","CDXC7","QDXC7","R7_2","CRDPREV","AGE4064","GALL","ALLRACE","RFHT","RFNO","POINT (-66.590149 18.220833)"
"2016","2016","MA","Massachusetts","MSCANCC","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","All Orbital and external disease","65-84 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","1.39",,,"0.08","6.08","0","100","25","TCOND","CDXC14","QDXC14","R14_ALL","CRDPREV","AGE6584","GF","ALLRACE","RFDM","RFYES","POINT (-72.08269067 42.27687047)"
"2016","2016","KY","Kentucky","MSCANCC","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","Strabismus","All ages","Female","All races","Hypertension","No","%","Crude Prevalence","0.49",,,"0.46","0.52","1300","270400","21","TCOND","CDXC9","QDXC9","R9_1","CRDPREV","AGEALL","GF","ALLRACE","RFHT","RFNO","POINT (-84.77497105 37.64597027)"
"2016","2016","AL","Alabama","MSCANCC","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Other/unspecified infectious and inflammatory diseases","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0.23",,,"0.22","0.25","900","381800","1","TCOND","CDXC13","QDXC13","R13_5","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT (-86.63186076 32.84057112)"
"2016","2016","ME","Maine","MSCANCC","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Disorders of the globe","0-17 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.04",,,"0.01","0.09","0","13300","23","TCOND","CDXC14","QDXC14","R14_6","CRDPREV","AGE017","GALL","ALLRACE","RFALL","RFTOT","POINT (-68.98503134 45.25422889)"
"2016","2016","OR","Oregon","MSCANCC","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Early stage age-related macular degeneration","40-64 years","Male","All races","All patients","Total","%","Crude Prevalence","0.19",,,"0.16","0.23","100","60300","41","TCOND","CDXC3","QDXC3","R3_2","CRDPREV","AGE4064","GM","ALLRACE","RFALL","RFTOT","POINT (-120.1550313 44.56744942)"
"2016","2016","OR","Oregon","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Non-congenital cataract","0-17 years","Female","All races","Hypertension","No","%","Crude Prevalence","0.02",,,"0.01","0.04","0","38900","41","TCOND","CDXC6","QDXC6","R6_2","CRDPREV","AGE017","GF","ALLRACE","RFHT","RFNO","POINT (-120.1550313 44.56744942)"
"2016","2016","ID","Idaho","MSCANCC","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Keratoconus","18-39 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","0.47",,,"0.16","1.08","0","1100","16","TCOND","CDXC16","QDXC16","R16_1","CRDPREV","AGE1839","GM","ALLRACE","RFDM","RFYES","POINT (-114.36373 43.68263001)"
"2016","2016","RI","Rhode Island","MSCANCC","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Wet-form age-related macular degeneration","18-39 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","1.83","0","200","44","TCOND","CDXC3","QDXC3","R3_4","CRDPREV","AGE1839","GF","ALLRACE","RFDM","RFYES","POINT (-71.52247031 41.70828019)"
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Other/unspecified infectious and inflammatory diseases","18-39 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0.25",,,"0.01","1.38","0","400","99","TCOND","CDXC13","QDXC13","R13_5","CRDPREV","AGE1839","GALL","ALLRACE","RFDM","RFYES",
"2016","2016","NM","New Mexico","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Congenital Cataract","0-17 years","Female","All races","Hypertension","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"35","TCOND","CDXC6","QDXC6","R6_3","CRDPREV","AGE017","GF","ALLRACE","RFHT","RFYES","POINT (-106.240581 34.52088095)"
"2016","2016","MD","Maryland","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Other/unspecified other retinal disorders","40-64 years","Female","All races","Hypertension","No","%","Crude Prevalence","1.25",,,"1.15","1.35","600","49000","24","TCOND","CDXC4","QDXC4","R4_10","CRDPREV","AGE4064","GF","ALLRACE","RFHT","RFNO","POINT (-76.60926011 39.29058096)"
"2016","2016","OH","Ohio","MSCANCC","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Any age related macular degeneration treatment","18-39 years","Male","All races","Hypertension and AMD","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"39","TUTL","CAMDTX","QAMD","RAMDANY","CRDPREV","AGE1839","GM","ALLRACE","RFHTAMD","RFYES","POINT (-82.40426006 40.06021014)"
"2016","2016","DE","Delaware","MSCANCC","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Astigmatism","18-39 years","All genders","All races","Diabetes","No","%","Crude Prevalence","0.49",,,"0.43","0.55","300","55000","10","TCOND","CDXC7","QDXC7","R7_3","CRDPREV","AGE1839","GALL","ALLRACE","RFDM","RFNO","POINT (-75.57774117 39.00883067)"
"2016","2016","NM","New Mexico","MSCANCC","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Wet-form age-related macular degeneration","0-17 years","All genders","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.02","0","15900","35","TCOND","CDXC3","QDXC3","R3_4","CRDPREV","AGE017","GALL","ALLRACE","RFALL","RFTOT","POINT (-106.240581 34.52088095)"
"2016","2016","NM","New Mexico","MSCANCC","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Infectious diseases","65-84 years","Female","All races","Diabetes","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"35","TCOND","CDXC13","QDXC13","R13_1","CRDPREV","AGE6584","GF","ALLRACE","RFDM","RFYES","POINT (-106.240581 34.52088095)"
"2016","2016","MN","Minnesota","MSCANCC","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Disorders of the globe","40-64 years","Female","All races","Diabetes","No","%","Crude Prevalence","0.01",,,"0","0.02","0","52700","27","TCOND","CDXC14","QDXC14","R14_6","CRDPREV","AGE4064","GF","ALLRACE","RFDM","RFNO","POINT (-94.7942005 46.35564874)"
"2016","2016","RI","Rhode Island","MSCANCC","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Retinal detachment repair","40-64 years","Male","All races","Diabetes","No","%","Crude Prevalence","0.12",,,"0.07","0.21","0","10500","44","TUTL","CDRTX","QDRTX","RDRRET","CRDPREV","AGE4064","GM","ALLRACE","RFDM","RFNO","POINT (-71.52247031 41.70828019)"
"2016","2016","OK","Oklahoma","MSCANCC","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Other/unspecified orbital and external disease","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.26","0","1400","40","TCOND","CDXC14","QDXC14","R14_2","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT","POINT (-97.52107021 35.47203136)"
"2016","2016","SD","South Dakota","MSCANCC","Service Utilization","Vision Correction","Percentage of people who had a vision correction visit or supplies claim","Any vision correction","18-39 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","2.27",,,"0.62","5.72","0","200","46","TUTL","CVC","QVC","RVCANY","CRDPREV","AGE1839","GALL","ALLRACE","RFDM","RFYES","POINT (-100.3735306 44.35313005)"
"2016","2016","HI","Hawaii","MSCANCC","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Stereo fundus exam","All ages","All genders","All races","Diabetes","Yes","%","Crude Prevalence","10.06",,,"6.07","15.43","0","200","15","TUTL","CTEST","QTEST","RFUN","CRDPREV","AGEALL","GALL","ALLRACE","RFDM","RFYES","POINT (-157.8577494 21.30485044)"
"2016","2016","WA","Washington","MSCANCC","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Photodynamic therapy","40-64 years","Male","All races","Hypertension","No","%","Crude Prevalence","0",,,"0","0.01","0","83800","53","TUTL","CAMDTX","QAMD","RPHOTO","CRDPREV","AGE4064","GM","ALLRACE","RFHT","RFNO","POINT (-120.4700108 47.52227863)"
"2016","2016","MS","Mississippi","MSCANCC","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","All Refraction and accommodation disorders","40-64 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","2.15",,,"1.9","2.42","300","12500","28","TCOND","CDXC7","QDXC7","R7_ALL","CRDPREV","AGE4064","GF","ALLRACE","RFDM","RFYES","POINT (-89.53803082 32.7455101)"
"2016","2016","WI","Wisconsin","MSCANCC","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","All Cornea disorders","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.79",,,"0.74","0.84","1000","132500","55","TCOND","CDXC16","QDXC16","R16_ALL","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT (-89.81637074 44.39319117)"
"2016","2016","TX","Texas","MSCANCC","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Other diabetes related eye disorders","0-17 years","Male","All races","Diabetes","No","%","Crude Prevalence","0",,,"0","0","0","323600","48","TCOND","CDXC2","QDXC2","R2_5","CRDPREV","AGE017","GM","ALLRACE","RFDM","RFNO","POINT (-99.42677021 31.82724041)"
"2016","2016","HI","Hawaii","MSCANCC","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Photodynamic therapy","All ages","Male","All races","Hypertension and AMD","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"15","TUTL","CAMDTX","QAMD","RPHOTO","CRDPREV","AGEALL","GM","ALLRACE","RFHTAMD","RFYES","POINT (-157.8577494 21.30485044)"
"2016","2016","PA","Pennsylvania","MSCANCC","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Eyelid disorders","All ages","Male","All races","Hypertension","Yes","%","Crude Prevalence","0.76",,,"0.69","0.83","400","58500","42","TCOND","CDXC14","QDXC14","R14_4","CRDPREV","AGEALL","GM","ALLRACE","RFHT","RFYES","POINT (-77.86070029 40.79373015)"
"2016","2016","CT","Connecticut","MSCANCC","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Dry eye syndrome","All ages","Female","All races","Hypertension","Yes","%","Crude Prevalence","5.33",,,"4.97","5.71","800","14500","9","TCOND","CDXC14","QDXC14","R14_5","CRDPREV","AGEALL","GF","ALLRACE","RFHT","RFYES","POINT (-72.64984095 41.56266102)"
"2016","2016","IA","Iowa","MSCANCC","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Retinal detachment repair","0-17 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","5.96","0","100","19","TUTL","CDRTX","QDRTX","RDRRET","CRDPREV","AGE017","GF","ALLRACE","RFDM","RFYES","POINT (-93.81649056 42.46940091)"
"2016","2016","CT","Connecticut","MSCANCC","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Unspecified-age related macular degeneration","18-39 years","Male","All races","Hypertension","No","%","Crude Prevalence","0.01",,,"0","0.02","0","51500","9","TCOND","CDXC3","QDXC3","R3_1","CRDPREV","AGE1839","GM","ALLRACE","RFHT","RFNO","POINT (-72.64984095 41.56266102)"
"2016","2016","AK","Alaska","MSCANCC","Eye Health Conditions","Disorders of Optic Nerve and Visual Pathways","Annual prevalence of treated disorders of optic nerve and visual pathways","Optic nerve disorders","18-39 years","All genders","All races","Hypertension","No","%","Crude Prevalence","0.09",,,"0.04","0.17","0","10600","2","TCOND","CDXC11","QDXC11","R11_1","CRDPREV","AGE1839","GALL","ALLRACE","RFHT","RFNO","POINT (-147.722059 64.84507996)"
"2016","2016","IA","Iowa","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Branch retinal artery occlusion","All ages","Female","All races","Hypertension","No","%","Crude Prevalence","0",,,"0","0","0","94200","19","TCOND","CDXC4","QDXC4","R4_5","CRDPREV","AGEALL","GF","ALLRACE","RFHT","RFNO","POINT (-93.81649056 42.46940091)"
"2016","2016","IL","Illinois","MSCANCC","Eye Health Conditions","Retinal Detachment and Defects","Annual prevalence of treated retinal detachment and defects","All Retinal detachment and defects","18-39 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0.5",,,"0.31","0.76","0","4400","17","TCOND","CDXC1","QDXC1","R1_ALL","CRDPREV","AGE1839","GALL","ALLRACE","RFDM","RFYES","POINT (-88.99771018 40.48501028)"
"2016","2016","VT","Vermont","MSCANCC","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","Surgical complication of the eye","40-64 years","Female","All races","Diabetes","No","%","Crude Prevalence","0.1",,,"0.03","0.25","0","4100","50","TCOND","CDXC10","QDXC10","R10_3","CRDPREV","AGE4064","GF","ALLRACE","RFDM","RFNO","POINT (-72.51764079 43.62538124)"
"2016","2016","WV","West Virginia","MSCANCC","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","All Diabetic eye diseases","All ages","All genders","All races","Hypertension","No","%","Crude Prevalence","0.12",,,"0.09","0.15","100","56200","54","TCOND","CDXC2","QDXC2","R2_ALL","CRDPREV","AGEALL","GALL","ALLRACE","RFHT","RFNO","POINT (-80.71264013 38.6655102)"
"2016","2016","MT","Montana","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Macular edema (not diabetic)","65-84 years","All genders","All races","Diabetes","No","%","Crude Prevalence","0",,,"0","1.83","0","200","30","TCOND","CDXC4","QDXC4","R4_7","CRDPREV","AGE6584","GALL","ALLRACE","RFDM","RFNO","POINT (-109.4244206 47.06652897)"
"2016","2016","WV","West Virginia","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Central retinal arterial occlusion","18-39 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","0.74","0","500","54","TCOND","CDXC4","QDXC4","R4_4","CRDPREV","AGE1839","GALL","ALLRACE","RFDM","RFYES","POINT (-80.71264013 38.6655102)"
"2016","2016","OR","Oregon","MSCANCC","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Other/unspecified visual disturbances","18-39 years","All genders","All races","Diabetes","No","%","Crude Prevalence","0.56",,,"0.52","0.61","600","107500","41","TCOND","CDXC12","QDXC12","R12_4","CRDPREV","AGE1839","GALL","ALLRACE","RFDM","RFNO","POINT (-120.1550313 44.56744942)"
"2016","2016","OK","Oklahoma","MSCANCC","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Eyelid disorders","40-64 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","1.55",,,"1.32","1.81","200","10400","40","TCOND","CDXC14","QDXC14","R14_4","CRDPREV","AGE4064","GF","ALLRACE","RFDM","RFYES","POINT (-97.52107021 35.47203136)"
"2016","2016","LA","Louisiana","MSCANCC","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Dry-form age-related macular degeneration","18-39 years","All genders","All races","Hypertension","No","%","Crude Prevalence","0.01",,,"0.01","0.01","0","436200","22","TCOND","CDXC3","QDXC3","R3_3","CRDPREV","AGE1839","GALL","ALLRACE","RFHT","RFNO","POINT (-92.44568007 31.31266064)"
"2016","2016","WI","Wisconsin","MSCANCC","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Retinal detachment repair","All ages","All genders","All races","Diabetes and diabetic retinopathy","Yes","%","Crude Prevalence","0.75",,,"0.42","1.23","0","2000","55","TUTL","CDRTX","QDRTX","RDRRET","CRDPREV","AGEALL","GALL","ALLRACE","RFDMDR","RFYES","POINT (-89.81637074 44.39319117)"
"2016","2016","KS","Kansas","MSCANCC","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Any diabetic retinopathy treatment","40-64 years","All genders","All races","Diabetes","No","%","Crude Prevalence","1.28",,,"1.21","1.37","1000","74200","20","TUTL","CDRTX","QDRTX","RDRANY","CRDPREV","AGE4064","GALL","ALLRACE","RFDM","RFNO","POINT (-98.20078123 38.3477403)"
"2016","2016","OH","Ohio","MSCANCC","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Lacrimal diseases","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.1","0","3700","39","TCOND","CDXC14","QDXC14","R14_3","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT (-82.40426006 40.06021014)"
"2016","2016","OH","Ohio","MSCANCC","Eye Health Conditions","Cancer and Neoplasms of the Eye","Annual prevalence of treated cancer and neoplasms of the eye","All Cancer and neoplasms of the eye diseases","65-84 years","Male","All races","Hypertension","No","%","Crude Prevalence","0.07",,,"0.01","0.26","0","2700","39","TCOND","CDXC15","QDXC15","R15_ALL","CRDPREV","AGE6584","GM","ALLRACE","RFHT","RFNO","POINT (-82.40426006 40.06021014)"
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Retinopathy of prematurity","18-39 years","Male","All races","Diabetes","No","%","Crude Prevalence","0.01",,,"0","0.04","0","17800","99","TCOND","CDXC4","QDXC4","R4_11","CRDPREV","AGE1839","GM","ALLRACE","RFDM","RFNO",
"2016","2016","ME","Maine","MSCANCC","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Any age related macular degeneration treatment","18-39 years","All genders","All races","Hypertension","No","%","Crude Prevalence","1.25",,,"1.1","1.42","200","19300","23","TUTL","CAMDTX","QAMD","RAMDANY","CRDPREV","AGE1839","GALL","ALLRACE","RFHT","RFNO","POINT (-68.98503134 45.25422889)"
"2016","2016","AL","Alabama","MSCANCC","Eye Health Conditions","Cancer and Neoplasms of the Eye","Annual prevalence of treated cancer and neoplasms of the eye","All Cancer and neoplasms of the eye diseases","18-39 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","0.15",,,"0.07","0.29","0","5900","1","TCOND","CDXC15","QDXC15","R15_ALL","CRDPREV","AGE1839","GF","ALLRACE","RFHT","RFYES","POINT (-86.63186076 32.84057112)"
"2016","2016","IL","Illinois","MSCANCC","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","All Other visual disturbances","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0.52",,,"0.48","0.56","800","151100","17","TCOND","CDXC12","QDXC12","R12_ALL","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT (-88.99771018 40.48501028)"
"2016","2016","MN","Minnesota","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Occlusive retinal vascular disease","65-84 years","All genders","All races","Hypertension","No","%","Crude Prevalence","0",,,"0","0.33","0","1100","27","TCOND","CDXC4","QDXC4","R4_1","CRDPREV","AGE6584","GALL","ALLRACE","RFHT","RFNO","POINT (-94.7942005 46.35564874)"
"2016","2016","SD","South Dakota","MSCANCC","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Vision impairment one eye","All ages","Male","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","0.61","0","600","46","TCOND","CDXC8","QDXC8","R8_3","CRDPREV","AGEALL","GM","ALLRACE","RFDM","RFYES","POINT (-100.3735306 44.35313005)"
"2016","2016","WY","Wyoming","MSCANCC","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Other diabetes related eye disorders","40-64 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","4.12",,,"2.4","6.56","0","400","56","TCOND","CDXC2","QDXC2","R2_5","CRDPREV","AGE4064","GF","ALLRACE","RFDM","RFYES","POINT (-108.1098304 43.23554134)"
"2016","2016","MD","Maryland","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Retinopathy of prematurity","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0.02",,,"0.02","0.03","100","316500","24","TCOND","CDXC4","QDXC4","R4_11","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT (-76.60926011 39.29058096)"
"2016","2016","NV","Nevada","MSCANCC","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Early stage age-related macular degeneration","All ages","Male","All races","Diabetes","Yes","%","Crude Prevalence","0.15",,,"0.07","0.28","0","6200","32","TCOND","CDXC3","QDXC3","R3_2","CRDPREV","AGEALL","GM","ALLRACE","RFDM","RFYES","POINT (-117.0718406 39.49324039)"
"2016","2016","LA","Louisiana","MSCANCC","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Infectious diseases","All ages","Female","All races","Diabetes","No","%","Crude Prevalence","0.29",,,"0.28","0.3","1800","634900","22","TCOND","CDXC13","QDXC13","R13_1","CRDPREV","AGEALL","GF","ALLRACE","RFDM","RFNO","POINT (-92.44568007 31.31266064)"
"2016","2016","CA","California","MSCANCC","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Unspecified-age related macular degeneration","0-17 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","0.74","0","500","6","TCOND","CDXC3","QDXC3","R3_1","CRDPREV","AGE017","GM","ALLRACE","RFHT","RFYES","POINT (-120.9999995 37.63864012)"
"2016","2016","RI","Rhode Island","MSCANCC","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Dry eye syndrome","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","3.76",,,"1.59","7.42","0","200","44","TCOND","CDXC14","QDXC14","R14_5","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT","POINT (-71.52247031 41.70828019)"
"2016","2016","NJ","New Jersey","MSCANCC","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","Strabismus","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","1.92",,,"1.83","2.01","1800","93400","34","TCOND","CDXC9","QDXC9","R9_1","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT (-74.27369129 40.13057005)"
"2016","2016","NM","New Mexico","MSCANCC","Eye Health Conditions","Cancer and Neoplasms of the Eye","Annual prevalence of treated cancer and neoplasms of the eye","Malignant neoplasm","0-17 years","All genders","All races","Diabetes","No","%","Crude Prevalence","0",,,"0","0.02","0","15800","35","TCOND","CDXC15","QDXC15","R15_1","CRDPREV","AGE017","GALL","ALLRACE","RFDM","RFNO","POINT (-106.240581 34.52088095)"
"2016","2016","CT","Connecticut","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Congenital Cataract","All ages","All genders","All races","Diabetes","No","%","Crude Prevalence","0.03",,,"0.02","0.04","100","286200","9","TCOND","CDXC6","QDXC6","R6_3","CRDPREV","AGEALL","GALL","ALLRACE","RFDM","RFNO","POINT (-72.64984095 41.56266102)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Profound bilateral imp., legal blindness","18-39 years","All genders","All races","Hypertension","No","%","Crude Prevalence","0.01",,,"0.01","0.01","1000","9610900","59","TCOND","CDXC8","QDXC8","R8_6","CRDPREV","AGE1839","GALL","ALLRACE","RFHT","RFNO",
"2016","2016","KS","Kansas","MSCANCC","Service Utilization","Cataract Surgery","Percentage of people with diagnosed cataract who had a treatment claim","Any cataract treatment","40-64 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","2.03",,,"1.6","2.53","100","3800","20","TUTL","CCATS","QCATS","RCATANY","CRDPREV","AGE4064","GF","ALLRACE","RFDM","RFYES","POINT (-98.20078123 38.3477403)"
"2016","2016","TX","Texas","MSCANCC","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Unspecified-age related macular degeneration","40-64 years","Male","All races","Diabetes","No","%","Crude Prevalence","0.04",,,"0.03","0.05","100","366700","48","TCOND","CDXC3","QDXC3","R3_1","CRDPREV","AGE4064","GM","ALLRACE","RFDM","RFNO","POINT (-99.42677021 31.82724041)"
"2016","2016","OH","Ohio","MSCANCC","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Victrectomy","All ages","Male","All races","Diabetes and diabetic retinopathy","Yes","%","Crude Prevalence","1.61",,,"1.18","2.14","0","2900","39","TUTL","CDRTX","QDRTX","RDRVIC","CRDPREV","AGEALL","GM","ALLRACE","RFDMDR","RFYES","POINT (-82.40426006 40.06021014)"
"2016","2016","PR","Puerto Rico","MSCANCC","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Infectious diseases","65-84 years","Female","All races","Hypertension","No","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"72","TCOND","CDXC13","QDXC13","R13_1","CRDPREV","AGE6584","GF","ALLRACE","RFHT","RFNO","POINT (-66.590149 18.220833)"
"2016","2016","MA","Massachusetts","MSCANCC","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Retinal detachment repair","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0.03",,,"0.02","0.05","0","78500","25","TUTL","CDRTX","QDRTX","RDRRET","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT (-72.08269067 42.27687047)"
"2016","2016","OK","Oklahoma","MSCANCC","Eye Health Conditions","Disorders of Optic Nerve and Visual Pathways","Annual prevalence of treated disorders of optic nerve and visual pathways","Visual pathway disorders","40-64 years","All genders","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0","0","161600","40","TCOND","CDXC11","QDXC11","R11_2","CRDPREV","AGE4064","GALL","ALLRACE","RFALL","RFTOT","POINT (-97.52107021 35.47203136)"
"2016","2016","AK","Alaska","MSCANCC","Eye Health Conditions","Retinal Detachment and Defects","Annual prevalence of treated retinal detachment and defects","All Retinal detachment and defects","0-17 years","All genders","All races","Hypertension","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"2","TCOND","CDXC1","QDXC1","R1_ALL","CRDPREV","AGE017","GALL","ALLRACE","RFHT","RFYES","POINT (-147.722059 64.84507996)"
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Other/unspecified other retinal disorders","40-64 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","2.74",,,"2.24","3.32","100","3700","99","TCOND","CDXC4","QDXC4","R4_10","CRDPREV","AGE4064","GALL","ALLRACE","RFDM","RFYES",
"2016","2016","MS","Mississippi","MSCANCC","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Photodynamic therapy","65-84 years","All genders","All races","Hypertension","No","%","Crude Prevalence","0",,,"0","0.23","0","1600","28","TUTL","CAMDTX","QAMD","RPHOTO","CRDPREV","AGE6584","GALL","ALLRACE","RFHT","RFNO","POINT (-89.53803082 32.7455101)"
"2016","2016","WY","Wyoming","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","All Other retinal disorders","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0.73",,,"0.64","0.83","200","31700","56","TCOND","CDXC4","QDXC4","R4_ALL","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT (-108.1098304 43.23554134)"
"2016","2016","GA","Georgia","MSCANCC","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Keratoconus","65-84 years","All genders","All races","Hypertension","No","%","Crude Prevalence","0.02",,,"0","0.09","0","6500","13","TCOND","CDXC16","QDXC16","R16_1","CRDPREV","AGE6584","GALL","ALLRACE","RFHT","RFNO","POINT (-83.62758035 32.83968109)"
"2016","2016","PR","Puerto Rico","MSCANCC","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Wet-form age-related macular degeneration","40-64 years","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.18","0","2100","72","TCOND","CDXC3","QDXC3","R3_4","CRDPREV","AGE4064","GM","ALLRACE","RFALL","RFTOT","POINT (-66.590149 18.220833)"
"2016","2016","FL","Florida","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Congenital glaucoma","18-39 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","0.03",,,"0","0.1","0","7900","12","TCOND","CDXC5","QDXC5","R5_7","CRDPREV","AGE1839","GF","ALLRACE","RFDM","RFYES","POINT (-81.92896054 28.93204038)"
"2016","2016","ID","Idaho","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Low-tension glaucoma","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0.02",,,"0.02","0.02","100","451000","16","TCOND","CDXC5","QDXC5","R5_3","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT (-114.36373 43.68263001)"
"2016","2016","NJ","New Jersey","MSCANCC","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Visual field defect","0-17 years","Female","All races","Diabetes","No","%","Crude Prevalence","0.05",,,"0.04","0.07","0","89000","34","TCOND","CDXC12","QDXC12","R12_1","CRDPREV","AGE017","GF","ALLRACE","RFDM","RFNO","POINT (-74.27369129 40.13057005)"
"2016","2016","OR","Oregon","MSCANCC","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Unqualified impairment in one eye, or unspecified","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0.02",,,"0.01","0.04","0","52000","41","TCOND","CDXC8","QDXC8","R8_2","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT (-120.1550313 44.56744942)"
"2016","2016","NJ","New Jersey","MSCANCC","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","All Cornea disorders","65-84 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","0.47",,,"0.05","1.75","0","400","34","TCOND","CDXC16","QDXC16","R16_ALL","CRDPREV","AGE6584","GF","ALLRACE","RFHT","RFYES","POINT (-74.27369129 40.13057005)"
"2016","2016","GA","Georgia","MSCANCC","Eye Health Conditions","Cancer and Neoplasms of the Eye","Annual prevalence of treated cancer and neoplasms of the eye","Benign neoplasm","65-84 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","0.17",,,"0","0.93","0","600","13","TCOND","CDXC15","QDXC15","R15_2","CRDPREV","AGE6584","GM","ALLRACE","RFDM","RFYES","POINT (-83.62758035 32.83968109)"
"2016","2016","UT","Utah","MSCANCC","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Anti-VEGF injections","18-39 years","All genders","All races","Diabetes","No","%","Crude Prevalence","1.28",,,"1.22","1.35","1500","114400","49","TUTL","CDRTX","QDRTX","RVEGF","CRDPREV","AGE1839","GALL","ALLRACE","RFDM","RFNO","POINT (-111.5871306 39.36070017)"
"2016","2016","CT","Connecticut","MSCANCC","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Other refraction and accommodation disorders","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","0.12",,,"0","0.69","0","800","9","TCOND","CDXC7","QDXC7","R7_5","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT","POINT (-72.64984095 41.56266102)"
"2016","2016","AL","Alabama","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","65-84 years","Female","All races","Diabetes","No","%","Crude Prevalence","1.59",,,"0.91","2.57","0","1000","1","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGE6584","GF","ALLRACE","RFDM","RFNO","POINT (-86.63186076 32.84057112)"
"2016","2016","UT","Utah","MSCANCC","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Drain","65-84 years","Female","All races","Diabetes","No","%","Crude Prevalence","0",,,"0","0.78","0","500","49","TUTL","CGLAUTX","QGLAU","RGLADRN","CRDPREV","AGE6584","GF","ALLRACE","RFDM","RFNO","POINT (-111.5871306 39.36070017)"
"2016","2016","KY","Kentucky","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Retinopathy of prematurity","0-17 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","0.61","0","600","21","TCOND","CDXC4","QDXC4","R4_11","CRDPREV","AGE017","GALL","ALLRACE","RFDM","RFYES","POINT (-84.77497105 37.64597027)"
"2016","2016","NM","New Mexico","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Open-angle glaucoma","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0.19",,,"0.16","0.23","100","67600","35","TCOND","CDXC5","QDXC5","R5_1","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT (-106.240581 34.52088095)"
"2016","2016","MN","Minnesota","MSCANCC","Eye Health Conditions","Retinal Detachment and Defects","Annual prevalence of treated retinal detachment and defects","All Retinal detachment and defects","65-84 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","3.62","0","100","27","TCOND","CDXC1","QDXC1","R1_ALL","CRDPREV","AGE6584","GM","ALLRACE","RFDM","RFYES","POINT (-94.7942005 46.35564874)"
"2016","2016","PA","Pennsylvania","MSCANCC","Eye Health Conditions","Disorders of Optic Nerve and Visual Pathways","Annual prevalence of treated disorders of optic nerve and visual pathways","All Disorders of optic nerve and visual pathways","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.48",,,"0.45","0.51","900","178500","42","TCOND","CDXC11","QDXC11","R11_ALL","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT (-77.86070029 40.79373015)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","All Injury, burns and surgical complications of the eye","0-17 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","1.25",,,"1.05","1.48","100","10800","59","TCOND","CDXC10","QDXC10","R10_ALL","CRDPREV","AGE017","GM","ALLRACE","RFHT","RFYES",
"2016","2016","NM","New Mexico","MSCANCC","Service Utilization","Cataract Surgery","Percentage of people with diagnosed cataract who had a treatment claim","Any cataract treatment","65-84 years","All genders","All races","Diabetes","No","%","Crude Prevalence","1.02",,,"0.21","2.95","0","300","35","TUTL","CCATS","QCATS","RCATANY","CRDPREV","AGE6584","GALL","ALLRACE","RFDM","RFNO","POINT (-106.240581 34.52088095)"
"2016","2016","TN","Tennessee","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Branch retinal vein occlusion","0-17 years","All genders","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0","0","189800","47","TCOND","CDXC4","QDXC4","R4_3","CRDPREV","AGE017","GALL","ALLRACE","RFALL","RFTOT","POINT (-85.77449091 35.68094058)"
"2016","2016","VA","Virginia","MSCANCC","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Glaucoma surgery","40-64 years","Female","All races","Hypertension","No","%","Crude Prevalence","0.01",,,"0","0.02","0","86900","51","TUTL","CGLAUTX","QGLAU","RGLASUR","CRDPREV","AGE4064","GF","ALLRACE","RFHT","RFNO","POINT (-78.45789046 37.54268067)"
"2016","2016","NH","New Hampshire","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Open-angle glaucoma","All ages","Male","All races","Hypertension","Yes","%","Crude Prevalence","1.17",,,"0.89","1.51","100","5000","33","TCOND","CDXC5","QDXC5","R5_1","CRDPREV","AGEALL","GM","ALLRACE","RFHT","RFYES","POINT (-71.50036092 43.65595011)"
"2016","2016","WY","Wyoming","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Other/unspecified glaucoma","40-64 years","Male","All races","Diabetes","No","%","Crude Prevalence","0.06",,,"0.01","0.18","0","4800","56","TCOND","CDXC5","QDXC5","R5_9","CRDPREV","AGE4064","GM","ALLRACE","RFDM","RFNO","POINT (-108.1098304 43.23554134)"
"2016","2016","GA","Georgia","MSCANCC","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Unspecified-age related macular degeneration","65-84 years","Female","All races","Hypertension","No","%","Crude Prevalence","0",,,"0","0.1","0","3800","13","TCOND","CDXC3","QDXC3","R3_1","CRDPREV","AGE6584","GF","ALLRACE","RFHT","RFNO","POINT (-83.62758035 32.83968109)"
"2016","2016","FL","Florida","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Branch retinal artery occlusion","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0","0","317500","12","TCOND","CDXC4","QDXC4","R4_5","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT (-81.92896054 28.93204038)"
"2016","2016","SD","South Dakota","MSCANCC","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Geographic atrophy","65-84 years","All genders","All races","Hypertension","No","%","Crude Prevalence","0",,,"0","3.62","0","100","46","TCOND","CDXC3","QDXC3","R3_3GA","CRDPREV","AGE6584","GALL","ALLRACE","RFHT","RFNO","POINT (-100.3735306 44.35313005)"
"2016","2016","WI","Wisconsin","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Macular edema (not diabetic)","40-64 years","Female","All races","Diabetes","No","%","Crude Prevalence","0.06",,,"0.05","0.08","100","122800","55","TCOND","CDXC4","QDXC4","R4_7","CRDPREV","AGE4064","GF","ALLRACE","RFDM","RFNO","POINT (-89.81637074 44.39319117)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Other Eye Disorders","Annual prevalence of treated other eye disorders","All Other eye disorders","0-17 years","All genders","All races","Hypertension","No","%","Crude Prevalence","0.74",,,"0.73","0.75","49600","6704700","59","TCOND","CDXC17","QDXC17","R17_ALL","CRDPREV","AGE017","GALL","ALLRACE","RFHT","RFNO",
"2016","2016","MA","Massachusetts","MSCANCC","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Moderate imp. better eye, profound imp. lesser eye","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0","0","235500","25","TCOND","CDXC8","QDXC8","R8_4","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT","POINT (-72.08269067 42.27687047)"
"2016","2016","IA","Iowa","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Aphakia and disorders of lens","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.03","0","40700","19","TCOND","CDXC6","QDXC6","R6_6","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT (-93.81649056 42.46940091)"
"2016","2016","OR","Oregon","MSCANCC","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Laser surgery","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.39","0","900","41","TUTL","CGLAUTX","QGLAU","RLASER","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT (-120.1550313 44.56744942)"
"2016","2016","RI","Rhode Island","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Retinopathy of prematurity","40-64 years","All genders","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.01","0","24600","44","TCOND","CDXC4","QDXC4","R4_11","CRDPREV","AGE4064","GALL","ALLRACE","RFALL","RFTOT","POINT (-71.52247031 41.70828019)"
"2016","2016","AR","Arkansas","MSCANCC","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","All Injury, burns and surgical complications of the eye","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.63",,,"0.57","0.7","400","60500","5","TCOND","CDXC10","QDXC10","R10_ALL","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT","POINT (-92.27449074 34.74865012)"
"2016","2016","OK","Oklahoma","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Other/unspecified other retinal disorders","All ages","Female","All races","Hypertension","Yes","%","Crude Prevalence","1.78",,,"1.64","1.93","600","34200","40","TCOND","CDXC4","QDXC4","R4_10","CRDPREV","AGEALL","GF","ALLRACE","RFHT","RFYES","POINT (-97.52107021 35.47203136)"
"2016","2016","XX","Missing Location","MSCANCC","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Victrectomy","65-84 years","All genders","All races","Diabetic retinopathy","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"99","TUTL","CDRTX","QDRTX","RDRVIC","CRDPREV","AGE6584","GALL","ALLRACE","RFDR","RFYES",
"2016","2016","ID","Idaho","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Secondary glaucoma","All ages","Male","All races","Diabetes","Yes","%","Crude Prevalence","0.12",,,"0.06","0.22","0","8900","16","TCOND","CDXC5","QDXC5","R5_10","CRDPREV","AGEALL","GM","ALLRACE","RFDM","RFYES","POINT (-114.36373 43.68263001)"
"2016","2016","NH","New Hampshire","MSCANCC","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Diabetic Retinopathy Telemedicine Screening","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.01","0","26200","33","TUTL","CSCRN","QSCRN","RSCNDR","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT","POINT (-71.50036092 43.65595011)"
"2016","2016","WV","West Virginia","MSCANCC","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Astigmatism","All ages","Male","All races","Hypertension","No","%","Crude Prevalence","0.63",,,"0.54","0.73","200","28300","54","TCOND","CDXC7","QDXC7","R7_3","CRDPREV","AGEALL","GM","ALLRACE","RFHT","RFNO","POINT (-80.71264013 38.6655102)"
"2016","2016","MT","Montana","MSCANCC","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Anti-VEGF injections","All ages","Female","All races","Diabetes","No","%","Crude Prevalence","1.1",,,"0.94","1.28","200","14900","30","TUTL","CDRTX","QDRTX","RVEGF","CRDPREV","AGEALL","GF","ALLRACE","RFDM","RFNO","POINT (-109.4244206 47.06652897)"
"2016","2016","PA","Pennsylvania","MSCANCC","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Presbyopia","65-84 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","1.18",,,"0.43","2.57","0","500","42","TCOND","CDXC7","QDXC7","R7_4","CRDPREV","AGE6584","GALL","ALLRACE","RFDM","RFYES","POINT (-77.86070029 40.79373015)"
"2016","2016","HI","Hawaii","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Central retinal vein occlusion","65-84 years","Female","All races","Diabetes","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"15","TCOND","CDXC4","QDXC4","R4_2","CRDPREV","AGE6584","GF","ALLRACE","RFDM","RFYES","POINT (-157.8577494 21.30485044)"
"2016","2016","TN","Tennessee","MSCANCC","Service Utilization","Vision Correction","Percentage of people who had a vision correction visit or supplies claim","Any vision correction","All ages","All genders","All races","Hypertension","Yes","%","Crude Prevalence","0.54",,,"0.5","0.58","800","141500","47","TUTL","CVC","QVC","RVCANY","CRDPREV","AGEALL","GALL","ALLRACE","RFHT","RFYES","POINT (-85.77449091 35.68094058)"
"2016","2016","NH","New Hampshire","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Central retinal vein occlusion","All ages","Female","All races","Hypertension","No","%","Crude Prevalence","0.01",,,"0","0.03","0","36500","33","TCOND","CDXC4","QDXC4","R4_2","CRDPREV","AGEALL","GF","ALLRACE","RFHT","RFNO","POINT (-71.50036092 43.65595011)"
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Night blindness","18-39 years","Female","All races","Diabetes","No","%","Crude Prevalence","0.03",,,"0.01","0.06","0","20300","99","TCOND","CDXC12","QDXC12","R12_3","CRDPREV","AGE1839","GF","ALLRACE","RFDM","RFNO",
"2016","2016","AZ","Arizona","MSCANCC","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","All Diabetic eye diseases","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.07",,,"0.06","0.08","100","186100","4","TCOND","CDXC2","QDXC2","R2_ALL","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT","POINT (-111.7638113 34.86597028)"
"2016","2016","GA","Georgia","MSCANCC","Service Utilization","Vision Correction","Percentage of people who had a vision correction visit or supplies claim","Eyeglasses","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","0.05",,,"0.04","0.07","100","152700","13","TUTL","CVC","QVC","RGLASS","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT (-83.62758035 32.83968109)"
"2016","2016","ID","Idaho","MSCANCC","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","Strabismus","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0.09",,,"0.07","0.11","100","78200","16","TCOND","CDXC9","QDXC9","R9_1","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT (-114.36373 43.68263001)"
"2016","2016","NM","New Mexico","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Macular edema (not diabetic)","40-64 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0.04",,,"0","0.21","0","2700","35","TCOND","CDXC4","QDXC4","R4_7","CRDPREV","AGE4064","GALL","ALLRACE","RFDM","RFYES","POINT (-106.240581 34.52088095)"
"2016","2016","IN","Indiana","MSCANCC","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Laser/photocoagulation","40-64 years","Male","All races","Diabetic retinopathy","Yes","%","Crude Prevalence","10.58",,,"8.79","12.6","100","1000","18","TUTL","CDRTX","QDRTX","RLASPH","CRDPREV","AGE4064","GM","ALLRACE","RFDR","RFYES","POINT (-86.14996019 39.76691045)"
"2016","2016","RI","Rhode Island","MSCANCC","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Glaucoma surgery","18-39 years","All genders","All races","Glaucoma","Yes","%","Crude Prevalence","0",,,"0","1.89","0","200","44","TUTL","CGLAUTX","QGLAU","RGLASUR","CRDPREV","AGE1839","GALL","ALLRACE","RFGLC","RFYES","POINT (-71.52247031 41.70828019)"
"2016","2016","LA","Louisiana","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Occlusive retinal vascular disease","18-39 years","Male","All races","Hypertension","No","%","Crude Prevalence","0",,,"0","0","0","208000","22","TCOND","CDXC4","QDXC4","R4_1","CRDPREV","AGE1839","GM","ALLRACE","RFHT","RFNO","POINT (-92.44568007 31.31266064)"
"2016","2016","NH","New Hampshire","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Branch retinal vein occlusion","40-64 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","0.06",,,"0.01","0.22","0","3300","33","TCOND","CDXC4","QDXC4","R4_3","CRDPREV","AGE4064","GF","ALLRACE","RFHT","RFYES","POINT (-71.50036092 43.65595011)"
"2016","2016","ND","North Dakota","MSCANCC","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Any age related macular degeneration treatment","0-17 years","All genders","All races","Diabetes and AMD","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"38","TUTL","CAMDTX","QAMD","RAMDANY","CRDPREV","AGE017","GALL","ALLRACE","RFDMAMD","RFYES","POINT (-100.118421 47.47531978)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Open-angle glaucoma","65-84 years","All genders","All races","Hypertension","No","%","Crude Prevalence","1.01",,,"0.96","1.07","1300","127600","59","TCOND","CDXC5","QDXC5","R5_1","CRDPREV","AGE6584","GALL","ALLRACE","RFHT","RFNO",
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","Strabismus","40-64 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.22",,,"0.22","0.22","25800","11741900","59","TCOND","CDXC9","QDXC9","R9_1","CRDPREV","AGE4064","GALL","ALLRACE","RFALL","RFTOT",
"2016","2016","UT","Utah","MSCANCC","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Vision impairment one eye","All ages","Female","All races","Diabetes","Yes","%","Crude Prevalence","0.06",,,"0.01","0.18","0","4600","49","TCOND","CDXC8","QDXC8","R8_3","CRDPREV","AGEALL","GF","ALLRACE","RFDM","RFYES","POINT (-111.5871306 39.36070017)"
"2016","2016","AR","Arkansas","MSCANCC","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Anti-VEGF injections","65-84 years","All genders","All races","Diabetic retinopathy","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"5","TUTL","CDRTX","QDRTX","RVEGF","CRDPREV","AGE6584","GALL","ALLRACE","RFDR","RFYES","POINT (-92.27449074 34.74865012)"
"2016","2016","AL","Alabama","MSCANCC","Service Utilization","Cataract Surgery","Percentage of people with diagnosed cataract who had a treatment claim","Any cataract treatment","18-39 years","Female","All races","Diabetes and cataract","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"1","TUTL","CCATS","QCATS","RCATANY","CRDPREV","AGE1839","GF","ALLRACE","RFDMCAT","RFYES","POINT (-86.63186076 32.84057112)"
"2016","2016","MT","Montana","MSCANCC","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Keratoconus","All ages","Male","All races","Diabetes","No","%","Crude Prevalence","0.05",,,"0.02","0.1","0","15000","30","TCOND","CDXC16","QDXC16","R16_1","CRDPREV","AGEALL","GM","ALLRACE","RFDM","RFNO","POINT (-109.4244206 47.06652897)"
"2016","2016","PA","Pennsylvania","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","65-84 years","All genders","All races","Hypertension","No","%","Crude Prevalence","0.5",,,"0.29","0.8","0","3400","42","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGE6584","GALL","ALLRACE","RFHT","RFNO","POINT (-77.86070029 40.79373015)"
"2016","2016","CO","Colorado","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Other/unspecified other retinal disorders","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","0.08",,,"0.06","0.11","0","51000","8","TCOND","CDXC4","QDXC4","R4_10","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT (-106.1336109 38.84384076)"
"2016","2016","TX","Texas","MSCANCC","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Glaucoma surgery","40-64 years","All genders","All races","Glaucoma","Yes","%","Crude Prevalence","0.31",,,"0.25","0.39","100","26300","48","TUTL","CGLAUTX","QGLAU","RGLASUR","CRDPREV","AGE4064","GALL","ALLRACE","RFGLC","RFYES","POINT (-99.42677021 31.82724041)"
"2016","2016","KS","Kansas","MSCANCC","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Any glaucoma treatment","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.1",,,"0.07","0.13","0","42300","20","TUTL","CGLAUTX","QGLAU","RGLAANY","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT (-98.20078123 38.3477403)"
"2016","2016","MA","Massachusetts","MSCANCC","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Photodynamic therapy","40-64 years","Male","All races","Age-related macular degeneration","Yes","%","Crude Prevalence","0",,,"0","0.77","0","500","25","TUTL","CAMDTX","QAMD","RPHOTO","CRDPREV","AGE4064","GM","ALLRACE","RFAMD","RFYES","POINT (-72.08269067 42.27687047)"
"2016","2016","NJ","New Jersey","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Aphakia and disorders of lens","All ages","Female","All races","Hypertension","No","%","Crude Prevalence","0.02",,,"0.02","0.03","100","326200","34","TCOND","CDXC6","QDXC6","R6_6","CRDPREV","AGEALL","GF","ALLRACE","RFHT","RFNO","POINT (-74.27369129 40.13057005)"
"2016","2016","NV","Nevada","MSCANCC","Service Utilization","Cataract Surgery","Percentage of people with diagnosed cataract who had a treatment claim","Cataract surgery","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0.23",,,"0.21","0.25","500","223100","32","TUTL","CCATS","QCATS","RCATSUR","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT (-117.0718406 39.49324039)"
"2016","2016","MI","Michigan","MSCANCC","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Other/unspecified orbital and external disease","65-84 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","0.07",,,"0","0.38","0","1500","26","TCOND","CDXC14","QDXC14","R14_2","CRDPREV","AGE6584","GF","ALLRACE","RFHT","RFYES","POINT (-84.71439027 44.66131954)"
"2016","2016","OR","Oregon","MSCANCC","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Anti-VEGF injections","65-84 years","Male","All races","Hypertension","No","%","Crude Prevalence","0.64",,,"0.21","1.48","0","800","41","TUTL","CDRTX","QDRTX","RVEGF","CRDPREV","AGE6584","GM","ALLRACE","RFHT","RFNO","POINT (-120.1550313 44.56744942)"
"2016","2016","WV","West Virginia","MSCANCC","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Retinal detachment repair","18-39 years","All genders","All races","Diabetes and diabetic retinopathy","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"54","TUTL","CDRTX","QDRTX","RDRRET","CRDPREV","AGE1839","GALL","ALLRACE","RFDMDR","RFYES","POINT (-80.71264013 38.6655102)"
"2016","2016","VT","Vermont","MSCANCC","Service Utilization","Vision Correction","Percentage of people who had a vision correction visit or supplies claim","Contact lens or fitting","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0.14",,,"0.07","0.24","0","8600","50","TUTL","CVC","QVC","RCONTAC","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT","POINT (-72.51764079 43.62538124)"
"2016","2016","MA","Massachusetts","MSCANCC","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","All Cornea disorders","18-39 years","Female","All races","Diabetes","No","%","Crude Prevalence","0.39",,,"0.35","0.43","300","83500","25","TCOND","CDXC16","QDXC16","R16_ALL","CRDPREV","AGE1839","GF","ALLRACE","RFDM","RFNO","POINT (-72.08269067 42.27687047)"
"2016","2016","MS","Mississippi","MSCANCC","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Any age related macular degeneration treatment","18-39 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","2.2",,,"1.43","3.23","0","1100","28","TUTL","CAMDTX","QAMD","RAMDANY","CRDPREV","AGE1839","GM","ALLRACE","RFDM","RFYES","POINT (-89.53803082 32.7455101)"
"2016","2016","NY","New York","MSCANCC","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Unspecified-age related macular degeneration","40-64 years","All genders","All races","Hypertension","No","%","Crude Prevalence","0.07",,,"0.06","0.08","400","617100","36","TCOND","CDXC3","QDXC3","R3_1","CRDPREV","AGE4064","GALL","ALLRACE","RFHT","RFNO","POINT (-75.54397043 42.82700103)"
"2016","2016","NV","Nevada","MSCANCC","Service Utilization","Cataract Surgery","Percentage of people with diagnosed cataract who had a treatment claim","Cataract surgery","All ages","Male","All races","Hypertension","No","%","Crude Prevalence","0.11",,,"0.09","0.13","100","95400","32","TUTL","CCATS","QCATS","RCATSUR","CRDPREV","AGEALL","GM","ALLRACE","RFHT","RFNO","POINT (-117.0718406 39.49324039)"
"2016","2016","MS","Mississippi","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Branch retinal vein occlusion","65-84 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","3.62","0","100","28","TCOND","CDXC4","QDXC4","R4_3","CRDPREV","AGE6584","GM","ALLRACE","RFDM","RFYES","POINT (-89.53803082 32.7455101)"
"2016","2016","PA","Pennsylvania","MSCANCC","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Flourescein angiography","40-64 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","0.44",,,"0.38","0.51","200","42700","42","TUTL","CTEST","QTEST","RANGIO","CRDPREV","AGE4064","GF","ALLRACE","RFHT","RFYES","POINT (-77.86070029 40.79373015)"
"2016","2016","HI","Hawaii","MSCANCC","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Anti-VEGF injections","65-84 years","Male","All races","Hypertension and diabetic retinopathy","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"15","TUTL","CDRTX","QDRTX","RVEGF","CRDPREV","AGE6584","GM","ALLRACE","RFHTDR","RFYES","POINT (-157.8577494 21.30485044)"
"2016","2016","OR","Oregon","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Non-Occlusive retinal vascular disease","40-64 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","0.52",,,"0.33","0.77","0","4600","41","TCOND","CDXC4","QDXC4","R4_6","CRDPREV","AGE4064","GF","ALLRACE","RFDM","RFYES","POINT (-120.1550313 44.56744942)"
"2016","2016","OH","Ohio","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Low-tension glaucoma","18-39 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","0.01",,,"0","0.06","0","9500","39","TCOND","CDXC5","QDXC5","R5_3","CRDPREV","AGE1839","GF","ALLRACE","RFHT","RFYES","POINT (-82.40426006 40.06021014)"
"2016","2016","MA","Massachusetts","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Other/unspecified glaucoma","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.18",,,"0.15","0.21","200","96100","25","TCOND","CDXC5","QDXC5","R5_9","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT (-72.08269067 42.27687047)"
"2016","2016","PR","Puerto Rico","MSCANCC","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Geographic atrophy","All ages","All genders","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","0.25","0","1500","72","TCOND","CDXC3","QDXC3","R3_3GA","CRDPREV","AGEALL","GALL","ALLRACE","RFHT","RFYES","POINT (-66.590149 18.220833)"
"2016","2016","IL","Illinois","MSCANCC","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Vision impairment one eye","18-39 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","0.16","0","2300","17","TCOND","CDXC8","QDXC8","R8_3","CRDPREV","AGE1839","GM","ALLRACE","RFDM","RFYES","POINT (-88.99771018 40.48501028)"
"2016","2016","GA","Georgia","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Other/unspecified other retinal disorders","65-84 years","Female","All races","Hypertension","No","%","Crude Prevalence","0.69",,,"0.45","1.01","0","3800","13","TCOND","CDXC4","QDXC4","R4_10","CRDPREV","AGE6584","GF","ALLRACE","RFHT","RFNO","POINT (-83.62758035 32.83968109)"
"2016","2016","NJ","New Jersey","MSCANCC","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Laser surgery","0-17 years","All genders","All races","Hypertension and glaucoma","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"34","TUTL","CGLAUTX","QGLAU","RLASER","CRDPREV","AGE017","GALL","ALLRACE","RFHTGLC","RFYES","POINT (-74.27369129 40.13057005)"
"2016","2016","PA","Pennsylvania","MSCANCC","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Gonioscopy","All ages","Male","All races","Diabetes","Yes","%","Crude Prevalence","1.76",,,"1.59","1.94","400","21400","42","TUTL","CTEST","QTEST","RGONIO","CRDPREV","AGEALL","GM","ALLRACE","RFDM","RFYES","POINT (-77.86070029 40.79373015)"
"2016","2016","PA","Pennsylvania","MSCANCC","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Tonometry?test","All ages","Female","All races","Diabetes","Yes","%","Crude Prevalence","0.02",,,"0.01","0.06","0","16600","42","TUTL","CTEST","QTEST","RTONO","CRDPREV","AGEALL","GF","ALLRACE","RFDM","RFYES","POINT (-77.86070029 40.79373015)"
"2016","2016","AZ","Arizona","MSCANCC","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Unqualified impairment, both eyes","65-84 years","Male","All races","Diabetes","No","%","Crude Prevalence","0",,,"0","0.41","0","900","4","TCOND","CDXC8","QDXC8","R8_1","CRDPREV","AGE6584","GM","ALLRACE","RFDM","RFNO","POINT (-111.7638113 34.86597028)"
"2016","2016","MD","Maryland","MSCANCC","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Eyelid disorders","0-17 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","1.41",,,"0.09","6.12","0","100","24","TCOND","CDXC14","QDXC14","R14_4","CRDPREV","AGE017","GF","ALLRACE","RFHT","RFYES","POINT (-76.60926011 39.29058096)"
"2016","2016","WY","Wyoming","MSCANCC","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","Surgical complication of the eye","All ages","All genders","All races","Hypertension","No","%","Crude Prevalence","0.04",,,"0.02","0.07","0","29000","56","TCOND","CDXC10","QDXC10","R10_3","CRDPREV","AGEALL","GALL","ALLRACE","RFHT","RFNO","POINT (-108.1098304 43.23554134)"
"2016","2016","NE","Nebraska","MSCANCC","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","Surgical complication of the eye","All ages","Male","All races","Diabetes","No","%","Crude Prevalence","0.04",,,"0.02","0.06","0","47300","31","TCOND","CDXC10","QDXC10","R10_3","CRDPREV","AGEALL","GM","ALLRACE","RFDM","RFNO","POINT (-99.36572062 41.64104099)"
"2016","2016","PA","Pennsylvania","MSCANCC","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Any glaucoma treatment","40-64 years","Male","All races","Hypertension and glaucoma","Yes","%","Crude Prevalence","4.51",,,"3.77","5.33","100","2800","42","TUTL","CGLAUTX","QGLAU","RGLAANY","CRDPREV","AGE4064","GM","ALLRACE","RFHTGLC","RFYES","POINT (-77.86070029 40.79373015)"
"2016","2016","RI","Rhode Island","MSCANCC","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Laser surgery","40-64 years","Male","All races","Glaucoma","Yes","%","Crude Prevalence","0",,,"0","0.6","0","600","44","TUTL","CGLAUTX","QGLAU","RLASER","CRDPREV","AGE4064","GM","ALLRACE","RFGLC","RFYES","POINT (-71.52247031 41.70828019)"
"2016","2016","PA","Pennsylvania","MSCANCC","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Any glaucoma treatment","All ages","Female","All races","Glaucoma","Yes","%","Crude Prevalence","4.38",,,"3.98","4.81","400","9500","42","TUTL","CGLAUTX","QGLAU","RGLAANY","CRDPREV","AGEALL","GF","ALLRACE","RFGLC","RFYES","POINT (-77.86070029 40.79373015)"
"2016","2016","AZ","Arizona","MSCANCC","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Wet-form age-related macular degeneration","All ages","Male","All races","All patients","Total","%","Crude Prevalence","0.02",,,"0.01","0.03","100","253300","4","TCOND","CDXC3","QDXC3","R3_4","CRDPREV","AGEALL","GM","ALLRACE","RFALL","RFTOT","POINT (-111.7638113 34.86597028)"
"2016","2016","PR","Puerto Rico","MSCANCC","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Dry eye syndrome","18-39 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","3.1",,,"0.67","8.66","0","100","72","TCOND","CDXC14","QDXC14","R14_5","CRDPREV","AGE1839","GALL","ALLRACE","RFDM","RFYES","POINT (-66.590149 18.220833)"
"2016","2016","OH","Ohio","MSCANCC","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Night blindness","0-17 years","Male","All races","Hypertension","No","%","Crude Prevalence","0.01",,,"0.01","0.02","0","156900","39","TCOND","CDXC12","QDXC12","R12_3","CRDPREV","AGE017","GM","ALLRACE","RFHT","RFNO","POINT (-82.40426006 40.06021014)"
"2016","2016","CT","Connecticut","MSCANCC","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Drain","0-17 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0.49",,,"0.01","2.67","0","200","9","TUTL","CGLAUTX","QGLAU","RGLADRN","CRDPREV","AGE017","GALL","ALLRACE","RFDM","RFYES","POINT (-72.64984095 41.56266102)"
"2016","2016","DE","Delaware","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Open-angle glaucoma","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0.08",,,"0.05","0.12","0","26300","10","TCOND","CDXC5","QDXC5","R5_1","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT (-75.57774117 39.00883067)"
"2016","2016","NE","Nebraska","MSCANCC","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Myopia","40-64 years","Male","All races","Diabetes","No","%","Crude Prevalence","1.46",,,"1.27","1.66","200","15100","31","TCOND","CDXC7","QDXC7","R7_1","CRDPREV","AGE4064","GM","ALLRACE","RFDM","RFNO","POINT (-99.36572062 41.64104099)"
"2016","2016","NY","New York","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Branch retinal vein occlusion","All ages","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0.19",,,"0.17","0.21","300","148000","36","TCOND","CDXC4","QDXC4","R4_3","CRDPREV","AGEALL","GALL","ALLRACE","RFDM","RFYES","POINT (-75.54397043 42.82700103)"
"2016","2016","NJ","New Jersey","MSCANCC","Eye Health Conditions","Retinal Detachment and Defects","Annual prevalence of treated retinal detachment and defects","All Retinal detachment and defects","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0.79",,,"0.43","1.32","0","1800","34","TCOND","CDXC1","QDXC1","R1_ALL","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT (-74.27369129 40.13057005)"
"2016","2016","TX","Texas","MSCANCC","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","Strabismus","65-84 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0.16",,,"0.02","0.59","0","1200","48","TCOND","CDXC9","QDXC9","R9_1","CRDPREV","AGE6584","GALL","ALLRACE","RFDM","RFYES","POINT (-99.42677021 31.82724041)"
"2016","2016","AZ","Arizona","MSCANCC","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Conjunctivitis","18-39 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","3.89",,,"3.26","4.61","100","3300","4","TCOND","CDXC13","QDXC13","R13_3","CRDPREV","AGE1839","GALL","ALLRACE","RFDM","RFYES","POINT (-111.7638113 34.86597028)"
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Geographic atrophy","0-17 years","Male","All races","Diabetes","No","%","Crude Prevalence","0",,,"0","0.03","0","14500","99","TCOND","CDXC3","QDXC3","R3_3GA","CRDPREV","AGE017","GM","ALLRACE","RFDM","RFNO",
"2016","2016","WY","Wyoming","MSCANCC","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","All Infectious and inflammatory diseases","0-17 years","Male","All races","Hypertension","No","%","Crude Prevalence","4.78",,,"4.19","5.43","200","4700","56","TCOND","CDXC13","QDXC13","R13_ALL","CRDPREV","AGE017","GM","ALLRACE","RFHT","RFNO","POINT (-108.1098304 43.23554134)"
"2016","2016","XX","Missing Location","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","All Other retinal disorders","40-64 years","All genders","All races","Diabetes","No","%","Crude Prevalence","1.61",,,"1.49","1.74","600","38700","99","TCOND","CDXC4","QDXC4","R4_ALL","CRDPREV","AGE4064","GALL","ALLRACE","RFDM","RFNO",
"2016","2016","PA","Pennsylvania","MSCANCC","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Drain","40-64 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","0.02",,,"0.01","0.04","0","51100","42","TUTL","CGLAUTX","QGLAU","RGLADRN","CRDPREV","AGE4064","GM","ALLRACE","RFHT","RFYES","POINT (-77.86070029 40.79373015)"
"2016","2016","WY","Wyoming","MSCANCC","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Optical coherence tomography","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.37",,,"0.27","0.5","0","11700","56","TUTL","CTEST","QTEST","ROCT","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT","POINT (-108.1098304 43.23554134)"
"2016","2016","PR","Puerto Rico","MSCANCC","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Dry-form age-related macular degeneration","0-17 years","All genders","All races","Hypertension","No","%","Crude Prevalence","0",,,"0","0.15","0","2400","72","TCOND","CDXC3","QDXC3","R3_3","CRDPREV","AGE017","GALL","ALLRACE","RFHT","RFNO","POINT (-66.590149 18.220833)"
"2016","2016","NC","North Carolina","MSCANCC","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Gonioscopy","0-17 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0.51",,,"0.1","1.47","0","600","37","TUTL","CTEST","QTEST","RGONIO","CRDPREV","AGE017","GALL","ALLRACE","RFDM","RFYES","POINT (-79.15925046 35.46622098)"
"2016","2016","MO","Missouri","MSCANCC","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Unqualified impairment, both eyes","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.02","0","106400","29","TCOND","CDXC8","QDXC8","R8_1","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT (-92.56630005 38.63579078)"
"2016","2016","PA","Pennsylvania","MSCANCC","Eye Health Conditions","Retinal Detachment and Defects","Annual prevalence of treated retinal detachment and defects","All Retinal detachment and defects","40-64 years","All genders","All races","Hypertension","No","%","Crude Prevalence","0.44",,,"0.41","0.47","1100","252400","42","TCOND","CDXC1","QDXC1","R1_ALL","CRDPREV","AGE4064","GALL","ALLRACE","RFHT","RFNO","POINT (-77.86070029 40.79373015)"
"2016","2016","PA","Pennsylvania","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Hereditary chorioretinal dystrophy","18-39 years","Female","All races","Hypertension","No","%","Crude Prevalence","0.02",,,"0.01","0.03","0","146200","42","TCOND","CDXC4","QDXC4","R4_8","CRDPREV","AGE1839","GF","ALLRACE","RFHT","RFNO","POINT (-77.86070029 40.79373015)"
"2016","2016","PR","Puerto Rico","MSCANCC","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Early stage age-related macular degeneration","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.14",,,"0.03","0.41","0","2100","72","TCOND","CDXC3","QDXC3","R3_2","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT (-66.590149 18.220833)"
"2016","2016","US","National","MSCANCC","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","All Refraction and accommodation disorders","65-84 years","Male","All races","Hypertension","No","%","Crude Prevalence","1.39",,,"1.3","1.49","800","57400","59","TCOND","CDXC7","QDXC7","R7_ALL","CRDPREV","AGE6584","GM","ALLRACE","RFHT","RFNO",
"2016","2016","WA","Washington","MSCANCC","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Profound bilateral imp., legal blindness","0-17 years","Female","All races","Diabetes","No","%","Crude Prevalence","0.01",,,"0","0.02","0","62500","53","TCOND","CDXC8","QDXC8","R8_6","CRDPREV","AGE017","GF","ALLRACE","RFDM","RFNO","POINT (-120.4700108 47.52227863)"
"2016","2016","AL","Alabama","MSCANCC","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Other diabetes related eye disorders","40-64 years","All genders","All races","Hypertension","No","%","Crude Prevalence","0.1",,,"0.08","0.12","100","93500","1","TCOND","CDXC2","QDXC2","R2_5","CRDPREV","AGE4064","GALL","ALLRACE","RFHT","RFNO","POINT (-86.63186076 32.84057112)"
"2016","2016","OH","Ohio","MSCANCC","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Other/unspecified orbital and external disease","All ages","Male","All races","Hypertension","Yes","%","Crude Prevalence","0.08",,,"0.06","0.1","100","94400","39","TCOND","CDXC14","QDXC14","R14_2","CRDPREV","AGEALL","GM","ALLRACE","RFHT","RFYES","POINT (-82.40426006 40.06021014)"
"2016","2016","MD","Maryland","MSCANCC","Service Utilization","Cataract Surgery","Percentage of people with diagnosed cataract who had a treatment claim","Cataract surgery","18-39 years","All genders","All races","Diabetes and cataract","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"24","TUTL","CCATS","QCATS","RCATSUR","CRDPREV","AGE1839","GALL","ALLRACE","RFDMCAT","RFYES","POINT (-76.60926011 39.29058096)"
"2016","2016","NY","New York","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Other/unspecified glaucoma","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0.01","0.02","0","226000","36","TCOND","CDXC5","QDXC5","R5_9","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT (-75.54397043 42.82700103)"
"2016","2016","AR","Arkansas","MSCANCC","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","All Infectious and inflammatory diseases","65-84 years","Female","All races","Diabetes","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"5","TCOND","CDXC13","QDXC13","R13_ALL","CRDPREV","AGE6584","GF","ALLRACE","RFDM","RFYES","POINT (-92.27449074 34.74865012)"
"2016","2016","FL","Florida","MSCANCC","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Stereo fundus exam","40-64 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","3.12",,,"3.03","3.22","4000","127000","12","TUTL","CTEST","QTEST","RFUN","CRDPREV","AGE4064","GM","ALLRACE","RFHT","RFYES","POINT (-81.92896054 28.93204038)"
"2016","2016","IN","Indiana","MSCANCC","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Anti-VEGF injections","All ages","All genders","All races","Hypertension and diabetic retinopathy","Yes","%","Crude Prevalence","0.63",,,"0.3","1.15","0","1600","18","TUTL","CDRTX","QDRTX","RVEGF","CRDPREV","AGEALL","GALL","ALLRACE","RFHTDR","RFYES","POINT (-86.14996019 39.76691045)"
"2016","2016","AZ","Arizona","MSCANCC","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","Ocular injury","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0.4",,,"0.11","1.02","0","1000","4","TCOND","CDXC10","QDXC10","R10_1","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT (-111.7638113 34.86597028)"
"2016","2016","VA","Virginia","MSCANCC","Eye Health Conditions","Disorders of Optic Nerve and Visual Pathways","Annual prevalence of treated disorders of optic nerve and visual pathways","Optic nerve disorders","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0.08",,,"0","0.43","0","1300","51","TCOND","CDXC11","QDXC11","R11_1","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT (-78.45789046 37.54268067)"
"2016","2016","HI","Hawaii","MSCANCC","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Laser surgery","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","1.18","0","300","15","TUTL","CGLAUTX","QGLAU","RLASER","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT (-157.8577494 21.30485044)"
"2016","2016","GA","Georgia","MSCANCC","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","Ocular injury","0-17 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","0.92","0","400","13","TCOND","CDXC10","QDXC10","R10_1","CRDPREV","AGE017","GF","ALLRACE","RFDM","RFYES","POINT (-83.62758035 32.83968109)"
"2016","2016","WA","Washington","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","All Glaucoma","40-64 years","All genders","All races","Diabetes","No","%","Crude Prevalence","2.97",,,"2.9","3.04","6600","223900","53","TCOND","CDXC5","QDXC5","R5_ALL","CRDPREV","AGE4064","GALL","ALLRACE","RFDM","RFNO","POINT (-120.4700108 47.52227863)"
"2016","2016","NH","New Hampshire","MSCANCC","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Keratoconus","All ages","Male","All races","Hypertension","Yes","%","Crude Prevalence","0.16",,,"0.07","0.32","0","5000","33","TCOND","CDXC16","QDXC16","R16_1","CRDPREV","AGEALL","GM","ALLRACE","RFHT","RFYES","POINT (-71.50036092 43.65595011)"
"2016","2016","CT","Connecticut","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Senile cataract","40-64 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","12.06",,,"11.46","12.68","1300","11000","9","TCOND","CDXC6","QDXC6","R6_1","CRDPREV","AGE4064","GALL","ALLRACE","RFDM","RFYES","POINT (-72.64984095 41.56266102)"
"2016","2016","SD","South Dakota","MSCANCC","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Early stage age-related macular degeneration","All ages","All genders","All races","Hypertension","Yes","%","Crude Prevalence","0.28",,,"0.13","0.53","0","3200","46","TCOND","CDXC3","QDXC3","R3_2","CRDPREV","AGEALL","GALL","ALLRACE","RFHT","RFYES","POINT (-100.3735306 44.35313005)"
"2016","2016","CT","Connecticut","MSCANCC","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Primary open-angle glaucoma","65-84 years","All genders","All races","Hypertension","No","%","Crude Prevalence","0",,,"0","0.28","0","1300","9","TCOND","CDXC5","QDXC5","R5_2","CRDPREV","AGE6584","GALL","ALLRACE","RFHT","RFNO","POINT (-72.64984095 41.56266102)"
"2016","2016","PR","Puerto Rico","MSCANCC","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Diabetic Retinopathy Telemedicine Screening","40-64 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.02",,,"0","0.13","0","4200","72","TUTL","CSCRN","QSCRN","RSCNDR","CRDPREV","AGE4064","GALL","ALLRACE","RFALL","RFTOT","POINT (-66.590149 18.220833)"
"2016","2016","KY","Kentucky","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Non-congenital cataract","65-84 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0.49",,,"0.1","1.44","0","600","21","TCOND","CDXC6","QDXC6","R6_2","CRDPREV","AGE6584","GALL","ALLRACE","RFDM","RFYES","POINT (-84.77497105 37.64597027)"
"2016","2016","KY","Kentucky","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Macular edema (not diabetic)","0-17 years","All genders","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0","0","146300","21","TCOND","CDXC4","QDXC4","R4_7","CRDPREV","AGE017","GALL","ALLRACE","RFALL","RFTOT","POINT (-84.77497105 37.64597027)"
"2016","2016","NJ","New Jersey","MSCANCC","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Visual field defect","All ages","All genders","All races","Hypertension","No","%","Crude Prevalence","0.11",,,"0.1","0.12","700","635700","34","TCOND","CDXC12","QDXC12","R12_1","CRDPREV","AGEALL","GALL","ALLRACE","RFHT","RFNO","POINT (-74.27369129 40.13057005)"
"2016","2016","MN","Minnesota","MSCANCC","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Lacrimal diseases","0-17 years","Male","All races","Hypertension","No","%","Crude Prevalence","0.45",,,"0.39","0.52","200","40800","27","TCOND","CDXC14","QDXC14","R14_3","CRDPREV","AGE017","GM","ALLRACE","RFHT","RFNO","POINT (-94.7942005 46.35564874)"
"2016","2016","NE","Nebraska","MSCANCC","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Non-Occlusive retinal vascular disease","All ages","Female","All races","Hypertension","No","%","Crude Prevalence","0.03",,,"0.02","0.05","0","45100","31","TCOND","CDXC4","QDXC4","R4_6","CRDPREV","AGEALL","GF","ALLRACE","RFHT","RFNO","POINT (-99.36572062 41.64104099)"
"2016","2016","WI","Wisconsin","MSCANCC","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Stereo fundus exam","18-39 years","All genders","All races","Hypertension","Yes","%","Crude Prevalence","1.55",,,"1.27","1.88","100","6800","55","TUTL","CTEST","QTEST","RFUN","CRDPREV","AGE1839","GALL","ALLRACE","RFHT","RFYES","POINT (-89.81637074 44.39319117)"
"2016","2016","RI","Rhode Island","MSCANCC","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Eyelid disorders","All ages","Male","All races","Diabetes","No","%","Crude Prevalence","0.33",,,"0.27","0.4","100","28300","44","TCOND","CDXC14","QDXC14","R14_4","CRDPREV","AGEALL","GM","ALLRACE","RFDM","RFNO","POINT (-71.52247031 41.70828019)"
"2016","2016","MT","Montana","MSCANCC","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Dry eye syndrome","All ages","All genders","All races","Hypertension","Yes","%","Crude Prevalence","1.96",,,"1.47","2.56","100","2700","30","TCOND","CDXC14","QDXC14","R14_5","CRDPREV","AGEALL","GALL","ALLRACE","RFHT","RFYES","POINT (-109.4244206 47.06652897)"
"2016","2016","FL","Florida","MSCANCC","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Non-congenital cataract","All ages","Female","All races","Hypertension","Yes","%","Crude Prevalence","0.79",,,"0.75","0.84","1200","147100","12","TCOND","CDXC6","QDXC6","R6_2","CRDPREV","AGEALL","GF","ALLRACE","RFHT","RFYES","POINT (-81.92896054 28.93204038)"
"2016","2016","WA","Washington","MSCANCC","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Infectious diseases","40-64 years","Male","All races","All patients","Total","%","Crude Prevalence","0.21",,,"0.18","0.24","200","115800","53","TCOND","CDXC13","QDXC13","R13_1","CRDPREV","AGE4064","GM","ALLRACE","RFALL","RFTOT","POINT (-120.4700108 47.52227863)"
"2016","2016","MS","Mississippi","MSCANCC","Service Utilization","Cataract Surgery","Percentage of people with diagnosed cataract who had a treatment claim","Any cataract treatment","All ages","Male","All races","Diabetes","No","%","Crude Prevalence","0.2",,,"0.18","0.22","300","150200","28","TUTL","CCATS","QCATS","RCATANY","CRDPREV","AGEALL","GM","ALLRACE","RFDM","RFNO","POINT (-89.53803082 32.7455101)"
"2016","2016","AR","Arkansas","MSCANCC","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Dry-form age-related macular degeneration","0-17 years","Female","All races","Diabetes","No","%","Crude Prevalence","0.01",,,"0","0.04","0","19200","5","TCOND","CDXC3","QDXC3","R3_3","CRDPREV","AGE017","GF","ALLRACE","RFDM","RFNO","POINT (-92.27449074 34.74865012)"
